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Abstract 
 
It is well documented that temporarily abstinent smokers who undergo 
an acute bout of moderate intensity exercise experience a reduction in 
nicotine craving and withdrawal. Conversely, available research in 
chronic exercise and smoking cessation does not reliably demonstrate 
that combining exercise with well established treatments increases 
smoking abstinence rates. The overall aim of this dissertation was to 
investigate mechanisms underlying the beneficial effects of exercise in 
a group of female smokers taking part in a 14 week exercise plus 
nicotine replacement therapy (NRT) patch programme. Determining 
how smokers may benefit from exercise has important implications for 
designing effective interventions. Three independent yet related studies 
were conducted. The specific aims of study one (Chapter two) were to 
determine whether an acute bout of exercise would further reduce 
craving and withdrawal symptoms in a group of female quitters using 
NRT, and to explore whether the magnitude of this relief would relate to 
quit success. It was demonstrated that exercise provided additional 
craving and withdrawal benefit for these quitters. Magnitude of relief 
was not found to be related to end of programme quit status. Study 
two (Chapter three) sought to examine what bearing exercise 
expectancy (EXP) and credibility (CRED) beliefs of recently quit smokers 
had on self-reported craving and withdrawal following an acute bout 
of exercise, and to compare participants’ beliefs regarding NRT and 
exercise as quit smoking aids. Results showed that high exercise EXP 
and/or exercise CRED were found to be related to craving relief. 
Participants believed both NRT and exercise to be effective cessation 
aids. Study three (Chapter four) examined whether participants 
reported using exercise as a relapse prevention aid, and how readily 
these two behaviours can be concurrently changed. It was 
demonstrated that participants were able to simultaneously increase 
their exercise behaviour and decrease their smoking behaviour. 
iv 
 
Exercise was not reportedly used as a relapse prevention strategy. 
Overall, the results of these studies provide evidence that exercise is a 
worthwhile adjunct smoking cessation treatment, and elucidate some 
of the reasons as to how it may help individuals quit smoking. The 
clinical implications of the findings are discussed throughout. 
 
Keywords: Exercise, smoking cessation, withdrawal, craving, relapse, 
coping, expectancy, credibility, nicotine replacement therapy. 
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1 CHAPTER ONE: GENERAL INTRODUCTION 
 
 
1.1 A short history of the tobacco problem 
Nicotiana tabacum is native to the Western Hemisphere, and in Native 
American culture tobacco was frequently used for religious and 
recreational purposes. In the 16th and 17th centuries Spanish and 
Portuguese travellers brought tobacco back from the Western 
Hemisphere as a novelty. During this colonial era tobacco use spread, 
as the Portuguese cultivated tobacco wherever they had trading 
colonies. Interestingly, during this time tobacco was used as a form of 
currency or an exchange medium. Indeed, George Washington, the 
first president of the United States (U.S.) is said to have paid the rent on 
his farm with tobacco (TTS, 2010). 
 
A number of developments, when taken together, led to the 
widespread cigarette use seen today. Around 1835, novel approaches 
to tobacco processing taking place in North Carolina, led to the 
development of the flue-cured process. This process chemically 
changed the tobacco, making it less harsh and easier to inhale. By the 
1870’s a market for flue-cured tobacco had developed, such that 
factories making hand rolled cigarettes began to appear. In the 1880’s, 
Buck Duke obtained the rights to a cigarette making machine, which 
quickly replaced hand rollers. With this machine, Duke was able to 
lower the costs of cigarette production and soon bought out all the 
competition. The problem for Duke then became that he was able to 
produce far more cigarettes than there was a market for. To expand 
the existing market he did two things: (1) he advertised to get new 
cigarette smokers (at this stage mostly young men); and (2) he sought 
overseas markets. During this period, improvements in railroads were 
made, safety matches were invented, and mass media began in the 
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form of nationally circulated magazines; all of which contributed to the 
rise of the cigarette (TTS, 2010). 
 
From the early 1900’s until the 1950’s cigarette use rose rapidly with no 
real serious opposition from medical or public health groups. In 1950, 
U.S. and British case control studies began to emerge, linking cigarettes 
to lung cancer. In the late 1950’s, British American Tobacco 
commissioned a team of scientists to investigate the problem of lung 
cancer and smoking. Without exception, these scientists concluded 
that cigarettes were a cause of lung cancer. For the first time public 
perception of tobacco began to change and people attempted to 
quit smoking. From the 1950’s until present day the battle rages 
between the public health system and the tobacco companies. 
Despite tobacco companies actively opposing public health measures, 
slowly the public health side seems to be gaining important ground 
(TTS, 2010).  
 
1.2 Damage caused by smoking and the benefits of quitting 
Smoking is the leading preventable cause of death worldwide 
(USDHHS, 2004). It is estimated that, in the United States alone, each 
day more than 1200 people die from smoking cigarettes. No doubt 
about it, smoking kills. Adults who smoke will on average lose 13 years 
of their life, and half of all lifetime smokers will die early because they 
started, and continued to smoke (USDHHS, 2004) 
  
Lung cancer was one of the first diseases found to be caused by 
smoking. Since the 1960’s, the number of cancers linked to smoking has 
grown to include: mouth, throat, larynx, esophagus, pancreas, kidney, 
bladder, stomach, cervix, and acute myeloid leukemia. Smokers are 
about 20 times more likely to develop lung cancer than non-smokers 
and the vast majority of lung cancer cases are a result of cigarette 
smoking (USDHHS, 2004).  
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Heart disease and stroke are cardiovascular diseases caused by 
smoking. Coronary heart disease is the leading cause of death in 
middle and high income countries (WHO, 2008). Compared to non-
smokers, smokers are four times more likely to die from heart disease. 
Smoking harms lung health and causes injury to lung tissues. This tissue 
damage leads to chronic obstructive pulmonary disease (COPD). 
COPD is the third and fourth leading cause of death in middle and high 
income countries and 90% of deaths related to COPD are caused by 
smoking (USDHHS, 2010; WHO, 2008). Sudden respiratory illnesses, such 
as bronchitis or pneumonia are cause by viral or bacterial infections. 
Smokers have more upper (nose, throat, and larynx) and lower 
respiratory (below the larynx) tract infections than non smokers. This is 
because smoking damages the body’s defences against infection 
(USDHHS, 2004).  
 
In general, smokers are less healthy than non-smokers. As well as being 
more likely to suffer from cancer, cardiovascular disease, and 
respiratory illness, smokers are also more likely to experience: (1) 
absence from work; (2) dental disease; (3) difficulty with wound 
healing; (4) hip fractures; (5) reproductive difficulties; (6) an increased 
risk of cataracts, a leading cause of blindness; and (7) peptic ulcers 
(USDHHS, 2004). The economic costs of smoking to the health system 
are astronomical. It is estimated that between 1995 – 1999, in the United 
States each year, the cost of smoking was $157.7 billion (USDHHS, 2004).  
 
It is considered never too late to quit smoking, and the benefits of 
doing so are great. For example, a year or two after quitting, the excess 
risk of developing heart disease as a result of smoking may be reduced 
by 50% (USDHHS, 1990; USDHHS, 2001). In addition, people who quit 
smoking after having a heart attack are less likely to die within the next 
10 years compared to those who continue to smoke (USDHHS, 1990). 
Five to 15 years post quit the chances of stroke are the same as those 
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who have never smoked (USDHHS, 1990). Quitting reduces the risk of 
lung cancer such that, ten years after quitting the risk of developing 
lung cancer is 30 – 50% that of the risk of those who smoke (USDHHS, 
1990). Quitting also increases life expectancy, and the sooner the 
smoker quits the greater the number of years in life expectancy gained 
(USDHHS, 1990).  
 
1.3 How bad is the problem today? 
Despite the morbidity and mortality risks, a proportion of the population 
continue to smoke. It is estimated that 18% of the Canadian population 
aged 15 years or older smoke. More males (20%) report smoking than 
females (16%) (CTUMS, 2008). In the U.S., the prevalence rates are 
comparable. In a recent U.S. National Health Interview Survey, 20.6% of 
adults over 18 years of aged reported smoking (CDC, 2007). Twenty 
three percent of men were smokers compared to 18.3% of women 
(CDC, 2007). Increased tobacco use is associated with a number of 
socio-demographic factors, such as: low socio-economic status, 
ethnicity, and low education level (CDC, 2007; CTUMS, 2008). 
 
1.4 What makes quitting smoking difficult? 
In human nature there is a strong tendency to maintain a steady state 
and to resist change, and change when it comes to smoking, takes a 
great deal of work (TTS, 2010). Smoking behaviour is influenced by 
biological, psychological, and social factors.  
 
Nicotine is the addictive substance found in cigarettes. Once an 
individual becomes dependent on nicotine physical cravings develop 
in response to a decrease in the body’s level of nicotine (TTS, 2010). This 
dependence also has a psychological component; a nicotine 
deprived individual becomes pre-occupied with thoughts of smoking. 
In addition, nicotine is a psychoactive substance and has various 
effects on the central nervous system. Smokers will light another 
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cigarette to reduce the nicotine withdrawal symptoms that 
accompany nicotine abstinence. These withdrawal symptoms are 
many and varied and include: anxiety, depression, irritability, difficulty 
concentrating, difficulty sleeping, decreased heart rate, increased 
appetite and weight gain, and dizziness (American Psychiatric 
Association, 1994). 
 
Smokers continue to smoke for the immediate positive consequences 
they come to expect. This positive expected benefit of smoking and 
the learned habit of continual pairing smoking with positive outcomes 
creates a psychological dependence on smoking (Abrams, Niaura, 
Brown, Emmons, Goldstein, & Monti, 2003). Smoking becomes a form of 
self-medication to cope with everyday life (Abrams et al., 2003). 
Smokers may use smoking to accomplish specific goals, such as: to 
relax, to control weight, to cope with boredom, or to feel less awkward 
in a social situation (TTS, 2010). 
 
For many smokers cigarettes become integrated into social aspects of 
their lives. People smoke in a wide array of social settings (both positive 
and negative), and as a consequence, smoking becomes ingrained 
into many situations and events. In this way, smoking is associated with 
family, friends and identity. For instance, people smoke with their 
husbands or wives and it becomes part of their relationship. Smoking 
becomes a way of being connected to others and a way of expressing 
feelings toward others (e.g., light up a cigarette to express anger) (TTS, 
2010). The complex interaction of the biopsychosocial pull of cigarettes 
makes it incredibly difficult for nicotine dependent individuals to quit 
smoking.  
 
1.5 Smoking cessation interventions 
For over 50 years health practitioners have been working to determine 
how best to treat nicotine dependence (USDHHS, 2010). Much work has 
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been done in this area and a good set of Clinical Practice Guidelines 
exist, developed by The Public Health Service (PHS) in the U.S. (Fiore, 
Jaen, & Baker, 2008). Smoking cessation is treated with interventions at 
the individual level and policy level interventions. The research 
contained with this dissertation concerns the individual. The best 
practice evidence based information will be presented.  
 
1.5.1 Evidence-based cessation interventions for the individual 
Cognitive behavioural interventions such as individual, group, and 
telephone counselling can dramatically increase the likelihood of quit 
success over and above attempting to quit unassisted. The chances of 
quitting successfully with these types of interventions increases with the 
number of different types of counselling formats utilised, the intensity 
and duration of the counselling sessions, as well as the number of 
counselling sessions completed (Fiore et al., 2008). Pharmacotherapy 
(e.g., nicotine replacement therapy, bupropion, varenicline) has been 
shown to double a smokers’ chance of quit success. Combining 
pharmacotherapy with cognitive behavioural therapy increases a 
smokers’ chance of quitting successfully even further. Research 
suggests that emerging technologies (e.g., web assisted interventions) 
may provide a promising modality in which to offer cessation services 
with a broad reach (Fiore et al., 2008) (Table 1.1).      
  
7 
 
 
 
Table 1.1. Chances of quit success at six months compared to treatment strategy 
(Fiore et al., 2008; West & Shiffman, 2007). 
Cessation strategy Maintained abstinence 
at six months (%) 
Unassisted 4 – 7 
Physician advice 10 
Tailored online intervention 7 – 10 
Individual cognitive behavioural therapy (CBT) 9 – 12 
Group CBT 9 – 12 
Telephone support 11 – 14  
Pharmacotherapy 
     Nicotine patch 
     Nicotine gum 
     Nicotine lozenge 
     Bupropion 
     Varenicline 
 
15 
19 
16 
20 
23 
Combined pharmacotherapy with CBT 25 – 33 
 
1.5.2 Population-based interventions to promote cessation  
Research has established that mass media campaigns can increase 
smoking cessation rates, particularly when they are part of a 
comprehensive tobacco control programme. For example, a study by 
Biener et al. (2006) surveyed a group of smokers and recently quit 
smokers. They found that most smokers reported an awareness of anti-
tobacco advertisements on television and 30% of recent quitters 
surveyed reported these advertisements contributed to their quitting 
(Biener, Reimer, Wakefield, Szczypka, Rigotti, & Connolly, 2006).  
 
A number of population level policy strategies have been implemented 
in an attempt to control the tobacco problem. For example, numerous 
studies have shown that tax increases and smoke-free policies (e.g., 
banning smoking in public places) reduce adults smoking rates and 
indirectly impact smoking initiation by changing social norms. Tax 
increases and smoke-free policies have been more effective at 
reducing smoking rates than any other intervention (Farrelly, Pechacek, 
Thomas, & Nelson, 2008; TTS, 2010).  
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1.5.3 Alternative smoking cessation interventions 
A number of alternative smoking cessation interventions exist including: 
acupuncture, laser therapy, and hypnotherapy. A recent Cochrane 
review concluded that there is not enough evidence to definitively 
state that acupuncture or related techniques such as, electro-
stimulation or laser acupuncture therapy, successfully improve quit 
smoking rates (White, Rampes, Liu, Stead, & Campbell, 2011). However, 
these authors also state that there is not enough evidence to dismiss 
the possibility that acupuncture may be a more effective quit smoking 
strategy than a placebo (White et al., 2011). A Cochrane review of the 
hypnotherapy literature found insufficient evidence to support its 
effectiveness as a quit smoking aid (Barnes, Dong, McRobbie, Walker, 
Mehta, & Stead, 2010). 
 
1.5.4 Smoking cessation intervention summary 
Population based indirect approaches that help smokers reduce or 
eliminate their tobacco use are effective. However, population based 
interventions can only do so much and it is essential that smokers are 
also provided with individual tobacco treatment. Effective smoking 
cessation programmes exist and have come a long way in the last 15 
years (TTS, 2010). However, quit rates at six months, even with 
comprehensive programmes that include both pharmacotherapy and 
cognitive behavioural therapy have limited success (Table 1.1). 
Currently, there is insufficient evidence for alternative smoking cessation 
treatment strategies. Therefore, the importance of identifying adjunct 
therapies that improve and sustain quit smoking rates should be 
emphasised. 
 
1.6 Exercise – a novel evidence based smoking cessation aid 
Exercise has been proposed as an adjunct smoking cessation aid. 
Overall, of all the quit smoking adjuncts, exercise stands out as being 
the most evidence based. Two excellent reviews of the exercise and 
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smoking cessation literature have been conducted: (1) on the acute 
effects of exercise on craving, withdrawal, affect, and smoking 
behaviour (Taylor, Ussher, & Faulkner, 2007); and (2) on the effects of 
chronic exercise interventions on smoking cessation rates (Ussher, 
Taylor, & Faulkner, 2008). The following two sections will outline the key 
findings of these reviews and add to them.  
 
1.6.1 Acute exercise evidence based studies 
In a recent review of the acute exercise and smoking literature, Taylor 
and colleagues (2007) found that nine out of ten studies showed 
exercise to reduce cigarette cravings during temporary smoking 
abstinence (moderate to large effect sizes [ES] between 0.50–4.6). 
Significant reductions in desire to smoke have been observed for 
different intensities and types of exercise. For example, isometric 
exercise of a very low intensity and duration (five minutes) has been 
shown to reduce the urge to smoke by 0.7 on a seven point scale (ES = 
0.29)(Ussher, West, Doshi, & Sampuran, 2006); whereas 15-20 minutes of 
self-paced walking reduced the urge to smoke by 4.6 on the same 
scale (ES = 3.7) (Taylor, Katomeri, & Ussher, 2005). In addition, longer 
periods of exercise (e.g., approximately 15 minutes of brisk walking) at 
a light to moderate intensity have been shown to delay ad libitum 
smoking by up to 50 minutes, even when the individual is presented 
with a challenging mental task or a lit cigarette (Taylor & Katomeri, 
2006; Taylor & Katomeri, 2007; Taylor et al., 2005).  
 
The magnitude of the reduction in cravings is encouraging and 
comparable with an acute response to oral nicotine replacement 
therapy (NRT) (Taylor et al., 2007). In 2001, West and Shiffman 
conducted a review of the acute effects of oral NRT on craving and 
withdrawal. Although many of the studies included in this review did not 
report effect sizes, it is possible to conclude that the reduction in desire 
to smoke and withdrawal following an acute bout of exercise is 
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comparable to that of oral NRT. In addition, the effect of exercise on 
craving is faster than oral NRT. Temporarily abstinent smokers who 
engage in a brief bout of exercise, even just five minutes of isometric 
exercise (Ussher et al., 2006), experience some relief immediately 
whereas it takes approximately 20 minutes for oral NRT to result in 
craving relief (West & Shiffman, 2001).  
 
In terms of the withdrawal symptoms related to nicotine abstinence, 
Taylor and colleagues (2007) found eight out of nine studies reported a 
significant reduction in at least two withdrawal symptoms when the 
exercise group was compared to a control group. The withdrawal 
symptoms shown to be reduced by an acute bout of exercise include: 
stress, anxiety, tension, poor concentration, irritability, and restlessness 
(Taylor et al., 2007). However, it should be noted that an acute bout of 
exercise does not always successfully reduce all nicotine withdrawal 
symptoms experienced by temporarily abstinent smokers (Taylor et al., 
2007).   
 
Although results from the acute exercise and smoking paradigm are 
promising, this body of research has two inherent flaws that are worth 
mentioning. First, the majority of studies include temporarily abstinent 
smokers rather than people undergoing a real quit attempt. Therefore, 
the severity of symptoms experienced may not correspond entirely with 
those felt when a smoker is fully invested in their quit attempt. Second, 
acute studies often take place within a laboratory setting. Such an 
artificial environment bears little resemblance to actual scenarios in 
which a smoker attempting to quit may find themselves. These two 
flaws raise questions about the ecological validity of these studies and 
their findings.  
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1.6.2 Chronic exercise evidence based studies 
The results of the chronic exercise and smoking cessation literature are 
not as promising or perhaps just not as clear cut as those obtained in 
the acute exercise and smoking cessation research. The current 
literature does not reliably show that chronic exercise interventions 
improve smoking cessation rates long-term. However, there is also no 
evidence to suggest that exercise interventions undermine smoking 
cessation (Fiore et al., 2008; Ussher et al., 2008).  
 
The study with perhaps the most promising results to date was 
conducted in 1999 by Marcus and colleagues. In this study, participants 
engaged in a cognitive behavioural support programme combined 
with either: vigorous intensity exercise three times per week or equal 
contact time health education lectures. At the end of the 12 week 
programme, those in the exercise group had significantly higher levels 
of continuous abstinence compared to the control group. This same 
pattern of results was evident at three and 12 month follow-up. This led 
the authors to conclude that vigorous exercise when combined with 
cognitive behavioural smoking cessation support facilitates smoking 
cessation (Marcus, Albrecht, King, Parisi, Pinto, Roberts, Niaura, & 
Abrams, 1999). Following on from this work, studies that have 
administered moderate intensity exercise rather than vigorous intensity 
exercise have had mediocre results. Herein lies an intriguing disparity 
between the chronic and acute literature. That is, intensive exercise 
studies demonstrate that a vigorous programme of exercise yields 
better results than those that use a moderate intensity paradigm 
(Marcus et al., 1999; Prapavessis, Cameron, Baldi, Robinson, Borrie, 
Harper, & Grove, 2007) whereas in an acute exercise paradigm 
moderate intensity exercise appears to have an effect on craving and 
withdrawal which is as good if not better than a bout of vigorous 
intensity exercise (Taylor et al., 2007). It is possible that this disparity is 
related to poor adherence in intensive exercise programmes (Marcus, 
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Lewis, Hogan, King, Albrecht, Bock, Parisi, Niaura, & Abrams, 2005; 
Ussher, West, McEwen, Taylor, & Steptoe, 2003). Recently, Williams et al. 
(2010) sought to overcome the issue of poor adherence and determine 
if moderate intensity exercise would produce positive smoking 
cessation outcomes (Williams, Whiteley, Dunsiger, Jennings, Albrecht, 
Ussher, Ciccolo, Parisi, & Marcus, 2010). The findings from this trial 
indicate that if adherence is adequate, moderate intensity exercise 
may enhance the efficacy of a programme that combines the nicotine 
patch and cessation counselling. Although, the authors note that the 
study findings are preliminary and a larger trial is needed. If these results 
can be replicated it has important implications for chronic exercise 
interventions. Namely, a moderate intensity exercise programme is 
likely to be better tolerated amongst sedentary smokers than a 
vigorous intensity exercise programme and thus, more likely to be 
maintained. 
 
Recently, Abrantes and colleagues (2009) compared the quit rates of 
exercisers vs. non-exercisers following either 12 weeks of bupropion or 
placebo. They found that at the end of a 12 week course of bupropion 
abstinence rates were not significantly higher between regular 
exercisers (43.1%) and non-exercisers (42.4%). However, smokers in the 
placebo condition who exercised regularly (36.9%) were significantly 
more likely to be smoke free at the end of the programme than their 
non-exercising counterparts (24.1%) (Abrantes, Strong, Lloyd-
Richardson, Niaura, Kahler, & Brown, 2009). From this the authors 
concluded that exercise may a particularly useful smoking relapse 
strategy, thereby providing another dimension to exercise effects on 
smoking behaviour (Abrantes et al., 2009). 
 
Looking at the chronic exercise and smoking cessation literature as a 
whole, the results are mixed. However, it is important to mention that 
studies that do not support exercise as an adjunct smoking cessation 
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aid may be limited by: (1) small sample size; (2) poor adherence to the 
exercise programme; (3) inadequate duration of the exercise 
programme; (4) little instruction as to how exercise might be of benefit 
during nicotine abstinence; and (5) lack of generalisability due to 
recruitment of a predominantly white sedentary sample (Marcus et al., 
1999; Ussher et al., 2008). Considering the large number of studies that 
report the utility of exercise to acutely reduce craving and withdrawal 
and the studies that report some positive results in the chronic literature, 
it is reasonable to suggest that some smokers may derive benefit from 
exercise when combined with well established smoking cessation aids 
(e.g., CBT and pharmacotherapy).  
 
1.6.3 Summary of exercise as a smoking cessation aid 
There is little doubt that in a laboratory setting, with temporarily 
abstinent smokers (ranging from three hours to 18 hours) an acute bout 
of moderate intensity exercise (ranging from ten minutes to 30 minutes) 
can alleviate craving and withdrawal symptoms associated with 
nicotine deprivation (Taylor et al., 2007). Conversely, available research 
in chronic exercise and smoking cessation does not reliably 
demonstrate that combining exercise with well established treatments 
increases smoking abstinence rates  (Ussher et al., 2008). To elucidate 
why this contradiction between laboratory studies and exercise based 
interventions exists, and to improve abstinence rates in an exercise 
aided quit smoking programme, investigation of exercise mechanisms 
of action on smoking cessation may be worthwhile. Determining why 
and how exercise works may increase the effectiveness of exercise as a 
smoking cessation aid. 
 
1.7 Possible mechanisms and individual factors involved in the effects 
of exercise as a smoking cessation aid 
Although the literature is not extensive, studies researching the 
mechanisms and individual differences involved in exercise effects on 
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smoking cessation have been conducted, and are presented in the 
following sections.  
 
1.7.1 Shifts in attentional focus  
Approximately 60% of smokers report poor concentration as a nicotine 
withdrawal symptom (McEwen, Hajek, McRobbie, & West, 2006). There 
is evidence to suggest that after a period of 12 hours without nicotine a 
smoker will have difficulty concentrating on tasks that were previously 
uncomplicated, which has been shown to lead to increased injury rates 
(Waters, Jarvis, & Sutton, 1998). In the general population exercise has 
been shown to enhance executive control processes, the same 
processes involved in concentration (Kubesch, Bretschneider, 
Freudenmann, Weidenhammer, Lehmann, Spitzer, & Grön, 2003). 
Exercise might work to improve concentration during nicotine 
withdrawal by shifting attentional bias away from the urge to smoke. In 
this way it may increase attentional capacity towards the task at hand 
and ultimately reduce the withdrawal symptom of poor concentration 
(Janse Van Rensburg & Taylor, 2008).  
 
Janse Van Rensburg and Taylor (2008) sought to objectively measure 
cognitive performance in terms of ‘poor concentration’ amongst 
temporarily abstinent smokers. To do this, participants completed the 
computerised version of the Stroop (1935) colour-word interference task 
on two separate occasions. Following 15 hours of abstinence they 
completed the Stroop (1935) task after either a passive control 
condition where they sat for 15 minutes or an exercise condition where 
they walked on a treadmill for 15 minutes at a self-pace. Contrary to 
their hypothesis – exercise did not enhance cognitive functioning, 
relative to the passive control condition (Janse Van Rensburg & Taylor, 
2008). The authors offer a number of plausible explanations as to why 
they believe exercise did not have a positive influence on cognitive 
function in this instance (see Janse Van Rensburg and Taylor, 2008 for 
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details). Ultimately, these researchers conclude that while exercise did 
not affect cognitive functioning, given the limitations, future research in 
this area is warranted.  
 
Continuing on from this work, shifts in attentional focus have been 
investigated as a possible mechanism underlying the effects of exercise 
on craving and withdrawal (Janse Van Rensburg, Taylor, & Hodgson, 
2009). Research has demonstrated that smokers show an enhanced 
attentional bias towards smoking cues (Waters, Shiffman, Bradley, & 
Mogg, 2003). For instance, a recently quit smoker may find themselves 
inadvertently staring at a person smoking a cigarette. It is postulated 
that when attentional bias toward smoking related cues increases so 
too does craving. It is also suggested that this attentional bias-craving 
relationship is associated with relapse. (Waters et al., 2003)  Therefore, 
attentional bias toward smoking related cues is implicated as a 
mechanism for craving, and it was proposed by Janse Van Resburg et 
al. (2009) that exercise may diminish this relationship. The aim was to 
determine if 15 minutes of moderate intensity exercise (vs. passive 
sitting) had the ability to shift attentional focus away from smoking 
related images amongst temporarily abstinent smokers, as well as to 
examine the relationship between attentional bias and cigarette 
craving (Janse Van Rensburg et al., 2009). To measure attentional bias, 
a randomised cross-over design was utilised, and participants were 
shown matched paired smoking and neutral images (e.g., hand 
holding a cigarette and hand holding a pen). Percentage of dwell 
time and direction of initial fixation was measured through an eye-
tracking system. It was demonstrated that: (1) exercise significantly 
reduced the amount of time spend looking at smoking images 
(percent dwell time); (2) exercise significantly reduced the tendency 
for participants to initially gravitate towards the smoking image; and (3) 
a negative correlation existed between initial image fixation and 
craving. This led the authors to conclude that exercise reduced 
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abstinent smokers’ attentional bias towards environmental smoking 
triggers, and may be one mechanism by which exercise alleviates 
cigarette craving (Janse Van Rensburg, Taylor, Hodgson, & 
Benattayallah, 2009). Contrary to previous studies these researchers 
found a negative relationship between craving and smoking salient 
cues. They hypothesised that this was perhaps a limitation of the 
images shown. That is, the images may have been too similar (i.e., 
hand holding a pen vs. hand holding a cigarette) and there may not 
have been enough time for participants to quickly differentiate 
between them. Also, perhaps this postulated mechanism is subject to 
individual differences, whereby it is the mechanism of action for some 
smokers but not others. As an example of this, McRobbie and 
colleagues found that when attempting to quit, some smokers found 
the smell of cigarettes pleasant and others did not, and this preference 
was not related to relapse (McRobbie, Hajek, & Locker, 2008). 
 
Additional work in this area by Janse Van Rensburg and colleagues 
(2009) was conducted with the primary aim of assessing the effects of 
10 minutes of moderate intensity exercise (cross-over design, exercise 
vs. seated passive control condition) on regional brain activation 
(functional Magnetic Resonance Imaging [fMRI]), amongst temporarily 
abstinent smokers while being exposed to smoking cues (i.e., smoking 
images). At baseline, this group of abstinent smokers showed an 
increased activation in brain areas associated with cravings and 
visuospatial attention (i.e., orbitofrontal cortex and caudate nucleaus). 
Interestingly, following 10 minutes of exercise this same group had no 
such brain activation when presented with the same images. These 
researchers suggest that an acute bout of moderate intensity exercise 
may reduce cravings by shifting brain activation away from areas 
involved in the urge to smoke when in the presence of smoking triggers.  
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1.7.2 Alleviates weight gain and weight gain fears 
Nicotine has been found to have powerful effects on the regulation of 
body weight. When a smoker quits it can lead to physiological pressure 
to gain weight (Grunberg & Bowden, 1985). The weight gain associated 
can have negative psychological consequences for the quitter and 
result in resumption of smoking (Brownell, Marlatt, Lichtenstein, & Wilson, 
1986; Schneider & Waters, 2007). A recent review of exercise 
interventions for smoking cessation found that such programmes do not 
consistently report an end of programme reduction in weight gain 
(Ussher et al., 2008). For example, Prapavessis et al. (2007) found that 
during and immediately following a 12 week quit smoking programme, 
weight gain was attenuated to a greater extent in the exercise group 
(vigorous intensity) when compared to those that received cognitive 
behavioural therapy only (Prapavessis et al., 2007). In contrast, Ussher et 
al. (2003) found no different in post intervention weight gain between a 
brief exercise counselling group and a health counselling group. 
However, perhaps Ussher et al. (2003) found no difference because the 
exercise group were not exercising at a vigorous intensity (84% of 
participants were exercising at a moderate intensity). In this instance, 
the potential for exercise to moderate weight gain post smoking 
cessation may have been mitigated (Ussher et al., 2003). Therefore, the 
utility of exercise to reduce post cessation weight gain may be 
dependent on the type of exercise engaged in. Regardless, the 
general pattern of results seems to be that, at best, exercise 
interventions may delay post cessation weight gain but at six month 
and one year follow-up there will be no difference between exercise 
and other groups (Ussher et al., 2008). 
 
In addition to actual weight gain, smoking specific weight concern 
(SSWC), the belief that smoking maintains weight and that quitting 
smoking will result in weight gain, has been investigated as a factor that 
may influence the success of an exercise smoking cessation 
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programme (Schneider & Waters, 2007). SSWC has been shown to be a 
barrier to cessation, is implicated in relapse to smoking, and has been 
shown to exacerbate negative affect during a quit attempt (Pinto, 
Borrelli, King, Bock, Clark, Roberts, & Marcus, 1999; Schneider & Waters, 
2007). In a cross-sectional study, Schneider et al. (2007) found that 
women who were higher in SSWC, who were also exercising, had less of 
an increase in negative affect one week post quit; whereas there was 
no relationship between change in negative affect and exercise 
amongst women who were low in SSWC. From this, these researchers 
concluded that SSWC may be a moderating factor in determining who 
gets the most affective benefit from exercise. As such, perhaps exercise 
works as a mechanism to counter SSWC amongst abstaining smokers 
who have high levels of SSWC thereby enabling them to better tolerate 
and resist relapse when faced with typical post cessation weight gain.  
 
1.7.3 Alleviates mood disturbance  
There is much evidence to suggest that negative affect maintains 
smoking behaviour and thwarts quit attempts (Tart, Leyro, Richter, 
Zvolensky, Rosenfield, & Smitts, 2010). Smokers with a history of major 
depression or those who are high in negative affect are very likely to 
relapse (TTS, 2010). Accordingly, psychological and pharmacological 
smoking cessation programmes that successfully reduce negative 
affect show improved abstinence outcomes amongst their clients 
(Haas, Munoz, Humfleet, Reus, & Hall, 2004; Richmond & Zwar, 2003).  
 
Exercise has been shown to have affect regulatory effects in both the 
general population and amongst those with major depression (Focht, 
Knapp, Gavin, Raedeke, & Hickner, 2007; North, McCullagh, & Tran, 
1990). There is also some evidence that exercise can reduce this 
nicotine withdrawal side effect (negative affect) in nicotine deprived 
smokers (Bock, Marcus, King, Borrelli, & Roberts, 1999; Schneider & 
Waters, 2007; Taylor et al., 2007). In a recent cross-sectional study 
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conducted by Tart and colleagues (2010) negative affect was shown 
to partially influence the positive effects of vigorous exercise on 
smoking. In contrast, Daniel et al. (2006) found that a reduction in 
cigarette craving experienced by temporarily abstinent smokers 
following 10 minutes of moderate intensity exercise was not due to 
exercise effects on mood. They reached this conclusion as they found 
no significant relationship between negative affect, positive affect, 
and desire for a cigarette (Daniel, Cropley, & Fife-Schaw, 2006).  
 
In addition to negative affect, Tart and colleagues (2010) also 
investigated the role anxiety sensitivity might play in the exercise-
smoking-negative affect relationship. Anxiety sensitivity (AS) refers to 
the fear of experiencing sensations associated with anxiety (e.g., rapid 
heart beat, sweating, nausea) (Tart et al., 2010). These researchers 
found that people who were high in AS were more likely to smoke when 
they experienced negative affect. It was also demonstrated that the 
relationship between vigorous intensity physical activity, smoking, and 
negative affect was stronger for individuals considered high in AS 
compared to those who were low in AS. These results suggest that 
smokers who are high in AS may derive greater benefit in vigorous 
exercise as a way to alleviate the negative affect associated with 
nicotine deprivation, which may in turn help them quit smoking. 
 
In 2006 Everson et al. conducted a study to see if exercise could induce 
a reduction in craving and withdrawal amongst a group of adolescents 
(16-19 years old) who were temporarily abstaining from cigarettes. 
Interestingly, they found that during ten minutes of cycling in a lab 
setting the moderate intensity exercise group experienced a greater 
degree of negative affect when compared to individuals in the 
placebo control condition (Everson, Daley, & Ussher, 2006). The group 
of adolescents chosen to take part in the study were all relatively 
sedentary and the researchers postulate that this group may have 
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found the moderate intensity exercise task demanding and distressing 
(Everson et al., 2006).  
 
In 2008 this same group of researchers conducted a study to determine 
the differential effects of 10 minutes of vigorous versus moderate 
intensity exercise on craving and withdrawal in a group of temporarily 
abstinent young adults (18-25 years old). They found vigorous intensity 
exercise to be associated with adverse mood outcomes during the 
exercise bout. Despite this, when compared to the control group, both 
the vigorous and moderate intensity exercise groups showed a 
reduction in craving, both during the exercise bout and five minutes 
following the exercise bout (Everson, Daley, & Ussher, 2008). These two 
studies in concert bring to light a few considerations: (1) exercise 
mechanisms may differ between adolescents and adult smokers trying 
to quit; (2) for adolescents, if exercise helps them to quit long-term it 
may not be because of acute post-exercise reduction in craving and 
withdrawal symptoms; and (3) exercise might alter craving and 
withdrawal through different mechanisms. 
 
It is evident amongst non-smokers that exercise decreases physiological 
and psychological responses to stress (Hughes, 1984; Sinyor, Schwartz, 
Peronnet, Brisson, & Seraganian, 1983). Lack of an alternative method 
for coping with stress is often cited by smokers as a reason for failed quit 
attempts (Shiffman, Kassel, Gwaltney, & McChargue, 2005). For 
temporarily abstinent smokers, self-paced walking has been shown to 
reduce tension both during the walk and up to 20 minutes after (Taylor, 
Katomeri, & Ussher, 2006). In this same study, exercise was shown to 
reduce craving up to 20 minutes after the brisk walk and this effect was 
found to be partially due to a reduction in tension (emotional stress) 
(Taylor et al., 2006). Therefore, the authors suggested that exercise can 
reduce the stress experienced during temporary abstinence which may 
in turn reduce the urge to smoke (Taylor et al., 2006).  
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1.7.4 Distraction 
Tobacco treatment specialists often recommend that smokers trying to 
quit use distraction as a technique to deal with the intense urge to 
smoke a cigarette (TTS, 2010). The idea being that if the smoker 
redirects their attention toward something else, then the urge will pass 
without them breaking their resolve (TTS, 2010). Daniel et al. (2006) 
conducted a study to determine if the influence of an acute bout of 
exercise on craving and withdrawal symptoms was due to distraction. 
Temporarily abstinent smokers were required to either: (1) cycle at a 
moderate intensity for ten minutes (40-60% HRR); or (2) engage in a 
cognitively distracting task for 10 minutes. The distraction task involved 
sequentially adding numbers, at a rate of one per second as they 
appeared upon a screen. The exercise group demonstrated a 
significant reduction in withdrawal symptoms immediately during and 
after exercise when compared to baseline. In contrast, when 
compared to baseline, the cognitive distraction group did not 
demonstrate any difference in withdrawal symptoms and desire to 
smoke. Therefore, the authors concluded that cognitive distraction is 
not one of the main mechanisms responsible for acute exercise effects 
on craving and withdrawal. There is one important limitation of this 
study that is worth noting. That is, the authors postulated that the 
distraction task in this instance may have been too difficult for some 
people, and as such, rather than simply being distracting it may have 
been anxiety producing.  
 
Taylor and Katomeri (2007) agreed with Daniel et al. (2006) in that 
distraction is not the main mechanism by which exercise works. These 
researchers found that following 15 minutes of light to moderate 
intensity exercise, followed by two mentally demanding tasks (Stroop 
colour word inference task and a speech task), temporarily abstinent 
smokers did not demonstrate an increase in craving in the presence of 
a lit cigarette. Additionally, an acute bout of exercise delayed the urge 
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to smoke for 50 minutes post exercise. Therefore, these researchers 
believe that the evidence does not support distraction as a 
mechanism. Namely, because it is difficult to comprehend that the 
distracting effects of 15 minutes worth of exercise could last as long as 
50 minutes (Taylor & Katomeri, 2007).  
 
In 2006 Ussher et al. compared five minutes of isometric exercise to five 
minutes of body scanning (relaxation technique). Up to five minutes 
post intervention both groups experienced a reduction in craving and 
withdrawal. They suggested that the short lived craving and withdrawal 
reduction demonstrated for both groups may implicate distraction as a 
plausible mechanism in this instance (Ussher et al., 2006). Considering 
these studies collectively, it is possible that distraction may play a small 
role in the mechanistic effects of exercise early on in the exercise bout, 
but it is unlikely to be the mechanism of action involved in any longer 
lasting effects.  
 
1.7.5 Expectancy 
Patient expectancy has been shown to influence treatment outcomes 
in populations such as those suffering from chronic lower back pain 
and generalised anxiety disorder (Newman & Fisher, 2010; Smeets, 
Beelen, Goossens, Schouten, Knottnerus, & Vlaeyen, 2008). In terms of 
exercise specifically, it has been proposed that expectancy of the 
benefits of exercise on mood may influence actual changes in mood 
following exercise (Salmon, 2001). Daniel et al. (2007) conducted a 
study to determine if smokers who enter an exercise programme may 
gain some relief from nicotine craving and withdrawal symptoms simply 
because they expect to (Daniel, Cropley, & Fife-Schaw, 2007). To 
achieve this, these researchers manipulated how credible participants 
believed exercise to be as a smoking cessation aid. Inactive smokers 
who had undergone a night of abstinence were then randomised into 
one of three groups: (1) positive – read a statement that exercise helps 
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with withdrawal; (2) negative – read a statement that exercise has no 
effect on withdrawal; and (3) ambiguous – read both a positive and a 
negative statement. The physical activity that all participants engaged 
in was 10 minutes on a stationary bicycle at a moderate intensity. These 
researchers found that regardless of the expectations of the 
participants, withdrawal symptoms were reduced both during and 
after exercise. From this they concluded that the expectation of the 
effects of exercise on withdrawal and craving does not influence 
actual reductions in these variables (Daniel et al., 2007). However, there 
were a number of limitations with this study that cast doubt as to 
whether or not expectancy as a mechanisms can be completely ruled 
out. These will be outlined and discussed in detail in study two (Chapter 
three) of this dissertation.  
 
In 2003, Ussher and colleagues conducted a large trial and randomised 
smokers to either: NRT plus CBT plus brief exercise counselling or NRT plus 
CBT plus brief health information counselling. They found no differences 
between these two groups in terms of expectancy of intervention 
efficacy, post intervention abstinence, or weight and fat gain. In this 
instance, because the two groups were the same in terms of 
expectancy and treatment outcomes it is not possible to rule out 
expectancy as an influential factor in the effect of exercise on smoking 
cessation. 
 
1.7.6 Incompatible behaviours 
In the exercise and smoking literature there is a significant cross-
sectional association between smoking cessation and exercise (King, 
Marcus, Pinto, Emmons, & Abrams, 1996). Research suggests that 
compared to sedentary individuals, people who engage in vigorous 
intensity exercise are less likely to smoke (Tart et al., 2010). It was 
demonstrated by Prochaska et al. (2008) that following a combined 
CBT and exercise intervention, individuals who at six month follow-up 
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were still exercising, were more likely to be smoke-free than their 
counterparts who were no longer active. It is postulated that an 
increase in confidence to quit smoking is associated with a concurrent 
increase in confidence to take up exercise and vice versa (King et al., 
1996). Although a causal relationship cannot be inferred, it seems 
possible that exercise may exert some influence over smoking 
behaviour because the two behaviours are distinctly incompatible. 
 
1.7.7 Neurobiological mechanisms 
A number of neurobiological mechanisms are involved in the 
maintenance of smoking behaviour. At this stage there are several 
mechanisms postulated to be involved in the link between exercise 
and the psychobiology of nicotine abstinence. Animal models have 
shown that exercise stimulates the release of dopamine into the 
striatum of the rat. This implies that exercise may be a mechanism for 
reducing the drive for drug administration in general, or nicotine 
specifically in the case of smoking (Wilson & Marsden, 1995). However, 
such a change in regional brain activation following vigorous exercise 
was not found in a group of regular exercisers (Wang, Volkow, Fowler, 
Franceschi, Logan, Pappas, Wong, & Netusil, 2000). Vigorous exercise 
has been shown to facilitate the release of endogenous opiods (e.g., 
Beta-endorphins), neurotransmitters that are also stimulated by smoking 
and known to enhance mood (Angelopoulos, 2001). An inherent 
difficulty with these neurotransmitter-exercise hypotheses is that both 
endogenous opoids and dopamine, the neurotransmitter so integrally 
linked to the addictive power of nicotine, are only triggered for release 
in vigorous exercise (Everson et al., 2008). Therefore, these mechanisms 
do not fit with the acute exercise finding that moderate intensity 
exercise is sufficient to reduce craving and withdrawal (Taylor et al., 
2007). 
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Smokers have higher cortisol levels than non-smokers (36% higher) 
(Ussher, West, Evans, Steptoe, McEwan, & Clow, 2006). Between 12 and 
24 hours after smokers quit, their cortisol levels will plummet (Steptoe & 
Ussher, 2006). It is hypothesised that this reduction in cortisol, makes 
quitting more difficult such that the greater the decline in cortisol the 
worse the craving and withdrawal experience (Steptoe & Ussher, 2006). 
Therefore, any method that could temporarily boost cortisol levels back 
up during a quit attempt has intuitive appeal. Exercise and cortisol 
have a unique relationship. Specifically, vigorous intensity exercise has 
been shown to increase cortisol levels among non-smokers (Jacks, 
Sowash, Anning, McGloughlin, & Andres, 2002). Scerbo and colleagues 
(2010) investigated the effects of exercise on cortisol amongst 
temporarily abstinent smokers in a cross-over design where participants 
engaged over three consecutive days in 15 minutes of: passive sitting, 
moderate intensity exercise (brisk walking), and vigorous intensity 
exercise (running). These researchers found that the decline in cortisol 
levels was attenuated in the vigorous intensity condition but not the 
moderate intensity exercise condition. However, no difference in 
cigarette craving was demonstrated between the two exercise 
conditions and participants experienced a reduction in craving during 
both exercise intensities (Scerbo, Faulkner, Taylor, & Thomas, 2010). 
Therefore, it is unlikely that reductions in cortisol contribute to the effect 
an acute bout of moderate intensity exercise has on craving and 
withdrawal. However, it cannot be ruled out as a possible physiological 
mechanism related to vigorous exercise effects on these variables. 
 
1.8 The appeal of exercise as a smoking cessation strategy 
The interest in multiple health behaviour change interventions is 
increasing (Prochaska, Spring, & Nigg, 2008). As a multiple behaviour 
change strategy, exercise and smoking cessation complement each 
other well. Recent research indicates that when smoking cessation is 
facilitated it may enhance an individual’s motivation to change other 
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health behaviours (e.g., increase exercise). Considering that smoking 
cessation may be a catalyst for change in other behaviours and that 
exercise has been shown to acutely reduce the debilitating symptoms 
of nicotine withdrawal, incorporating these two behaviours into one 
intervention is appealing.  
 
Due to the addictive nature of smoking cigarettes, those interested in 
quitting do not always achieve abstinence. This is evident by the fact 
that smoking rates amongst the general population in the developed 
world have remained at approximately 20% since the 1990’s (TTS, 2010). 
A proportion of the smoking population are hardened smokers who 
may have unsuccessfully tried many times to quit. For these individuals 
a harm reduction strategy might be appropriate. The primary objective 
of a harm reduction strategy is to minimise the risk of harmful 
consequences associated with tobacco use in smokers who find it 
extremely difficult to quit and those who are unwilling to quit (deRuiter 
& Faulkner, 2006). While becoming completely nicotine free offers the 
best protection against morbidity and mortality; harm reduction is a 
concept that, under the right circumstances, is gaining favour amongst 
tobacco treatment specialists (TTS, 2010). For a smoking cessation aid 
to be considered an effective harm reduction approach it must fulfil 
certain criteria such as: (1) it should not increase or contribute to the 
individuals’ level of nicotine dependence; and (2) the reduction 
approach should not present any additional harm to the individual   
(for the full list of harm reduction criteria see deRuiter and Faulkner 
[2006]). Presently, the only smoking cessation aid that fulfils all the 
criteria to be considered a harm reduction strategy is nicotine 
replacement therapy. The evidence is certainly shaping up to align 
physical activity as another harm reduction strategy (deRuiter & 
Faulkner, 2006; Hatsukami et al., 2004). 
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Smoking relapse rates are alarmingly high. Between 60% and 98% of 
quit attempts will end in relapse within the first year; with the majority 
(44%) occurring in the first two weeks (Garvey, Bliss, Hitchcock, Heinold, 
& Rosner, 1992). There are a number of reasons why people relapse 
that exercise may directly impact. For instance, post cessation weight 
gain (10 lbs on average) is a leading cause of relapse (Bush, Levine, 
Zbikowski, Deprey, Rabius, McAfee, & Wiatrek, 2009; Parsons, Shraim, 
Inglis, Aveyard, & Hajek, 2009). Although the research on the potential 
of exercise to ward off post cessation weight gain is equivocal, exercise 
is nevertheless an essential component of any weight management 
programme and should be encouraged (Fiore et al., 2008). Cigarette 
cravings are one of the most often expressed difficulties related to 
quitting. The intensity of craving experienced by an abstinent smoker 
over the first few days of quitting often predicts their success (Ferguson, 
Shiffman, & Gwaltney, 2006). The acute exercise and smoking literature 
has demonstrated that an acute bout of moderate intensity exercise 
has great potential to reduce cigarette cravings in temporarily 
abstinent smokers (Taylor et al., 2007). Thus, exercise has potential as a 
relapse prevention strategy. 
 
In summary, a number of benefits specific to the promotion of physical 
activity as a smoking cessation treatment cannot be overlooked: (1) it 
is cost effective as part of a multiple behaviour change intervention; (2) 
it is inexpensive for the smoker (as opposed to NRT); (3) it can safely be 
indefinitely sustained; (4) it has minimal negative side effects; (5) it has 
the opposite effect on morbidity and mortality amongst smokers and as 
such provides great health benefits (deRuiter & Faulkner, 2006); and (6) 
it is a quit smoking aid that spans the continuum of the quit process – 
from quit attempt to relapse prevention. Given these potential benefits 
continuing to pursue exercise as a quit smoking strategy is worthwhile 
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1.9 Objectives and hypotheses of this dissertation 
Much work has been done on the benefits of exercise as a smoking 
cessation intervention. This thesis will concentrate on an area of the 
research which has not been as well covered – mechanisms involved in 
the utility of exercise and individual factors that may contribute to how 
well exercise works as an adjunct smoking cessation aid. The objectives 
and hypotheses of each study are outlined below. 
 
1.9.1 Study one (Chapter two): Exercise provides further craving and 
withdrawal relief for recently quit women who are using nicotine 
replacement therapy (NRT)  
Study one is an examination of exercise mechanisms of action that 
might contribute to quit success in a combined NRT and exercise aided 
smoking cessation programme. Smokers followed during a 14 week NRT 
plus exercise aided smoking cessation programme which allowed for: 
(1) the first examination of exercise as an adjunct to NRT to reduce 
withdrawal symptoms and cigarette craving; (2) more accurate 
estimates of the craving and withdrawal relief experienced following 
exercise during a real quit attempt; and (3) exploration of exercise 
mechanisms of action that might contribute to quit success in a 
combined NRT and exercise aided smoking cessation programme 
(e.g., magnitude of withdrawal and craving relief experienced 
following a bout of exercise).  
 
It was hypothesised that an acute bout of exercise would reduce 
nicotine craving and withdrawal in a group of women attempting to 
quit using NRT and exercise. It was believed that the greatest 
withdrawal and craving relief would occur in the first week following 
the quit date and at the NRT (NicoDerm® patch) nicotine drop-down 
time points (i.e., 21mg to 14mg, 14mg to 7mg). It was further 
hypothesised that women who experience a greater magnitude of 
relief from craving and withdrawal following a 20-30 minute bout of 
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moderate intensity exercise would be more successful at abstaining 
from cigarettes at the end of the 14-week NRT plus structured exercise 
programme.  
 
1.9.2 Study two (Chapter three): Exercise may help smokers quit 
because they expect it will and because they believe it is a 
credible quit smoking aid 
Study two sought to examine whether treatment expectancy and 
credibility were associated with outcome in terms of self-reported 
craving and withdrawal in a group of women undergoing a real quit 
attempt. The women involved were supplied with nicotine replacement 
therapy patches (NRT) as well as an exercise regimen. This provided the 
opportunity to compare expectancy and credibility beliefs regarding a 
well established quit smoking aid such as NRT with a novel quit smoking 
aid such as exercise. Furthermore, rather than only assess treatment 
expectancy and credibility before the start of the treatment when 
participants may have difficulty judging their actual beliefs regarding 
treatment outcomes; it was possible to measure these two variables 
immediately after quitting and at the end of the programme once they 
had actually been through the process (Smeets et al., 2008). 
 
It was hypothesised that exercise expectancy and credibility beliefs 
would contribute to a reduction in craving and withdrawal symptoms 
following an acute bout of exercise. It was also hypothesised that as 
participants progressed through the NRT plus exercise quit smoking 
programme their exercise expectancy and credibility beliefs would 
increase.  
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1.9.3 Study three (Chapter four): Exercise may be an effective 
behavioural support strategy for coping with smoking 
temptations during a quit attempt 
The exercise and smoking literature supports the notion of exercise as a 
meaningful coping resource during abstinence to prevent relapse 
(Taylor et al., 2006). Exercise has been proposed as a strategy to 
enhance coping ability and confidence to remain smoke free (Ussher 
et al., 2008). However, it is not known if abstaining smokers would 
confidently report replacing smoking with exercise when imagining a 
relapse inducing situation. It is also unknown whether the quitter’s 
confidence in exercise as a behavioural support strategy is situation 
specific. With this in mind, the purpose of the present study was to 
determine: (1) if women taking part in a combined NRT and exercise 
aided smoking cessation programme report a temporal progression 
from smoking to exercising in high risk situations; and (2) whether 
confidence to use exercise as a coping strategy is situation dependent. 
 
It was hypothesised that women engaging in an exercise aided quit 
smoking programme would naturally substitute smoking for exercise as 
a means of coping with situations that promote the resumption of 
smoking. It was also hypothesised that of all high-risk relapse situations 
those related to affect, particularly negative affect, would be the most 
amenable to exercise as a coping strategy. Finally, it was hypothesised 
that women who showed an increase in confidence to quit smoking 
would demonstrate a reciprocal increase in exercise confidence.  
 
1.10 Integrated article format 
This dissertation is presented in an integrated article format. Therefore, 
there is some overlap in material throughout, which is a product of this 
dissertation style. 
 
31 
 
 
 
1.11 References 
Abrams, D. B., Niaura, R., Brown, R. A., Emmons, K. M., Goldstein, M. G., 
& Monti, P. M. (2003). The Tobacco Dependence Treatment Handbook: 
A Guide to Best Practices. The Guilford Press, New York 
  
Abrantes, A. M., Strong, D. R., Lloyd-Richardson, E. E., Niaura, R., Kahler, 
C. W., & Brown, R. A. (2009). Regular exercise as a protective factor in 
relapse following smoking cessation treatment. The American Journal 
on Addictions, 18, 100-101. 
  
American Psychiatric Association (1994). Diagnostic and statistical 
manual of mental disorders (4th ed.), Washington, DC: Author 
  
Angelopoulos, T. J. (2001). Beta-endorphin immunoreactivity during 
high-intensity exercise with and without opiate blockade. European 
Jouran of Applied Physiology, 86, 92-96. 
  
Barnes, J., Dong, C. Y., McRobbie, H., Walker, N., Mehta, M., & Stead, L. 
F. (2010). Hypnotherapy for smoking cessation. Cochrane Database of 
Systematic Reviews, Issue 10. Art. No.: CD001008. DOI: 
10.1002/14651858.CD001008.pub2, 
  
Biener, L., Reimer, R. L., Wakefield, M., Szczypka, G., Rigotti, N. A., & 
Connolly, G. (2006). Impact of smoking cessation aids and mass media 
among recent quitters. American Journal of Preventive Medicine, 
30,(3), 217-224. 
  
Bock, B. C., Marcus, B. H., King, T. K., Borrelli, B., & Roberts, M. R. (1999). 
Exercise effects on withdrawal and mood among women attempting 
smoking cessation. Addictive Behaviors, 24,(3), 399-410. 
  
Brownell, K. D., Marlatt, G. A., Lichtenstein, E., & Wilson, T. G. (1986). 
Understanding and preventing relapse. American Psychologist, 41,(7), 
765-782. 
  
Bush, T., Levine, M. D., Zbikowski, S., Deprey, M., Rabius, V., McAfee, T., & 
Wiatrek, D. E. (2009). Weight gain after quitting: attitudes, beliefs and 
counseling strategies of cessation counselors. The Journal of Smoking 
Cessation, 3, 124-132. 
  
CDC (2007). Centers for Disease Control and Prevention, Cigarette 
Smoking Among Adults - United States. MMWR, 2008. 57(45): 1221-1226. 
  
CTUMS (2008). Retrieved from: http://www.hc-sc.gc.ca. Canadian 
Tobacco Use Monitoring Survey, Health Canada. 
  
32 
 
 
 
Daniel, J. Z., Cropley, M., & Fife-Schaw, C. (2006). The effect of exercise 
in reducing desire to smoke and cigarette withdrawal symptoms is not 
caused by distraction. Addiction, 101, 1187-1192. 
  
Daniel, J. Z., Cropley, M., & Fife-Schaw, C. (2007). Acute exercise effects 
on smoking withdrawal symptoms and desire to smoke are not related 
to expectation. Psychopharmacology, 195, 125-129. 
  
deRuiter, W., & Faulkner, G. (2006). Tobacco harm reduction strategies: 
The case for physical activity. Nicotine & Tobacco Research, 8,(2), 157-
168. 
  
Everson, E. S., Daley, A. J., & Ussher, M. (2006). Does exercise have an 
acute effect on desire to smoke, mood and withdrawal symptoms in 
abstaining adolescent smokers? Addictive Behaviors, 31, 1547-1558. 
  
Everson, E. S., Daley, A. J., & Ussher, M. (2008). The effects of moderate 
and vigorous exercise on  desire to smoke, withdrawal symptoms and 
mood in abstaining young adults smokers. Mental Health and Physical 
Activity, 1,(1), 26-31. 
  
Farrelly, M. C., Pechacek, T. F., Thomas, K. Y., & Nelson, D. (2008). The 
impact of tobacco control programs on adult smoking. American 
Journal of Public Health, 98,(2), 304-309. 
  
Ferguson, S. G., Shiffman, S., & Gwaltney, C. J. (2006). Does reducing 
withdrawal severity mediate nicotine patch efficacy? A randomized 
clinial trial. Journal of Consulting and Clinical Psychology, 74,(6), 1153-
1161. 
  
Fiore, M. C., Jaen, C. R., & Baker, T. B. (2008). Treating Tobacco Use and 
Dependence: 2008 Update. Clinical Practice Guidelines. Rockville, MD, 
U.S. Department of Health and Human Services. Public Health Services. 
  
Focht, B. C., Knapp, D. J., Gavin, T. P., Raedeke, T. D., & Hickner, R. C. 
(2007). Affective and self-efficacy responses to acute aerobic exercise 
in sedentary older and younger adults. Journal of Aging and Physical 
Activity, 15, 123-138. 
  
Garvey, A. J., Bliss, R. E., Hitchcock, J. L., Heinold, J. W., & Rosner, B. 
(1992). Predictors of smoking relapse among self-quitters: A report from 
the Normative Aging Study. Addictive Behaviors, 17, 367-377. 
  
Grunberg, N. E., & Bowden, D. J. (1985). Coping with the sequelae of 
smoking cessation. Journal of Cardiopulmonary Rehabilitation, 5, 285-
289. 
  
33 
 
 
 
Haas, A. L., Munoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004). 
Influences of mood, depression history, and treatment modality on 
outcomes in smoking cessation. Journal of Consluting and Clinical 
Psychology, 72, 563-570. 
  
Hughes, J. R. (1984). Psychological effects of habitual exercise: a critical 
review. Preventive Medicine, 13, 66-78. 
  
Jacks, D. E., Sowash, J., Anning, J., McGloughlin, T., & Andres, F. (2002). 
Effect of exercse at three exercise intensities on salivary cortisol. Journal 
of Strength and Conditioning Research, 16, 286-289. 
  
Janse Van Rensburg, K., Taylor, A., & Hodgson, T. (2009). The effects of 
acute exercise on attentional bias towards smoking-related stimuli 
during temporary abstinence from smoking. Addiction, 104, 1910-1917. 
  
Janse Van Rensburg, K., Taylor, A., Hodgson, T., & Benattayallah, A. 
(2009). Acute exercise modulates cigarette cravings and brain 
activation in response to smoking-related images: an fMRI study. 
Psychopharmacology, 203, 589-598. 
  
Janse Van Rensburg, K., & Taylor, A. H. (2008). The effects of acute 
exercise on cognitive functioning and cigarette cravings during 
temporary abstinence from smoking. Human Psychopharmacology, 23, 
193-199. 
  
King, T. K., Marcus, B. H., Pinto, B. M., Emmons, K. M., & Abrams, D. B. 
(1996). Cognitive behavioral mediators of changing multiple 
behaviours: smoking and a sedentary lifestyle. Preventive Medicine, 25, 
684-691. 
  
Kubesch, S., Bretschneider, V., Freudenmann, R., Weidenhammer, N., 
Lehmann, M., Spitzer, M., & Grön, G. (2003). Aerobic endurance 
exercise improves executive functions in depressed patients. Journal of 
Clinical Psychiatry, 64, 1005-1012. 
  
Marcus, B. H., Albrecht, A. E., King, T. K., Parisi, A. F., Pinto, B. M., Roberts, 
M., Niaura, R. S., & Abrams, D. B. (1999). The efficacy of exercise as an 
aid for smoking cessation in women. Archives of Internal Medicine, 159, 
1229-1234. 
  
Marcus, B. H., Lewis, B. A., Hogan, J., King, T. K., Albrecht, A. E., Bock, B., 
Parisi, A. F., Niaura, R., & Abrams, D. B. (2005). The efficacy of moderate-
intensity exercise as an aid for smoking cessation in women: A 
randomized controlled trial. Nicotine & Tobacco Research, 7,(6), 871-
880. 
  
34 
 
 
 
McEwen, A., Hajek, P., McRobbie, H., & West, R. (2006). Manual of 
Smoking Cessation: a Guide for Counsellors and Practitioners. Blackwell 
Publishers, Oxford 
  
McRobbie, H., Hajek, P., & Locker, J. (2008). Does the reaction of 
abstaining smokers to the smell of other people's cigarettes predict 
relapse?  
. Addiction, 103,(11), 1883-1887. 
  
Newman, M. G., & Fisher, A. J. (2010). Expectancy/crediblity change as  
mediator of cognitive behavioral therapy fo generalized anxiety 
disorder: Mechansims of action or proxy for symptom change? 
International Journal of Cognitive Therapy, 3,(3), 245-261. 
  
North, C. T., McCullagh, P., & Tran, Z. V. (1990). Effect of exercise on 
depression. Exercise and Sport Science Reviews, 37, 379-415. 
  
Parsons, A., Shraim, M., Inglis, J., Aveyard, P., & Hajek, P. (2009). 
Interventions for preventing weight gain after smoking cessation. 
Cochrane Database Systematic  Review, DOI: 10 1002/14651858 
CD006219,(2), 
  
Pinto, B., Borrelli, B., King, T. K., Bock, B., Clark, M. M., Roberts, M., & 
Marcus, B. (1999). Weight control smoking among sedentary women. 
Addictive Behaviors, 24, 75-86. 
  
Prapavessis, H., Cameron, L., Baldi, J. C., Robinson, S., Borrie, K., Harper, 
T., & Grove, J. R. (2007). The effects of exercise and nicotine 
replacement therapy on smoking rates in women. Addictive Behaviors, 
32, 1416-1432. 
  
Prochaska, J. J., Spring, B., & Nigg, C. R. (2008). Multiple health behavior 
change research: An introduction and overview. Preventive Medicine, 
46, 181-188. 
  
Richmond, R., & Zwar, N. (2003). Review of bupropion for smoking 
cessation. Drug and Alcohol Review, 22, 203-220. 
  
Salmon, P. (2001). Effects of physical exercise on anxiety, depression, 
and sensitivity to stress: a unifying theory. Clinical Psychology Review, 
21,(1), 33-61. 
  
Scerbo, F., Faulkner, G., Taylor, A., & Thomas, S. (2010). Effects of 
exercise on cravings to smoke: The role of exercise intensity and cortisol. 
Journal of Sport Sciences, 28,(1), 11-19. 
  
35 
 
 
 
Schneider, K., & Waters, A. J. (2007). Affective benefits of exercise while 
quitting smoking: Influence of smoking specific weight concern. 
Psychology of Addictive Behaviors, 21, 255-260. 
  
Shiffman, S., Kassel, J. A., Gwaltney, C. J., & McChargue, D. (2005). 
Relapse prevention for smoking. Relapse Prevention: Maintenance 
Strategies in the Treatment of Addictive Behaviors. G. A. Marlatt & D. M. 
Donovan. New York, The Guilford Press: 92-129. 
  
Sinyor, D., Schwartz, S. G., Peronnet, F., Brisson, G., & Seraganian, P. 
(1983). Aerobic fitness level and reactivity to psychosocial stress: 
Physiological, biochemical, and subjective measures. Psychosomatic 
Medicine, 45, 205-217. 
  
Smeets, R. J. E. M., Beelen, S., Goossens, M. E. J. B., Schouten, E. G. W., 
Knottnerus, J. A., & Vlaeyen, J. W. S. (2008). Treatment expectancy and 
credibility are associated with the outcome of both physical and 
cognitive-behavioral treatment in chronic low back pain. Clinical 
Journal of Pain, 305-315. 
  
Steptoe, A., & Ussher, M. (2006). Smoking, cortisol and nicotine. 
International Journal of Psychophysiology, 59, 228-235. 
  
Tart, C. D., Leyro, T. M., Richter, A., Zvolensky, M. J., Rosenfield, D., & 
Smitts, J. A. (2010). Negative affect as a mediator of the relationship 
between vigorous-intensity exercise and smoking. Addictive Behaviors, 
35, 580-585. 
  
Taylor, A., & Katomeri, M. (2006). Effects of a brisk walk on blood 
pressure responses to the Stroop, a speech task and a smoking cue 
among temporarily abstinent smokers. Psychopharmacology, 184, 247-
253. 
  
Taylor, A., & Katomeri, M. (2007). Walking reduces cue-elicited 
cigarette cravings and withdrawal symptoms, and delays ad libitum 
smoking. Nicotine & Tobacco Research, 9,(11), 1183-1190. 
  
Taylor, A., Katomeri, M., & Ussher, M. (2006). Effects of walking on 
cigarette cravings and affect in the context of nesbitt's paradox and 
the circumplex model. Journal of Sport and Exercise Psychology, 28, 18-
31. 
  
Taylor, A. H., Katomeri, M., & Ussher, M. (2005). Acute effects of self-
paced walking on urges to smoke during temporary smoking 
abstinence. Psychopharmacology, 181, 1-7. 
  
36 
 
 
 
Taylor, A. H., Ussher, M. H., & Faulkner, G. (2007). The acute effects of 
exercise on cigarette cravings, withdrawal symptoms, affect and 
smoking behaviour: a systematic review. Addiction, 102, 534-543. 
  
TTS (2010). Massachusetts Tobacco Treatment Specialist Training. 
Worcester, MA, Center for Tobacco Treatment Research and Training, 
University of Massachusetts Medical School. 
  
USDHHS (1990). U.S. Department of Health and Human Services, The 
Health Benefits of Smoking Cessation: A Report of the Surgeon General. 
U.S. Department of Health and Human Services, Publich Health Service, 
Centers for Disease Control and Prevention. Atlanta, GA. 
  
USDHHS (2001). U.S. Department of Health and Human Services, 
Women and Smoking: A Report of the Surgeon General. U.S. 
Department of Health and Human Services, Public Health Service, 
Centers for Disease Control, Centre for Chronic Disease. Atlanta, GA. 
  
USDHHS (2004). U.S. Department of Health and Human Services. The 
Health Consequences of Smoking: what it means to you. U.S. 
Department of Health and Human Services, Centers for Disease Control 
and Prevention, National Center for Chronic Disease Prevention and 
Health Promotion, Office on Smoking and Health. Atlanta, GA. 
  
USDHHS (2010). How Tobacco Smoke Causes Disease: The Biology and 
Behavioral Basis for Smoking-Attributed Disease: A Report of the 
Surgeon General. U.S. Department of Health and Human Services, 
Centers for Disease Control and Prevention, National Center  for 
Chronice Disease Prevention and Health Promotion, Office on Smoking 
and Health. Atlanta, GA. 
  
Ussher, M., Taylor, A., & Faulkner, G. (2008). Exercise interventions for 
smoking cessation. Cochrane Database of Systematic Reviews, 4, 
CD002295. 
  
Ussher, M., West, R., Doshi, R., & Sampuran, A. K. (2006). Acute effect of 
isometric exercise on desire to smoke and tobacco withdrawal 
symptoms. Human Psychopharmacology, 21, 39-46. 
  
Ussher, M., West, R., Evans, P., Steptoe, A., McEwan, A., & Clow, A. 
(2006). Reduction in cortisol following smoking cessation among users of 
nicotine patches. Psychosomatic Medicine, 68, 299-306. 
  
Ussher, M., West, R., McEwen, A., Taylor, A., & Steptoe, A. (2003). 
Efficacy of exercise counselling as an aid for smoking cessation: A 
randomized controlled trial. Addiction, 98, 523-532. 
  
37 
 
 
 
Wang, G. J., Volkow, N. D., Fowler, J. S., Franceschi, D., Logan, J., 
Pappas, N. R., Wong, C. T., & Netusil, N. (2000). PET studies of the effects 
of aerobic exercise on human striatal dopamine release. The Journal of 
Nuclear Medicine, 41, 1352-1356. 
  
Waters, A. J., Jarvis, M. J., & Sutton, S. R. (1998). Nicotine withdrawal and 
accident rates. Nature, 394, 137. 
  
Waters, A. J., Shiffman, S., Bradley, B. P., & Mogg, K. (2003). Attentional 
shits to smoking cues in smokers. Addiction, 98, 1409-1417. 
  
West, R., & Shiffman, S. (2001). Effect of oral nicotine dosing forms on 
cigarette withdrawal symptoms and craving: a systematic review. 
Psychopharmacology, 155, 115-122. 
  
West, R., & Shiffman, S. (2007). Fast facts: Smoking cessation (2nd ed.). 
Health Press Ltd, Abingdon, England 
  
White, A. R., Rampes, H., Liu, J. P., Stead, L. F., & Campbell, J. (2011). 
Acupuncture and related interventions for smoking cessation. 
Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD000009. 
DOI: 10.1002/14651858.CD000009.pub3., 
  
WHO (2008). World Health Organization. Retrieved from: 
http://www.who.int/mediacentre/factsheets/fs310/en/index.html, 
  
Williams, D. M., Whiteley, J. A., Dunsiger, S., Jennings, E. G., Albrecht, A. 
E., Ussher, M. H., Ciccolo, J. T., Parisi, A. F., & Marcus, B. M. (2010). 
Moderate intensity exercise as an adjunct to standard smoking 
cessation treatment for women: A pilot study. Psychology of Addictive 
Behaviors, 24,(2), 349-354. 
  
Wilson, W. M., & Marsden, C. A. (1995). Extracellular dopamine in a 
nucleus accumbens of the rate during treadmill running. Acta 
Physiological Scandanavia, 155, 465-466. 
  
 
 
  
38 
 
 
 
2 CHAPTER TWO: EXERCISE PROVIDES FURTHER 
CRAVING AND WITHDRAWAL RELIEF FOR RECENTLY 
QUIT WOMEN WHO ARE USING NICOTINE 
REPLACEMENT THERAPY 
 
 
2.1 Introduction 
Cigarettes kill millions of people worldwide every year (USDHHS, 2010). 
For over 50 years health practitioners have been working to determine 
how best to treat nicotine dependence (USDHHS, 2010). Current 
guidelines recommend tobacco treatment specialists advocate a 
combination of tobacco dependence counselling, and 
pharmacotherapy (Fiore, Jaen, & Baker, 2008). First line 
pharmacotherapies such as the nicotine patch, bupropion, and 
varenicline have been shown to double chances of quitting (TTS, 2010). 
Unfortunately, this increased chance of becoming smoke-free only 
equates to a 23% success rate at six months. Even comprehensive 
programmes, that include both pharmacotherapy and behavioural 
support, have limited success, with six month abstinence rates of 30% 
(Fiore et al., 2008). Sobering statistics like these highlight the need for 
identifying adjunct therapies that improve and sustain quit smoking 
rates. 
 
Cigarette cravings are one of the most often expressed difficulties 
related to quitting. The intensity of craving experienced by an abstinent 
smoker over the first few days of quitting often predicts their success 
(Ferguson, Shiffman, & Gwaltney, 2006). When undergoing a period of 
abstinence, smokers are likely to experience two forms of cigarette 
cravings, background and episodic (Ferguson et al., 2006). Background 
craving denotes a steady state of craving where the individual is 
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plagued by a constant desire for a cigarette. Background craving may 
be controlled by pharmacotherapy such as the nicotine patch, 
bupropion and varenicline. Episodic cravings are surges in craving that 
result in an intense desire to light up a cigarette. These are triggered by 
exposure to stimuli associated with smoking (e.g., after a coffee or 
when having a bad day at work) (Ferguson & Shiffman, 2009). The only 
pharmacotherapy known to assist with episodic craving is oral nicotine 
replacement therapy (NRT; e.g., gum and lozenge) (Ferguson & 
Shiffman, 2009). A single session of exercise has been shown to have an 
acute effect on cigarette cravings. In a recent review of the acute 
exercise and smoking literature, Taylor and colleagues (2007) found 
that nine out of ten studies showed exercise to reduce cigarette 
cravings during temporary smoking abstinence (moderate to large 
effect sizes [ES] between 0.50–4.6). Significant reductions in desire to 
smoke have been observed for different intensities and types of 
exercise. For example, isometric exercise at a very low intensity and of 
a five minute duration has been shown to reduce the urge to smoke by 
0.7 on a seven point scale (ES = 0.29)(Ussher, West, Doshi, & Sampuran, 
2006) whereas 15-20 minutes of self-paced walking reduced the urge to 
smoke by 4.6 on the same scale (ES = 3.7) (Taylor, Katomeri, & Ussher, 
2005). In addition, longer periods of exercise (e.g., approximately 15 
minutes of brisk walking) at a light-moderate intensity have been shown 
to delay ad libitum smoking by up to 50 minutes, even when the 
individual is presented with a challenging mental task or a lit cigarette 
(Taylor & Katomeri, 2006; Taylor & Katomeri, 2007; Taylor et al., 2005). 
The magnitude of the reduction in cravings is encouraging and 
comparable with an acute response to oral NRT (Taylor, Ussher, & 
Faulkner, 2007). Given the literature, it is plausible that the magnitude of 
craving and withdrawal relief an abstinent smoker experiences through 
a bout of exercise might influence their quit success. 
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Although results from the acute exercise and smoking paradigm are 
promising, this body of research has two inherent flaws. First, the 
majority of studies include temporarily abstinent smokers rather than 
quitters per se. Therefore, the severity of symptoms experienced may 
not correspond entirely with those felt when an individual is fully 
invested in their quit attempt. It also provides little insight into the utility 
of exercise to help people quit more long-term and no insight into the 
utility of exercise to help decrease withdrawal symptoms while on 
pharmacotherapy (i.e., nicotine replacement therapy). Second, acute 
studies take place within a laboratory setting. Such an artificial 
environment bears little resemblance to an actual scenario a smoker 
attempting to quit may experience. In short, these two flaws raise 
questions about the ecological validity of these studies and their 
findings. 
 
Only one study appears to have combined an examination of the 
acute and long-term effects of exercise on craving, withdrawal, and 
smoking status amongst the same group of participants (Bock, Marcus, 
King, Borrelli, & Roberts, 1999). Sixty two women (44 exercise, 18 contact 
control) participated in 12 weeks of one hour weekly smoking cessation 
cognitive behavioural therapy plus either: (1) three times per week, 30-
40 minutes of vigorous intensity exercise, or (2) three times per week 30-
40 minutes of wellness information. Cigarette craving and nicotine 
withdrawal measures were administered immediately before and after 
the last exercise session of each week of the programme. When 
compared to the contact control, the exercise group reported 
significantly less craving and withdrawal symptoms immediately 
following exercise most weeks of the programme. These researchers 
showed that exercise can be used throughout a quit attempt to 
decrease feelings of nicotine withdrawal and cigarette cravings. 
Additionally, exercise was found to be beneficial for weeks into a quit 
attempt and reduced negative symptoms related to abstinence 
41 
 
 
 
unrelated to the presence of a smoking trigger. The effects of an 
exercise aided pharmacological based smoking cessation programme 
(i.e., NRT) on nicotine withdrawal and cravings is unknown. There is 
some evidence, however, that exercise combined with NRT facilitates 
smoking cessation (Prapavessis, Cameron, Baldi, Robinson, Borrie, 
Harper, & Grove, 2007). It should be noted that not all combined NRT 
and exercise protocols yield promising results. Those that find no benefit 
from exercise may be partially explained by poor adherence to the 
exercise protocol (Kinnunen, Leeman, Korhonen, Quiles, Terwal, 
Garvey, & Hartley, 2008; Ussher, Taylor, & Faulkner, 2008).  
 
The present study followed smokers during a 14 week nicotine 
replacement therapy patch plus exercise aided smoking cessation 
programme which allowed for: (1) the first examination of exercise as 
an adjunct to NRT to reduce withdrawal symptoms and cigarette 
craving; (2) more accurate estimates of the craving and withdrawal 
relief experienced following exercise during a real quit attempt; (3) 
determination of how structured and progressive acute exercise relates 
to quit success; and (4) exploration of exercise mechanisms of action 
that might contribute to quit success in a combined NRT and exercise 
aided smoking cessation programme (e.g., magnitude of withdrawal 
and craving relief experienced following a bout of exercise). 
 
It was hypothesised that an acute bout of exercise would reduce 
nicotine craving and withdrawal in a group of women attempting to 
quit and using NRT. It was believed that the greatest withdrawal and 
craving relief would occur in the first week following the quit date and 
at the NRT (NicoDerm® patch) nicotine drop-down time points (i.e., 
21mg to 14mg, 14mg to 7mg).  It was further hypothesised that women 
who experience a greater magnitude of relief from craving and 
withdrawal following a 20 minute bout of moderate intensity exercise 
42 
 
 
 
would be more successful at abstaining from cigarettes at the end of 
the 14 week NRT plus structured exercise programme.  
 
2.2 Method 
 
2.2.1 Participants 
Participants included 119 females undertaking the first and second 
round of the Getting Physical on Cigarettes trial. Inclusion criteria 
included: (1) aged between 18 and 70 years; (2) smoked in excess of 
10 cigarettes per day for the past two years; and (3) wished to achieve 
smoking abstinence. Exclusion criteria included: (1) contraindication to 
regular exercise (e.g., disability, unstable angina); (2) contraindication 
to using NRT; and (3) pregnancy. Participants provided written consent 
and were also required to obtain written consent from a physician, 
verifying that they were fit to exercise and use NRT before beginning 
the programme.  
 
It is important to emphasise that all participants taking part in the 
research contained within this dissertation were female. A purely 
female population was chosen because, in terms of quitting, women 
are reported as being less successful than men (Jung, Fitzgeorge, 
Prapavessis, Faulkner, & Maddison, 2010). In addition, women often 
report post-cessation weight gain concern, which has been shown to 
be associated with relapse (USDHHS, 2001). Given this, exercise may be 
a particularly pertinent adjunct smoking aid for women (USDHHS, 2001). 
Perhaps the most important reason of all is that some women, 
especially those who prior to the trial were sedentary, would not have 
taken part in this research if it involved exercising in front of men. 
Therefore, to improve adherence to the programme it was determined 
that an all female environment would be best. However, this means 
that the findings contained within this body of work are not able to be 
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generalised to men. In addition, determining gender differences is 
beyond the scope of this dissertation  
 
2.2.2 Ethical approval 
The conduct of the trial followed the principles outlined in the 
Declaration of Helsinki (World Medical Association, 2008) and the World 
Health Organization, 2002 Good Clinical Research Practice. The 
conduct and reporting of the trial followed CONSORT principles 
(www.consort-statement.org). Ethical approval was obtained from the 
University of Western Ontario Health Sciences Research Ethics Board 
(#16306) and participation was entirely voluntary.  
 
2.2.3 Design 
 
2.2.3.1 Getting Physical on Cigarettes 
The Getting Physical on Cigarettes (GPOC) trial was a Canadian 
Cancer Society Research Institute funded trial (#019876) examining 
smoking relapse prevention following a smoking cessation intervention. 
The 14 weeks of the trial consisted of an exercise and NRT smoking 
cessation intervention. On the fourth week participants quit smoking 
and began the NicoDerm® 10 week transdermal patch programme. 
Participants took part in three supervised exercise sessions per week 
(between 20-30 minutes duration each session) for weeks one through 
eight of the programme; followed by two supervised sessions per week 
during weeks nine through 11, and one supervised session per week 
during weeks 12, 13, and 14. For more information on the trial rationale 
and method of Getting Physical on Cigarettes please see Jung, 
Fitzgeorge, Prapavessis, Faulkner, and Maddision (2010). The Getting 
Physical on Cigarettes trial registration can be found at clinicaltrials.gov 
identifier NCT01305447. The women who took part in the GPOC trial 
were the same as those who took part in the present study. 
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2.2.3.2 The Exercise and Health Psychology Laboratory 
The trial was delivered at the Exercise and Health Psychology 
Laboratory (EHPL; www.ehpl.uwo.ca) at The University of Western 
Ontario in London, Ontario.  The laboratory houses aerobic exercise 
machines (treadmills, stair climbers, stationary bicycles, and rowing 
machines) as well as a conference room for participants to complete 
questionnaires pre- and/or post-exercise. 
 
2.2.3.3 General procedure 
The present study consisted of three acute exercise sessions, which 
occurred on week five, week 11 and week 13. The first acute exercise 
session (week five) occurred shortly after the participants quit smoking 
and started NRT (week four). The second and third exercise bout 
coincided with the period of time soon after participants reduced the 
level of NRT patch strength from 21 mg to 14 mg (week 11) and 14 mg 
to 7 mg (week 13). A flow-chart of the research design is displayed in 
Figure 2.1 and a time line of the measurements and assessments in 
Table 2.1. 
 
Participants completed the Shiffman-Jarvik withdrawal scale (Shiffman 
& Jarvik, 1976) immediately prior to and following the three acute 
exercise sessions.  Change in smoking withdrawal symptoms due to an 
acute bout of exercise was determined by comparing Shiffman-Jarvik 
subscale scores pre- to post-exercise. To be eligible for this analysis, 
participants had to demonstrate that they were smoke-free (CO < six 
ppm), adhered to their NRT programme, and followed their acute 
exercise regime at the appropriate intensity (see Figure 2.1). 
  
45 
 
 
 
Table 2.1. Schedule of Assessments 
 Week 
 Base-
line 
4 5 11 13 14 
Quit smoking  X     
Acute Exercise Session       
Moderate/Vigorous Intensity   X X X  
Exercise Intensity Verification       
Peak VO2 Fitness Assessment X      
Heart-Rate Monitor   X X X  
Smoking Abstinence Verification       
Carbon Monoxide Assessment X  X X X X 
Measures       
Shiffman-Jarvik Withdrawal Scale (pre-exercise)   X X X  
Shiffman-Jarvik Withdrawal Scale (post-exercise)   X X X  
Fagerström Nicotine Dependence X      
Demographics Questionnaire X      
Actical Exercise Behaviour X     X 
Smoking Information X      
Note. Baseline refers to pre-trial and week 14 refers to post-trial. Week five acute 
exercise session occurred just after the quit smoking date (week four); week 11 and 
week 13 acute exercise sessions occurred just after a drop-down in nicotine patch 
strength. 
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Participants’ heart rate max was determined by the max heart rate 
achieved during an aerobic fitness test completed at baseline.  
Aerobic fitness was evaluated using a standardised, maximal, 
incremental exercise protocol (Bruce Test) on a Woodway PPS 
treadmill.  
 
As a part of the GPOC trial participants were asked to adhere to an 
individualised set exercise regimen for the 14 weeks of the trial. Exercise 
sessions on week one through week three participants’ exercised at a 
mild intensity, defined as 40-50% of their heart-rate reserve (HRR) (e.g., 
40% of HRR was defined as, heart-rate max [HRMax] – resting heart-rate 
[RHR] x .4) + RHR) (CSEP). For exercise sessions from week four (quit 
week) to week six participants were to exercise at a moderate intensity, 
defined as 50-60% of their HRR (CSEP). For weeks seven to nine they 
were required to exercise at between 60-70% of their HRR. From week 
10 until the end of the programme participants were asked to engage 
in vigorous intensity exercise, defined as 70%+ of their HRR (CSEP). 
Inspection of the Polar heart-rate data revealed that all participants 
met the week one – three exercise prescription. For the following weeks 
(week four – 14) participants engaged in at least moderate intensity 
exercise, or 50-60% of their HRR (CSEP). That is, not all participants 
engaged in vigorous intensity exercise although it was asked of them. 
 
2.2.4.1 Acute exercise session: week five protocol 
The first acute exercise session, which occurred on week five, consisted 
of 20 minutes of moderate intensity exercise. Moderate intensity 
exercise was defined as the participant’s heart-rate being between 
50% and 60% of heart-rate reserve (HRR). For example, 60% of the 
participants’ HRR was defined as, (heart-rate max [HRMax] – resting 
heart-rate [RHR] x .6) + RHR (CSEP). 
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2.2.4.2 Acute exercise session: week 11 protocol 
The second acute exercise session, which occurred on week 11, 
consisted of 20 minutes of vigorous intensity exercise. Vigorous intensity 
exercise was defined as the participant’s heart-rate being at least 70% 
of her HRR ([HRMax – RHR x .75] + RHR) (CSEP). 
 
2.2.4.3 Acute exercise session: week 13 protocol 
The third acute exercise session, which occurred on week 13, consisted 
of 20 minutes of vigorous intensity exercise (CSEP).  
 
2.2.5 Nicotine replacement therapy regimen 
All participants were provided with NRT in the form of NicoDerm® 
transdermal patches. Participants were asked to wear the nicotine 
patches for 24 hours a day, seven days a week, for 10 weeks as per the 
manufacturer’s recommendations. 
 
2.2.5.1 NicoDerm® three step programme 
The NicoDerm® 10 week, three step programme, designed for smokers 
who smoke 10 (or more) cigarettes per day, was followed. Accordingly, 
a step one (21 mg) patch was to be applied daily for six weeks, 
followed by a step two (14 mg) patch applied daily for two weeks, and 
finally a step three (7 mg) patch applied daily for two weeks.  
 
At the beginning of week four participants were given seven, step one 
(21 mg) patches. Participants were to quit smoking and start the 
patches within two to three days; hence, by week five participants had 
been on NRT for three to five days. Patches containing 21 mg of 
nicotine were distributed for six weeks. On week 10, participants were 
given seven, step two (14 mg) patches; hence, by week 11 participants 
had ‘stepped down’ to the lower dose of NRT. Patches containing 14 
mg of nicotine were distributed for two weeks. Finally, on week 12, 
participants were given seven, step 3 (7 mg) patches; hence, by the 
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week 13 exercise session, participants had ‘stepped down’ again to a 
lower dose of NRT. Patches containing the lowest dose of nicotine, 7 
mg, were distributed for two weeks. Participants were not given 
patches at the exercise session on week 14. Post-intervention, week 14, 
assessments were scheduled at the end of the week to ensure 
participants were no longer on NRT (absorbing nicotine).  
 
2.2.5.2 NicoDerm® two step programme 
Although all participants were smoking at least 10 cigarettes per day at 
baseline, a few decreased their smoking prior to the week four quit 
date. The participants who were smoking less than 10 cigarettes per 
day at the week four quit date completed the NicoDerm® two step, 10 
week, NRT patch programme (n = 14). The two step programme 
consisted of step two (14 mg) and step three (7 mg) patches and is 
designed specifically for smokers who smoke less than 10 cigarettes per 
day. A step two (14 mg) patch was to be applied once daily for six 
weeks, followed by a step three (7 mg) patch applied once daily for 
four weeks. 
 
Participants on the two patch 10 week protocol ‘stepped down’ from 
14 mg NRT to 7 mg NRT on week 11. These participants, like the three 
step programme participants, finished the 10 week system on week 14.  
 
2.2.6 Demographic measures 
Participant demographic information was gathered via self-report, 
including age, employment, language spoken at home, number of 
children and household income. These variables are described in Table 
2.2. See Appendix 1 for a copy of this questionnaire. 
 
2.2.6.1 Programme adherence 
Programme adherence was determined by attendance to the exercise 
sessions. One session had to be cancelled due to a national holiday. 
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Participants’ attendance was compared to a total number of 32 
exercise sessions ([eight weeks x three sessions] + [three weeks x two 
sessions] + [three weeks x one session] – one session). 
 
2.2.6.2 Nicotine dependence and other smoking characteristics 
The Fagerström Test for Nicotine Dependence (FTND) (Heatherton, 
Kozlowski, Frecker, & Fagerstrom, 1991) was administered at baseline 
(Figure 2.1) to measure perceived cigarette dependence. The FTND is 
scored out of 10 points (total) and is interpreted as follows: a score of 
zero to two is indicative of very low addiction; a score of three to four, 
low addiction; a score of five is related to medium addiction; a score of 
six to seven, high addiction; and a score of eight to10 is related to very 
high addiction. The FTND has shown high internal consistency and 
adequate retest reliability (Pomerleau, Carton, Lutzke, & Flessland, 
1994). This variable is described in Table 2.2. See Appendix 3 for a copy 
of this questionnaire. 
 
In addition to the FTND, participants were asked to indicate the number 
of previous quit attempts they have undergone, length of the longest 
quit attempt, the number of years they have smoked, the number of 
cigarettes they smoked per day, and the percentage of family and 
friends who smoke. These questions were asked of participants during 
baseline assessments prior to the first exercise session. These variables 
are described in Table 2.2. See Appendix 2 for a copy of this 
questionnaire. 
 
2.2.7 Physical activity behaviour  
 
2.2.7.1 Actical® accelerometer 
Moderate and vigorous (MV) intensity structured exercise minutes 
(bouts of 10 minutes plus) were measured objectively pre- and post-
intervention using the Actical® Accelerometer (Minimitter, Oregon). The 
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Actical® Accelerometer is sensitive to low frequency movements in the 
range of 0.5-3.2 Hz, which is the common range for human movement 
and has been shown to be a valid and reliable measure of physical 
activity (Heil, 2006). Participants were instructed to wear the device on 
the right hip for seven consecutive days during waking hours for the 
week prior to the first exercise session (baseline). For complete data, 
participants were required to provide a minimum of 10 hours per day 
for at least five days (including one weekend day) (Trost, McIver, & 
Pate, 2005). The raw data were analysed using custom software 
KineSoft version 2.0.95 (KineSoft, New Brunswick, Canada). These 
variables are described in Table 2.2. 
  
2.2.7.2 Peak VO2 fitness assessment 
Aerobic fitness was evaluated using a standardised, maximal, 
incremental exercise protocol (Bruce Test) on a Woodway PPS 
treadmill. A Cosmed Quark b2 indirect calorimetry metabolic system 
(Cosmed S.r.I, Rome, Italy) was used to assess gas exchange variables. 
Peak VO2 was expressed in (ml/kg/min) units. These data were used to 
determine entry level fitness as well as fitness level changes from pre- to 
post-intervention (Sjostrand, 1947). These variables are described in 
Table 2.2. 
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Table 2.2. Demographic characteristics, exercise and smoking behaviour. 
Variable 
 
Mean (SD), % 
Demographics: 
Age 
Language spoken at home (English) 
Married  
Yearly household income: 
     Below $50,000 
     Between $50,000 and $75,000 
     Above $75,000 
Number of children 
Occupation: 
     Employed  
     Student  
     Unemployed  
 
40.64 (13.17) 
95 % 
25.9 % 
 
71.7 % 
12.3 % 
16.0 % 
1.22 (1.29) 
 
71.1 % 
9.6 % 
19.3 % 
Objective weekly physical activity (Actical): 
     Pre-intervention (exercise minutes at MV) 
     Post-intervention (exercise minutes at MV) 
 
20.89 (41.75) 
30.21 (55.00) 
Peak VO2 (ml/kg/min) 
     Pre-intervention 
     Post-intervention 
 
28.56 (7.01) 
30.42 (7.57) 
Carbon monoxide (CO) reading: 
Pre-intervention 
Post-intervention (14 weeks) 
 
17.33 (9.02) 
6.48 (10.71) 
Smoking behaviour at baseline: 
Cigarettes per day 
Number of years smoking 
Fagerström test of nicotine dependence 
Percentage of family and friends that smoke: 
     Between 0 and 10%  
     Between 10 and 20% 
     Above 20% 
Number of previous quit attempts 
 
16.76 (6.13) 
22.06 (12.16) 
5.65 (1.95) 
 
72 % 
12 % 
16 % 
3.91 (2.86) 
 
2.2.8 Primary outcome measures 
 
2.2.8.1 Smoking withdrawal  
The Shiffman-Jarvik withdrawal scale is a 15 item questionnaire that 
assesses withdrawal symptoms in abstaining smokers. The items were 
presented as seven-point scales, where one indicates ‘definitely not’ 
and seven indicates ‘definitely’. The items were divided into five 
subscales based on factor analysis: craving (five items), psychological 
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symptoms (five items), physical symptoms (three items), sedation (one 
item) and appetite (one item). Shiffman-Jarvik subscale scores do not 
tend to drift over repeated assessments and use factor analysis to 
group items according to their inter-correlations, which generally results 
in reliable scales (Shiffman, West, & Gilbert, 2004). Reliability analyses 
(Cronbach’s alpha scores) were computed at week five, week 11 and 
week 13 for the constructs of craving, psychological symptoms and 
physical symptoms. All alpha values reflected an acceptable level of 
reliability and are presented in Appendix 16 (Kline, 1993). 
 
The scale was administered immediately before and after the acute 
exercise sessions during week five, week 11 and week 13. Only data 
pertaining to those participants who reached the exercise intensity 
goals, followed the NRT protocol and abstained from smoking prior to 
the acute exercise sessions were included in the analyses. Data were 
expressed as an average value for each subscale (out of seven) for 
pre- and post-exercise as well as a percentage change (pre- to post-
exercise) reduction score.  
 
2.2.1 Secondary outcome measure 
 
2.2.1.1 Smoking abstinence 
Smoking abstinence was verified post-intervention by self-report, and a 
breath carbon monoxide (CO) reading of less than six parts per million 
(ppm). Participants who failed to attend the post-intervention 
assessment appointment, scored greater than six ppm breath carbon 
monoxide, and/or reported smoking behaviour were considered a 
smoker at week 14 (post-intervention). 
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2.2.2 Adherence challenges and considerations 
 
2.2.2.1 Smoking abstinence 
Smoking abstinence was verified before the three acute exercise 
sessions by self-report and a breath CO Smokerlyzer (the Micro 
Smokerlyzer®; Bedfont Scientific) reading of less than six ppm 
(Middleton & Morice, 2000). The measurement of breath CO level 
provided an immediate, non-invasive, method of assessing smoking 
status. Carbon monoxide monitors are sufficient to detect recent 
smoking; CO has a half-life of about five to six hours (Middleton & 
Morice, 2000). Withdrawal symptoms pre- and post-exercise from 
participants who scored greater than six ppm breath carbon monoxide 
and/or reported smoking within the last 10 hours were not included in 
the analyses.  
 
Although, CO measurement is acceptable it would have been prudent 
to also report salivary cotinine levels. Cotinine is a bi-product of nicotine 
and provides a more accurate representation of a smokers’ behaviour 
than CO. All participants who took part in the research contained in 
this dissertation provided salivary cotinine samples at baseline and 
week 14. Unfortunately, within the research time frame cotinine 
analyses were not received, and it is an acknowledged limitation of this 
dissertation as a whole. 
  
2.2.2.2 Acute exercise heart-rate prescription  
Although participants were cautiously introduced to exercise, the 
moderate and vigorous intensity did lead to discomfort for some of the 
women. Some women were not fond of sweating, working hard, or 
experiencing physical stiffness. To assist in alleviating stiffness and 
physical discomfort, research staff taught participants to properly 
warm-up prior to exercise, to cool down following an exercise session 
and to stretch. In addition, to promote appropriate exercise intensity, 
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research staff provided participants with a weekly exercise intensity 
goal at the beginning of each exercise session and remained visible 
throughout the exercise session.   
 
As previously mentioned, exercise intensity was monitored and 
recorded using polar heart-rate monitors. For the vigorous acute 
exercise sessions, a few participants did not reach the exercise intensity 
goal (week 11 - n =  8; week 13 - n = 4 ) but engaged in at least 
moderate intensity exercise, or 50-60% of their HRR (CSEP). These data 
were included in the analyses. Therefore, not all participants engaged 
in vigorous intensity exercise although it was asked of them. 
 
2.2.2.3 Nicotine replacement therapy  
Prior to week four, participants were aware of the NicoDerm® 10 week 
NRT protocol and which programme they were going to undertake 
(two step programme or three step programme). Before starting the 
patch, participants were told to read the booklet provided in the 
NicoDerm® box and call the NicoDerm® 1-800 number with questions 
and concerns.  
 
To facilitate compliance with the NRT protocol, the appropriate 
patches were distributed to each participant in weekly batches. 
Compliance with the NicoDerm® protocol was monitored via the 
completion of daily logs by participants. Recorded on the log was the 
time of day a new patch was administered, when patches were 
removed, any deviation from the 10 week NRT programme and any 
problems or concerns. At the beginning of each week, log sheets from 
the prior week were submitted to research staff and discussed with the 
participant. 
 
Failure to follow the NicoDerm® 10 week patch programme generally 
stemmed from one of three themes: (1) the misconception that the 
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patch eliminated all cigarette withdrawal symptoms or withdrawal 
symptoms being misinterpreted as incorrect nicotine patch strength; (2) 
the sense of eagerness to be finished using nicotine; or (3) sleep 
disturbance or vivid dreams. Reluctance to follow protocol was 
countered with the fact that smoking cessation is more likely when 
pharmacotherapy is used as a part of the quit attempt (TTS, 2010) and 
with the fact that smoking cessation using the NRT patch is highest 
when proper NRT protocol is followed (TTS, 2010). Of the participants 
who reported sleep disturbances, many persevered with 24 hour patch 
use until the disturbances decreased or until the end of the 10 week 
programme. However, 36 of the 119 participants opted to take the 
patch off while sleeping. These participants were warned that nicotine 
levels will be decreased in the morning and withdrawal symptoms and 
cravings may be higher. Data from these individuals were included in 
the analyses if the participants met the smoking abstinence and 
exercise intensity requirements. 
 
One participant (n = 1) a very heavy smoker, reported using self-
purchased patches in addition to the NRT provided by researchers.  This 
participant followed the NicoDerm® three step programme twice, 
concurrently (i.e., two patches per day). Data from this individual were 
included in the analyses if the participant met the appropriate smoking 
abstinence and exercise intensity requirements. 
 
One participant (n = 1) reported an ‘allergy’ to the NicoDerm® brand 
NRT patches.  To satisfy this individual, researchers provided her with the 
Life® brand NRT patches (i.e., 21mg, 14mg and 7mg). This individual 
followed the NicoDerm® protocol using Life® brand NRT patches. Data 
from this individual were included in the analyses if the participant met 
the appropriate smoking abstinence and exercise intensity 
requirements. 
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Participants who did not wear the patch daily and/or did not ‘step 
down’ at the proper time (week 11, week 13) were removed from 
subsequent analyses. Withdrawal and craving data for the participants 
who completed the two step 10 week NRT programme were analysed 
separately from the participants who completed the three step 
protocol for week five (n = 14) and week 11 (n = 9). No differences were 
revealed between the two protocols, hence the data were combined. 
Participants who did the two step patch protocol did not provide week 
13 withdrawal and craving data because they did not decrease patch 
nicotine at that time.  
 
2.2.2.4 Participant retention 
Although no costs were incurred by the participants for the use of the 
exercise equipment, NRT, or for campus parking, retention of 
participants for 14 weeks was a challenge. Despite contacting 
participants via telephone and email to keep them in the trial, 
participant drop-out still occurred. See the flow chart for a schedule of 
participant drop-out (Figure 2.1). Participants who dropped out prior to 
week 14 assessments and/or did not attend week 14 assessments were 
considered to be smoking post-intervention. 
 
Due to attrition, absenteeism and/or smoking lapses from week to 
week, the number of participants fluctuated over the three acute 
exercise sessions (week five, n = 69; week 11, n = 37; week 13, n = 26) 
(Figure 2.1). A total of 20 participants engaged in all three acute 
exercise sessions. 
 
2.2.3 Power calculation 
25 participants are required at week five, week 11, and week 13 
exercise sessions to provide power of 80% (p < 0.05) to detect a 0.8 (SD 
– 1.2) difference between pre- and post-exercise cigarette craving 
(SamplePower 3-IBM SPSS). No power calculation was computed for 
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the exploratory research question – is there a difference between week 
14 non-smokers and week 14 smokers on the magnitude of change of 
withdrawal symptoms pre- to post-exercise.  
 
2.2.4 Statistical Analyses  
Separate repeated ANOVAs were used to analyse differences in the 
withdrawal scales of the Shiffman-Jarvik questionnaire pre- to post-
exercise for each acute exercise session (week five, week 11, week 13). 
Bonferroni correction set the alpha at .003. Planned comparison t-tests 
at week five were used to compare the magnitude of relief found on 
the scales of the Shiffman-Jarvik questionnaire between week 14 
smokers and non-smokers.  In addition, t-tests were used to analyse 
differences in pre-exercise withdrawal symptoms for week 14 smokers 
and non-smokers. Because pre-exercise craving scores differed for 
week 14 smokers and non-smokers, an ANCOVA was used to compare 
the craving magnitude between the two groups (non-smokers vs. 
smokers at week 14). Assumptions for ANCOVA (i.e., homogeneity of 
regression) were met. A chi-square was used to determine the 
relationship between week 14 smoking abstinence and exercise 
programme adherence. 
 
2.3 Results 
 
2.3.1 Did exercise reduce withdrawal? 
Significant reductions in cigarette craving were demonstrated following 
exercise at all three time points (week five: F[1,68] = 28.281, p < .001, η2 
= .294; week 11: F[1,36] = 12.245, p < .001, η2 = .252; week 13: F[1,25] = 
4.522, p < .05, η2 = .153) 1 (Figure 2.2).  
  
                                             
1. No difference was found between withdrawal results at any of the time points dependent 
on mg dose of NRT. Therefore, all individuals wearing a patch and meeting inclusion criteria 
were included in each craving and withdrawal analysed time point. 
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Figure 2.2. Cigarette craving before and after an acute bout of exercise for women 
that met inclusion criteria at each time point (week five n = 69, heart-rate [HR] ≥ 50% 
of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n = 26, HR ≥ 70% 
of HRR).  
* p < 0.05 difference in cigarette craving before and after exercise.  
** p < 0.001 difference in cigarette craving before and after exercise. 
 
Significant increases in the physical symptoms related to nicotine 
withdrawal were demonstrated following exercise at all three time 
points (week 5: F[1,68] = 21.698, p < .001, η2 = .242; week 11: F[1,36] = 
21.719, p < .001, η2 = .376; week 13: F[1,25] = 5.849, p < .05, η2 = .190) 
(Figure 2.3) 
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Figure 2.3. Physical withdrawal symptoms before and after an acute bout of exercise 
for women that met inclusion criteria at each time point (week five n = 69, heart-rate 
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n = 
26, HR ≥ 70% of HRR). 
* p < 0.05 difference in nicotine withdrawal symptoms before and after exercise. 
** p < 0.001 difference in cigarette craving before and after exercise. 
 
A significant reduction in the nicotine withdrawal symptom of sedation 
was shown following exercise at week five (F[1,68] = 20.464, p < .001, η2 
= .231) and 11 (F[1,36] = 8.945, p < .001, η2 = .199) (4). No significant 
acute change in sedation was observed at week 13. It is however 
worth noting that week 13 acute reductions in sedation approached 
significance (F[1, 25] = 3.585, p = .070 , η2 = .125) (Figure 2.4). 
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Figure 2.4. Sedation withdrawal symptoms before and after an acute bout of exercise 
for women that met inclusion criteria at each time point (week five n = 69, heart-rate 
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n = 
26, HR ≥ 70% of HRR). 
* p < 0.001 difference in nicotine withdrawal symptoms before and after exercise. 
 
Significant reductions in psychological withdrawal symptoms were 
demonstrated following exercise at week five (F[1,68] = 28.354, p < .001, 
η2 = .294) and 11 (F[1,36] = 16.885, p < .001, η2 = .319) (Figure 2.5). No 
significant acute change in psychological withdrawal was observed at 
week 13. However, it should be noted that week 13 acute reductions in 
this withdrawal symptom approached significance (F[1, 25] = 3.252, p = 
.083 , η2 = .115) (Figure 2.5).  
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Figure 2.5. Psychological withdrawal symptoms before and after an acute bout of 
exercise for women that met inclusion criteria at each time point (week five n = 69, 
heart-rate [HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; 
week 13 n = 26, HR ≥ 70% of HRR). 
* p < 0.001 difference in nicotine withdrawal symptoms before and after exercise. 
 
No significant reduction in appetite was shown following exercise at 
week five (F[1,68] = .169, p < .682, η2 = .002), week 11 (F[1,36] = .030, p < 
.865, η2 = 0.865) or week 13 (F[1,25] = .658, p < .425, η2 = .026) (Figure 
2.6).  
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Figure 2.6. Appetite withdrawal symptoms before and after an acute bout of exercise 
for women that met inclusion criteria at each time point (week five n = 69, heart-rate 
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n = 
26, HR ≥ 70% of HRR). 
 
2.3.2 Did the magnitude of withdrawal relief experienced following 
exercise relate to end of programme abstinence? 
There was no difference in the magnitude of change in the withdrawal 
subscales experienced following an acute bout of exercise at week 
five between women classified as non-smokers at week 14 and smokers 
at week 14 (Figure 2.7).   
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Figure 2.7. The magnitude of change in withdrawal symptoms following an acute 
bout of exercise for women who that met inclusion criteria at week five. Smoking (n = 
22) vs. non-smoking (n = 47) status is as at week 14. A negative score denotes a 
reduction in symptoms; a positive score denotes an increase in symptoms. 
 
2.3.3 Smoking cessation outcomes  
Fifty eight percent (n = 69) of participants were able to quit smoking on 
the week four quit date (CO < six ppm). At the end of the programme 
(week 14) 51.3% of participants were considered smoke free (CO < six 
ppm). Smoking abstinence was related to attendance to the exercise 
programme (x2[2, n=119] = 52.27, p < .001) (Table 2.3).  
 
Participants smoking at week 14 (M=4.19, SD=1.45) experienced greater 
craving prior to exercise than those considered smoke-free at week 14 
(M=3.43, SD=1.48) (t = -2.007, p < .05).  
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Table 2.3. Breakdown of participants smoking status at week 14 in relation to 
attendance to the exercise portion of the programme (n = 119) 
 Exercise Programme Attendance  
 80-100% 60-80% <60% Total 
Non-smoking at week 14     
   Number of participants 45 12 4 61 
   Percent of total 37.8% 10.1% 3.4% 51.3% 
Smoking at week 14     
   Number of participants 7 17 34 58 
   Percent of total 5.9% 14.3% 28.6% 48.7% 
 
2.4 Discussion 
 
2.4.1 Craving and withdrawal 
The present study examined the potential of exercise to reduce 
withdrawal symptoms and cigarette cravings related to smoking 
abstinence. The results were obtained in a design that overcame 
numerous limitations of previous acute exercise and smoking cessation 
research (e.g., a more ecologically valid setting, used NRT, true quit 
attempt) and made several novel contributions to the literature.  
 
Results of the present study indicate that an acute bout of moderate to 
vigorous intensity aerobic exercise can reduce symptoms of nicotine 
withdrawal and cigarette craving early in the quit attempt of women 
trying to give up cigarettes. Three to five days into the quit attempt, 
exercise reduced craving and withdrawal for individuals on NRT. These 
first few days and weeks of the quit attempt often determine success or 
failure (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). These findings 
demonstrate that early in a quit attempt, exercise is a useful tool for the 
kit of a smoker attempting to quit; a tool that does not become 
redundant in the presence of NRT. In exercise, tobacco treatment 
specialists have an evidence based adjunct therapy to recommend for 
reducing craving and withdrawal symptoms during this critical time in 
their quit attempt.  
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The results suggest that there may be a timing effect for exercise. That 
is, it may have the greatest effect during the early stages of a quit 
attempt. However, seven and nine weeks into the quit attempt (week 
11 and 13 of the programme) the beneficial effects of exercise were still 
visible, although they were not always significant. These results 
correspond with those demonstrated by Bock et al. (1999). These 
researchers also found a reduction in craving and withdrawal following 
exercise for the majority of the weeks they measured it. The important 
distinction between their work and the present study is the absence of 
NRT. No doubt when used appropriately, over time NRT improves 
abstinent rates. Perhaps, NRT so effectively controlled withdrawal 
symptoms later in the quit attempt that exercise no longer made a 
significant contribution. Nevertheless, the effect size for overall 
withdrawal at week 13 (.128) was large enough to warrant 
recommending exercise at any point in the quit attempt. In addition, 
the decrease in craving demonstrated at all time points justifies 
promoting exercise as a strategy for dealing with cue-elicited cigarette 
cravings.   
 
Craving can be conceptually compartmentalised into two categories - 
cue-induced craving and background craving. Clinically, craving is 
one of the most common symptoms that smokers are concerned 
about and the average intensity level of craving an abstinent smoker 
experiences in the first few days or weeks of the quit attempt often 
predicts quit success (Shiffman et al., 1996). The identification of 
adjunct quit smoking therapies to address both types of craving is of 
clinical importance. 
 
Exercise has been shown to ameliorate cue-induced craving in 
temporarily abstinent smokers (Janse Van Rensburg, Taylor, Hodgson, & 
Benattayallah, 2009; Taylor & Katomeri, 2007). In a laboratory setting, 
exercise has the potential to reduce an individual’s cigarette craving 
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reactions to a smoking related cue and delay ad libitum smoking. Cue-
induced, or episodic cravings, are generally conceptualised as bouts 
of intense craving characterised by a surge in craving usually triggered 
by exposure to stimuli associated with smoking (Ferguson & Shiffman, 
2009). In this case, no such stimuli was presented and, when 
participants entered the facility, the craving they were experiencing 
was not greatly spiked, as evident by the before exercise craving 
scores at all time points. Therefore, it seems reasonable to suggest that 
background craving was being assessed and that early on in a quit 
attempt exercise has the ability to at least temporarily reduce 
background craving. This finding is novel for two reasons. First, up until 
now, research evidence suggested that exercise was useful for 
reducing episodic craving but provided limited protection against 
background craving. Second, it highlights the potential of exercise as a 
harm reduction strategy – extending the period of time between 
cigarettes and effectively reducing the number of cigarettes smoked in 
a day (deRuiter & Faulkner, 2006). 
 
A review of the acute exercise and smoking literature suggests that a 
single session of exercise has the ability to reduce craving, withdrawal 
and negative affect (Taylor et al., 2007). The DSM-IV lists eight 
symptoms related to nicotine withdrawal (depressed mood, insomnia, 
irritability, anxiety, difficulty concentrating, restlessness, decreased heart 
rate, increased appetite or weight gain) (American Psychiatric 
Association, 1994) and exercise has been shown to acutely reduce 
many of these (Taylor & Katomeri, 2007). However, it is important to 
note that exercise does not consistently alleviate these symptoms. For 
example, Ussher and colleagues (2001) found that 10 minutes of 
moderate intensity exercise reduced the symptom of poor 
concentration, whereas Janse Van Rensburg et al. (2008), using the 
same duration and intensity, did not (Janse Van Rensburg & Taylor, 
2008; Ussher, Nunziata, Cropley, & West, 2001). The results of the present 
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study also suggest that an acute bout of exercise may reduce some 
nicotine withdrawal symptoms to a greater extent than others. 
 
Within the present study the withdrawal symptoms were broken down 
into four categories: psychological symptoms, physical symptoms, 
appetite, and sedation. This made it possible to specify which 
withdrawal constructs exercise was able to ameliorate and at what 
stage in the quit attempt.  
 
Research supports the psychological mood enhancing benefits of 
acute exercise within the general adult population (Biddle, 2000). The 
same also seems to be true for female smokers undergoing a quit 
attempt (Bock et al., 1999). The present study demonstrated that an 
acute bout of both moderate and vigorous exercise is an effective way 
to reduce psychological withdrawal symptoms at the beginning and 
throughout a quit attempt. At week 13 of the programme the results 
were non-significant. This may be a result of the combination of 
variables that made up psychological withdrawal on the Shiffman-
Jarvik scale. For instance, the withdrawal symptoms of irritability and 
concentration both contributed to this variable. As previously 
mentioned exercise does not consistently reduce concentration 
difficulties associated with quitting; a lack of effect in this instance 
would have diminished any significant psychological withdrawal effect. 
An alternative explanation is that the sample size at week 13 was too 
small for a significant difference to be detected, considering the size of 
the effect (.115) this is definitely possible.  
 
Amongst the general population vigorous intensity exercise has been 
shown to suppress appetite (Blundell & King, 2000). It is very common for 
women to gain weight when they quit smoking (average five 
kilograms) (Parsons, Shraim, Inglis, Aveyard, & Hajek, 2009). For many 
women this weight gain is unacceptable and drives them back to 
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smoking (Schneider & Waters, 2007). Identifying adjunct therapies that 
can assist quitters trying to avoid weight gain is essential. To our 
knowledge only one other study has assessed the effect of exercise on 
the self-reported withdrawal symptom of appetite (Ussher et al., 2001). 
These researchers found exercise had no effect on appetite, perhaps 
because they used a less than vigorous intensity exercise protocol. 
However, the present study found similar results to that of Ussher et al. 
(2001) when quitters were exercising at both moderate and vigorous 
intensities. Exercise interventions for smoking cessation do not always 
report a reduction in post cessation weight gain at the end of the 
programme (Ussher et al., 2008). If exercise does not effectively reduce 
the increase in appetite experienced during quitting then potential 
weight reduction benefits may be thwarted by powerful food cravings. 
Further research is needed to determine whether exercise leads to a 
delay in snack foods high in fat and sugar content (Thayer, Peters III, 
Takahashi, & Birkhead-Flight, 1993). 
 
Following an acute bout of both moderate and vigorous intensity 
exercise participants experienced an increase in the physical 
symptoms associated with withdrawal. This finding is most likely a result 
of the question ‘is your heart beating faster than usual’. As you would 
expect following a bout of moderate to vigorous intensity exercise 
participants answered yes to this question. Perhaps of clinical 
importance is determining individual differences, which may influence 
recommending exercise as an adjunct therapy. For instance, 
individuals who suffer from anxiety or panic disorders, of which a rapid 
heartbeat is a distressing symptom, may benefit from reassurance that 
an increased heartbeat is a normal consequence of exercise 
(American Psychiatric Association, 1994). Furthermore, it has been 
suggested that because the decrease in heart-rate is most likely an 
offset effect (due to less nicotine in the body), there is no relevance for 
using heart-rate decrease to assess withdrawal (Shiffman et al., 2004). 
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Hence, the inclusion of heart-rate questioning in the Shiffman-Jarvik 
scale may be perceived as a limitation of this assessment. 
 
Within the smoking and exercise literature, Taylor and colleagues (2006) 
reported increases in energy following a one mile brisk walk amongst 
temporarily abstinent smokers; and Thayer et al. (1993) demonstrated 
that immediately following five minutes of brisk walking, smokers’ 
energy levels were increased (Taylor, Katomeri, & Ussher, 2006; Thayer 
et al., 1993). The present study demonstrated that following an acute 
bout of moderate or vigorous intensity exercise the physical withdrawal 
symptom of sedation was significantly reduced. Smokers who quit are 
often plagued by extreme fatigue (TTS, 2010). Present study findings 
combined with previous research indicate that exercise has great 
potential to alleviate this debilitating withdrawal symptom.  
 
The current study involved abstinent smokers engaging in both 
moderate and vigorous intensity exercise. Bock and colleagues (1999) 
demonstrated that vigorous exercise has the ability to produce acute 
improvements in withdrawal symptoms, cigarette craving, and 
negative affect among sedentary women attempting to quit smoking. 
In comparison, other studies have found vigorous intensity exercise 
increased withdrawal symptoms in young, adult, sedentary smokers 
whereas moderate intensity did not (Everson, Daley, & Ussher, 2008).  
 
It was demonstrated that early in a quit attempt involving NRT a bout of 
moderate intensity exercise was enough to reduce craving and 
withdrawal symptoms. Later on in the quit process, once smokers 
garnered some exercise experience, vigorous intensity exercise 
continued to reduce craving and some withdrawal symptoms. 
Unfortunately, as the two intensities of exercise occurred at such 
different times in the quit attempt it was not possible to directly 
compare intensity effects. It is however possible to infer that an exercise 
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programme that moves individuals from moderate through to vigorous 
intensity exercise is feasible. If recently quit smokers can leave a 
structured exercise programme working out at a vigorous intensity then 
they have a health advantage over those who leave at a moderate 
intensity (CSEP). Future research should compare the effects of 
moderate versus vigorous intensity exercise at different points during 
the quit attempt. 
 
2.4.2 Magnitude of acute exercise relief as a factor of quit success 
The acute exercise paradigm more often than not involves a smoker 
undergoing a period of temporary abstinence before engaging in 
exercise. It is assumed from these experimental studies that measures of 
cigarette craving and nicotine withdrawal symptoms provide a 
prediction of how well exercise works to keep people off cigarettes 
(Taylor & Katomeri, 2007). However, a disconnect exists within the 
literature; whereas temporarily abstinent smokers in an acute setting 
show a reduction in craving and withdrawal symptoms long-term 
exercise interventions do not reliably boost smoking abstinence rates 
(Fiore et al., 2008; Taylor et al., 2007; Ussher et al., 2008).  
 
This study attempted to bridge the gap between these two bodies of 
research and investigate a possible mechanism responsible for the 
beneficial effects of exercise. The magnitude of craving and 
withdrawal relief experienced did not differ between successful and 
unsuccessful quitters (in an NRT and exercise programme). This finding 
highlights the complexity of quit success and suggests that numerous 
factors are involved in determining an individual’s quit status.  
 
Craving ratings are a reliable indicator of relapse (Shiffman et al., 1996). 
Indeed, the present study showed that those who would eventually 
relapse by the end of the programme started out with higher cigarette 
cravings following initial smoking abstinence. The findings suggest that 
72 
 
 
 
the benefits of exercise are not discriminatory. If the effort is made to 
exercise during abstinence, regardless of background craving levels, 
most individuals will experience some acute craving relief. This implies 
that health practitioners can confidently recommend exercise as a 
cessation aid to any woman attempting to quit and know that in all 
likelihood she will experience some acute craving relief. In addition, 
irrespective of smoking outcome, increases in physical activity should 
be seen as an important outcome in its own right (deRuiter & Faulkner, 
2006).   
 
2.4.3 Limitations 
As with any research, there are limitations to this study that are worth 
noting. The fact that the present study did not include an equal 
contact control group is a limitation. As such, it cannot be said for 
certain that any reduction in craving and withdrawal following exercise 
was specifically related to exercise and not to other environmental 
factors such as group interaction. However, the main aim was not to 
determine how well an acute bout of moderate-vigorous intensity 
exercise reduces craving and withdrawal, as this is reasonably well 
established, but to determine what factors might be related to exercise 
effectiveness; and whether exercise reduces craving and withdrawal 
when on NRT. Regardless, in the future it may be advantageous to 
have a standard treatment control condition (e.g., NRT plus cognitive 
behavioural therapy) (Bock et al., 1999).  
 
The findings from the present study are only generalisable to female 
smokers who managed to use NRT. A large number of individuals were 
excluded from the analyses because they were not considered smoke 
free at the time of the intervention. The women included in the week 
five analyses had a mean Fagerström nicotine dependence score of 
5.65, which is considered a medium level of dependence. It may be 
that this type of intervention in general is more suited to individuals who 
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are only moderately dependent on nicotine and who can tolerate 
both regular exercise and NRT use.  
 
Finally, there were many criteria that had to be met (e.g., CO < six 
ppm, on NRT, came for exercise) before an individual was included in 
the dataset. The strict inclusion criteria invariably led to a small sample 
size by week 13, which resulted in the analyses being underpowered.  
 
2.4.4 Future direction  
A number of important research questions remain unanswered. For 
example, the duration of craving and withdrawal relief experienced 
following the exercise bout was not assessed. Therefore, it remains 
unclear as to how long post exercise relief persists. Determining the 
duration of relief exercise provides would help provide insight into the 
clinical relevance of this type of adjunct as a harm reduction 
technique.   
 
The present study determined that it is not just the craving and 
withdrawal relief experienced from a bout of exercise per se that 
makes exercise a useful tool for quitters. Future research should 
continue to explore the mechanisms underpinning the beneficial 
effects of exercise. Determining how exercise works and for whom 
would allow clinicians to prescribe this cessation aid more effectively. 
 
2.4.5 Conclusions 
Promoting exercise among individuals using NRT is appropriate; and 
can reduce withdrawal and craving symptoms associated with 
smoking abstinence. The findings demonstrate that exercise can 
alleviate negative withdrawal symptoms and cigarette cravings at any 
point during the quit attempt but is of upmost importance early on in 
the quit. It is important for clinicians recommending exercise to consider 
the potential benefits (e.g., will help with craving) and limitations (e.g., 
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may not help with all psychological withdrawal symptoms) of exercise 
as a quit smoking aid. The magnitude of the relief felt does not translate 
to nicotine abstinence success in a 14 week exercise and NRT aided 
smoking cessation programme. Knowledge of these mechanisms is vital 
as it offers precise guidance and understanding for both the health 
professional and quitter. No matter what the mechanism, the 
immediate relief that female quitters experience following exercise are 
concrete and universal. 
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3 CHAPTER THREE: EXERCISE MAY HELP SMOKERS QUIT 
BECAUSE THEY EXPECT IT WILL AND BECAUSE THEY 
BELIEVE IT IS A CREDIBLE QUIT SMOKING AID 
 
 
3.1 Introduction 
There is much research to suggest that moderate intensity exercise has 
a positive acute effect on cigarette craving and withdrawal symptoms 
in temporarily abstinent smokers (Taylor, Ussher, & Faulkner, 2007). The 
magnitude of reduction in craving and withdrawal reported in these 
experimental studies shows an acute bout of exercise to be at least as 
effective as oral nicotine replacement therapy (NRT) (Taylor et al., 2007; 
West & Shiffman, 2001). However, while there is enough evidence to 
support clinicians recommending exercise as an adjunct therapy to 
reduce nicotine craving and withdrawal, there remains scope for 
improving its effectiveness.  
 
One way to improve the effectiveness of exercise interventions is to 
identify modifiable factors accountable for the influence of exercise on 
craving and withdrawal. Beliefs related to treatment credibility and 
expectancy have been proposed as two such factors in other 
treatable conditions, such as chronic lower back pain and generalised 
anxiety disorder (Newman & Fisher, 2010; Smeets, Beelen, Goossens, 
Schouten, Knottnerus, & Vlaeyen, 2008). These two variables have been 
shown to be distinct from one another. Credibility refers to how 
believable, convincing, and logical the treatment seems whereas 
expectancy refers to treatment outcomes the individual believes or 
hopes will take place (Kazdin, 1979).  Both definitions involve beliefs, 
which are thought to consist of cognitive and affective components 
(Devilly & Borkovec, 2000). It is proposed that credibility beliefs are 
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cognitive in nature whereas expectancy beliefs are affective, similar to 
those involved in hope (Devilly & Borkovec, 2000).  
  
Patient expectancy and credibility has been shown to influence 
treatment outcomes in a number of populations. For example, Smeet 
and colleagues (2008) showed that treatment credibility and 
expectancy had modest predictive power when it came to treatment 
outcomes for sufferers of chronic lower back pain (Smeets et al., 2008). 
Newman and Fisher (2010) found evidence for their hypothesis that 
positive changes in expectancy and credibility with regards to 
cognitive behavioural therapy led to positive symptom changes in 
those suffering from generalised anxiety disorder (Newman & Fisher, 
2010). In terms of exercise specifically, it has been proposed that 
expectancy of the benefits of exercise on mood may influence actual 
changes in mood following exercise (Salmon, 2001). As an example, 
Desharnais et al. (1993) conducted an experiment to determine if the 
exercise-psychological enhancement connection was based on 
expectancy. They found that following 10 weeks of supervised exercise 
the control group and experimental group (received information that 
exercise enhances psychological well-being) had the same fitness 
improvements. However, the experimental group showed a significant 
increase in self-esteem over time whereas the control group did not 
(Desharnais, Jobin, Cote, Levesque, & Godin, 1993). Research on 
whether credibility beliefs are involved in the actual mood enhancing 
benefits of exercise does not seem to have been conducted.  
 
Given the research on the psychological constructs of expectancy and 
credibility it seems reasonable that these beliefs may be associated 
with the effects of exercise on craving and withdrawal outcomes in an 
exercise aided quit smoking programme. Daniel and colleagues (2007) 
have published the only known study to investigate exercise 
expectations and specific craving and withdrawal outcomes. These 
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researchers examined whether expectations of the effects of exercise 
would relate to reductions in cigarette craving and withdrawal in 
temporarily abstinent smokers following a 10 minute bout of moderate 
intensity exercise (Daniel, Cropley, & Fife-Schaw, 2007). Forty five 
sedentary smokers were randomised into one of three groups where 
they read either a positive, negative or neutral statement concerning 
the effects of exercise on the withdrawal symptoms associated with 
smoking abstinence; the manipulation of participants’ exercise 
expectations was deemed successful. Immediately prior to reading the 
expectancy text and completing a credibility questionnaire, 
temporarily abstinent smokers engaged in 10 minutes of moderate 
intensity exercise. Regardless of group, all participants showed a 
significant reduction in cigarette craving and withdrawal symptoms 
(e.g., irritability, depression, tension, restlessness, stress, difficulty 
concentrating) following the bout of exercise. This led these researchers 
to conclude that “expectations of the effects of exercise on withdrawal 
and desire to smoke does not influence actual reductions in withdrawal 
symptoms and desire to smoke” (p. 129). However, the conclusion 
reached by Daniel et al. (2007) requires further investigation before it 
can be accepted confidently.  
 
The results of Daniel et al. (2007) were based on the manipulation of 
expectancy but measured on a credibility scale. Though the terms 
expectancy and credibility are sometimes used interchangeably there 
is evidence to suggest that these two constructs are distinct (Devilly & 
Borkovec, 2000). As such, distinguishing between these two constructs is 
important (Devilly & Borkovec, 2000). In addition, the results were 
garnered from a group of temporarily abstinent smokers rather than a 
group of quitters. Therefore, the severity of symptoms experienced may 
not correspond entirely with those felt when an individual is fully 
invested in their quit attempt. As such, it is not possible to generalise 
these findings to smokers undergoing a real quit attempt. Finally, Daniel 
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et al. (2007) manipulated exercise expectancy beliefs through text and 
categorised smokers as either: high, ambiguous or low in expectancy. 
External validity might be improved by measuring actual exercise 
expectancy of smokers and categorising them accordingly (Newman 
& Fisher, 2010). All things considered, the results obtained by Daniel et 
al. (2007) do not definitively rule out expectancy effects as a possible 
mechanism for the reductions in craving and withdrawal demonstrated 
following an acute bout of exercise.      
 
The primary objective of the present study was to examine whether 
treatment expectancy and credibility were associated with outcome in 
terms of self-reported craving and withdrawal in a group of women 
undergoing a real quit attempt. The women involved were supplied 
with NRT patches as well as an exercise regimen. Thus providing the 
opportunity for the secondary objective, to compare expectancy and 
credibility beliefs regarding a well established quit smoking aid such as 
NRT with a novel quit smoking aid such as exercise. Furthermore, rather 
than only assess treatment expectancy and credibility before the start 
of the treatment, when participants may have difficulty judging their 
actual beliefs regarding treatment outcomes; the present study 
allowed for the measurement of participants’ credibility and 
expectancy beliefs of two treatments (exercise and NRT) immediately 
after quitting and at the end of the 14 week programme (Smeets et al., 
2008). 
 
It was hypothesised that exercise expectancy and credibility beliefs 
would contribute to a reduction in craving and withdrawal symptoms 
following an acute bout of exercise. It was also hypothesised that as 
participants progressed through the NRT plus exercise aided quit 
smoking programme their exercise expectancy and credibility beliefs 
would increase.  
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3.2 Methods 
 
3.2.1 Participants 
Participants included 58 females undertaking the third round of the 
Getting Physical on Cigarettes (GPOC) trial (Jung, Fitzgeorge, 
Prapavessis, Faulkner, & Maddison, 2010). The inclusion and exclusion 
criteria were the same as that outlined in section 2.2.1. 
 
3.2.2 Ethical approval 
See section 2.2.2 for details. 
 
3.2.3 Design 
 
3.2.3.1 Getting Physical on Cigarettes 
See section 2.2.3.1 for details. The 58 women who took part in the 
present study all took part in the GPOC trial. 
 
3.2.3.2 The Exercise and Health Psychology Laboratory 
See section 2.2.3.2 for details. 
 
3.2.3.3 General procedure 
The present study examined whether participants’ expectancy and 
credibility beliefs regarding exercise as a smoking cessation treatment 
were associated with change, from pre- to post-exercise, in self-
reported cigarette craving and withdrawal symptoms (psychological 
and sedation) at week five. This study also compared participants’ 
expectancy and credibility beliefs regarding NRT and exercise over a 
14 week exercise aided smoking cessation programme. 
 
Participants engaged in a 14 week exercise programme, GPOC (Jung 
et al., 2010), at the Exercise and Health Psychology Laboratory at the 
University of Western Ontario. On the fourth week of the exercise 
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programme participants began a smoking cessation attempt, and a 10 
week NicoDerm® NRT transdermal patch programme. Pre-intervention 
assessments were completed before week one, at baseline; post-
intervention assessments were completed on a date after the 
participants’ last exercise session, when they had finished the NRT 
programme, on week 14. A flow-chart of the research design is 
displayed in Figure 3.1 and a timeline of the measurements and 
assessments in Table 3.1. 
 
The acute bout of exercise under investigation occurred on the first 
exercise session on week five, shortly after the participants quit smoking 
and started NRT (week four). Participants completed the Shiffman-
Jarvik Withdrawal Scale (Shiffman & Jarvik, 1976) immediately prior to 
and following the 20 minute moderate intensity exercise session.  
Change in nicotine craving and withdrawal symptoms due to an acute 
bout of exercise was determined by comparing Shiffman-Jarvik 
subscale scores pre- to post-exercise. To be eligible for this analysis, 
participants had to demonstrate a carbon monoxide score of < six 
ppm, adhere to their NRT programme, and follow their acute exercise 
regime at the appropriate intensity. 
 
Questionnaires pertaining to participants’ perceived expectancy and 
credibility of the two smoking cessation aids (exercise and NRT) were 
completed immediately before the first exercise session on the 
appropriate week (Table 3.1). To be eligible for analyses, the 
participants had to adhere to the NRT programme, and follow the 
exercise regime.  
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Table 3.1. Schedule of Assessments 
 Week 
 Base- 
line 
4 5 14 
Quit Smoking  X   
     
Demographics Questionnaire X    
Smoking Ladder X    
Exercise Readiness  X    
     
Treatment  Expectancy and Credibility Scale X  X X 
     
Acute Exercise Regimen   X  
Shiffman-Jarvik Withdrawal Scale (pre-exercise)   X  
Shiffman-Jarvik Withdrawal Scale (post-exercise)   X  
     
Smoking Variables     
Carbon Monoxide Assessment X X X X 
Fagerström Nicotine Dependence X    
Smoking Information X    
Previous Patch Use X    
     
Exercise Variables     
Actical Exercise Behaviour X    
Godin Lesiure Time Questionnaire X   X 
Peak VO2 Fitness Assessment X   X 
Note. Baseline refers to pre-trial and week 14 refers to post-trial.  Participants began 
their smoking cessation attempt and nicotine replacement therapy (NRT) on week 
four (quit week). 
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3.2.5.2 NicoDerm® two step programme 
See section 2.2.5.2 for details. Seven of the 58 participants were on the 
two step programme.   
 
3.2.6 Demographic measures 
See section 2.2.6 for details. These variables are described in Table 3.2. 
 
3.2.6.1 Nicotine dependence and other smoking characteristics 
See section 2.2.6.2 for details. These variables are described in Table 
3.2. 
 
3.2.6.2 Previous patch use 
Participants were asked whether they had used the nicotine 
replacement therapy patch in the past, the number of quit attempts it 
was used with and whether they found it enhanced their previous quit 
attempt. These variables are described in Table 3.2. 
 
3.2.6.3 Programme adherence 
See section 2.2.6.1 for details. 
 
3.2.6.4 Smoking ladder scale 
The smoking ladder scale was administered at baseline and used to 
determine whether or not a participant was ready to quit smoking 
(Biener & Abrams, 1991; Prochaska & DiClemente, 1983). This scale 
separated smokers into one of five categories of varying degrees of 
readiness to quit, and is based on the stages of change: pre-
contemplation (one and two on the ladder); contemplation (three and 
four on the ladder); preparation (five and six on the ladder); 
maintenance (seven and eight on the ladder); and action (nine and 10 
on the ladder). Ten statements were presented (two based on each 
stage) and participants were asked to tick only one statement – the 
statement that best described their current thoughts about quitting 
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smoking. These variables are described in Table 3.2. See Appendix 5 for 
a copy of this questionnaire. 
 
3.2.7 Physical activity behaviour  
 
3.2.7.1 Godin leisure time exercise questionnaire (LTEQ) 
Subjective accounts of exercise behaviour were obtained via the 
Godin LTEQ at baseline and week 14 assessments. The Godin LTEQ 
measured exercise specifically, covering the frequency of mild, 
moderate and strenuous exercise performed during free time for at 
least 15 minutes during the past seven days. A total score was derived 
by summing the reported weekly frequency (f) of participation at each 
of the three intensity levels multiplied by the corresponding estimated 
metabolic equivalents (METs) value (e.g., [f]3 [mild] + [f]5 [moderate] + 
[f]9 [strenuous]). A MET is a unit that represents the metabolic 
equivalent of an activity expressed in multiples of resting rate of oxygen 
consumption (CSEP). These variables are described in Table 3.2. See 
Appendix 6 for a copy of this questionnaire. 
 
3.2.7.2 Actical® accelerometer 
See section 2.2.7.1 for details. Only the pre-intervention results for this 
objective measure of exercise behaviour were collected and 
presented. This variable is described in Table 3.2. 
 
3.2.7.3 Peak VO2 fitness assessment 
See section 2.2.7.2 for details. These variables are described in Table 
3.2. 
 
3.2.7.4 Stage of exercise readiness questionnaire 
The stage of exercise readiness questionnaire was administered at 
baseline and used to determine whether or not a participant was 
physically active on a regular basis (Prochaska & DiClemente, 1983). 
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This questionnaire separated people into one of five categories of 
varying degrees of exercise behaviour: pre-contemplation – do not 
exercise on a regular basis and are not thinking about changing in the 
next six months, contemplation – do not currently exercise on a regular 
basis but are thinking about changing in the next six months, 
preparation – exercise sometimes but not on a regular basis, 
maintenance – exercise regularly and have been doing so for the last 
six months, or action – exercise regularly and have done so for longer 
than six months. Five statements were presented (one based on each 
stage) and participants were asked to tick only one statement – the 
statement that best describes their current physical activity behaviour. 
The SERQ has a demonstrated reliability of 0.78 when taken over a two 
week period (Marcus, Rakowski, & Rossi, 1992). This variable is described 
in Table 3.2. See Appendix 7 for a copy of this questionnaire. 
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Table 3.2. Demographic characteristics, exercise and smoking behaviour. 
Variable 
 
Mean (SD), % 
Demographics: 
Age 
Language spoken at home (% English) 
Married 
Yearly household income: 
     Below $50,000 
     Between $50,000 and $75,000  
     Above $75,000  
Number of children 
Occupation: 
     Employed  
     Student  
     Unemployed  
 
42.72 (13.43) 
96 % 
32 % 
 
56 % 
11 % 
33 % 
1.89 (2.35) 
 
73 % 
13 % 
14 % 
Value quitting smoking at baseline (one - nine) 
    Four – six = somewhat 
    Seven – nine = extremely 
 
2% 
98% 
Readiness for Change: 
    Cessation Readiness:  
         Pre-contemplation  
         Contemplation 
         Preparation 
         Action 
         Maintenance 
    Exercise Readiness: 
         Pre-contemplation 
         Contemplation 
         Preparation 
         Action 
         Maintenance 
 
 
0 % 
0 % 
53 % 
40 % 
7 % 
 
0 % 
51 % 
35 % 
7 % 
7 % 
Exercise behaviour: 
     Objective physical activity (Actical) 
          Pre-intervention (minutes per week MPVA) 
          Pre-intervention (number of bouts > 10 minutes) 
     Self-report physical activity (Godin) 
          Pre-intervention (metabolic equivalent) 
          Post-intervention (metabolic equivalent) 
 
 
99.50 (73.31) 
0.80 (1.54) 
 
18.22 (17.13) 
39.69 (21.86) 
Peak VO2 (ml/kg/min): 
     Pre-intervention 
     Post-intervention 
 
 23.23 (6.32) 
31.16 (6.82) 
Carbon monoxide (CO) reading: 
Pre intervention (baseline) 
Post intervention (14 weeks) 
 
11.96 (9.25) 
6.83 (11.07) 
Smoking behaviour: 
Cigarettes per day 
Number of years smoking 
 
17.80 (8.24) 
22.54 (12.93) 
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Fagerström test of nicotine dependence 
Percentage of family and friends that smoke: 
     Between 0 and 10% 
     Between 10 and 20% 
     Above 20% 
Number of previous quit attempts 
5.02 (2.16) 
 
32 % 
14 % 
54 % 
6.49 (14.54) 
 Previously tried to quit smoking with nicotine patch 51% 
 Previous quit attempts with nicotine  patch: 
     One 
     Two 
     Three 
     Four 
 
56% 
26% 
9% 
9% 
 
3.2.8 Outcome Measures 
 
3.2.8.1 Treatment expectancy and credibility questionnaire  
The treatment expectancy and credibility questionnaire (ECQ) was 
developed by Devilly and Borkovec (2000) and adapted for use in the 
current study. The original showed good internal consistency and good 
test-retest reliability (Devilly & Borkovec, 2000).  The participant was 
asked to judge whether she thought or felt that the treatment would 
help her to quit smoking. The ECQ consisted of seven items. Items one, 
two, and three in set I, relate to the construct of credibility and are 
considered ‘think’ items. Item four from set I, and items one and two 
from set II, relate to the construct of expectancy. Expectancy item four 
was a ‘think’ item and items one and two were ‘feel’ questions. In 
addition, item five was a measure of how valued the outcome of 
quitting smoking was to the individual. The ECQ used a nine point scale, 
and responses to questions were either one (not at all) to nine 
(extremely), or one (none) to nine (all). For each question (except 
question five) participants had to provide a response for both exercise 
and NRT. To examine change over time, the CEQ was administered at 
baseline, week five, and week 14. Reliability analyses (Cronbach’s 
alpha scores) were computed for EX-EXP, EX-CRED, NRT-EXP, and NRT-
CRED at these time points. All alpha values reflected an acceptable 
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level of reliability and are presented in Appendix 16 (Kline, 1993). See 
Appendix 9 for a copy of this questionnaire. 
 
3.2.8.2 Smoking withdrawal  
See section 2.2.8.1 for details of the Shiffman-Jarvik withdrawal scale. 
Only the craving, sedation, and psychological symptoms subscales 
were analysed. The rationale was that only these variables exhibited 
pre- to post-exercise change in study one (chapter two). Reliability 
analyses (Cronbach’s alpha scores) were computed at week five, 
using the before acute exercise session raw data for the constructs of 
craving and psychological symptoms. All alpha values reflected an 
acceptable level of reliability and are presented in Appendix 16 (Kline, 
1993). 
 
The scale was administered immediately before and after the acute 
exercise session on week five; only data pertaining to those participants 
who reached the exercise intensity goal, followed the NRT protocol, 
and abstained from smoking were included in the analyses. Data were 
expressed as a magnitude of change (pre- to post-exercise) reduction 
score.  
 
3.2.8.3 Smoking abstinence 
See section 2.2.1.1 for details. 
 
3.2.9 Challenges and considerations 
 
3.2.9.1 High versus low exercise expectancy and credibility 
Participants were categorised as either ‘high’ or ‘low’ in terms of their 
perceptions of exercise credibility and expectancy as a smoking 
cessation treatment. The categories were developed using the cut 
point function in the IBM SPSS Statistics 19 software. The number of cut 
points chosen was one. The low group (credibility and expectancy) 
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was only low relative to the high group (M [low group] = 6.93 vs. M [high 
group] = 8.71, credibility; M [low group] = 7.01 vs. M [high group] = 8.80, 
expectancy). Descriptive statistics for the high and low exercise 
credibility and expectancy groups can be found on Table 3.3.  
 
3.2.9.2 Physical activity measurement 
Due to the time frame of the research it was not possible to obtain an 
objective measurement of post-intervention physical activity behaviour 
for this group of participants. Therefore, in terms of post-intervention 
physical activity behaviour only self-report data was available and 
reported in this study. It has been demonstrated that people tend to 
over report their physical activity data when they self-report, making it 
a less accurate measurement of physical activity than when 
objectively measured (Taber, Stevens, Murray, Elder, Webber, Jobe, & 
Lytle, 2009). 
 
3.2.9.3 Smoking abstinence 
See section 2.2.2.1 for details.  
 
3.2.9.4 Nicotine replacement therapy  
See section 2.2.2.3 for details. Specific to this group of women, four 
participants opted to take the patch off while sleeping. These 
participants were warned that their nicotine levels would be decreased 
in the morning and withdrawal symptoms and cravings may be higher. 
Data from these individuals were included in the analyses if the 
participants met the smoking abstinence and exercise intensity 
requirements. 
 
3.2.9.5 Participant retention 
Although no costs were incurred to the participants for the use of the 
exercise equipment, NRT, or for campus parking, retention of 
participants for 14-weeks was a challenge. Despite contact via 
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telephone and email to keep participants in the trial, participant drop-
out occurred. Participants who dropped out prior to week 14 
assessments and/or did not attend week 14 assessments were 
considered to be smoking post-intervention. 
 
The number of participants differed from week to week due to attrition 
and absenteeism. A total of 28 participants provided continuous 
(baseline, week five, week 14) abstinent smoker questionnaire data; 
nine participants provided continuous (baseline, week five, week 14) 
non-abstinent smoker questionnaire data.  
 
3.2.10 Power calculation 
20 participants would be required in both the high and low expectancy 
groups to provide power of 80% (p < 0.05) to detect a 1.1 mean 
difference (SD – 1.2) between groups (pre- to post-exercise) for 
cigarette cravings.  Hence, if the low expectancy group has a 0.7 
magnitude of change pre- to post-exercise, the high expectancy 
group must have a 1.8 magnitude of change to detect a significant 
difference. No power calculation was computed for the exploratory 
question – comparing between participants’ expectancy and 
credibility beliefs regarding NRT and exercise over a 14-week NRT plus 
exercise aided smoking cessation programme. 
 
3.2.11 Statistical analyses  
Separate repeated ANOVAs were used to analyse differences 
between the high and low expectancy groups in cigarette craving and 
psychological withdrawal pre- to post-exercise for the acute exercise 
session at week five. Separate repeated ANOVAs were also used to 
analyse differences in the expectancy and credibility constructs of 
exercise and NRT at different time points (baseline, week five, week 14), 
and to determine change over time. Univariate ANOVAs were 
conducted to compare week 14 EX-EXP between smokers and non-
94 
 
 
 
smokers, and differences between week 14 EX-CRED with NRT-CRED for   
non-smokers. Pearson product moment correlations were used to 
examine relationships between EX-EXP, EX-CRED, NRT-EXP, NRT-CRED, 
NRT patch experience, and exercise programme attendance. Planned 
comparison t-tests were used to compare baseline exercise variables to 
week 14 exercise variables. A chi-square was used to determine the 
relationship between week 14 smoking abstinence and exercise 
programme adherence. 
 
3.3 Results 
 
3.3.1 Does the magnitude of withdrawal relief relate to exercise 
expectancy and exercise credibility beliefs? 
Exercise expectancy and exercise credibility scores at week five were 
highly correlated (n = 47, r = .847, p < .001 [2-tailed]). Descriptive 
statistics for the high and low2 EX-EXP and EX-CRED groups are 
presented in Table 3.3.  
 
Table 3.3. Descriptive statistics for the classifications of high and low exercise 
expectancy and credibility at week five. 
 Exercise Expectancy Exercise Credibility 
 N Min Max Mean SD N Min Max Mean SD 
LOW 30 3.00 8.00 7.01 1.14 21 3.67 8.00 6.93 1.25 
HIGH 17 8.33 9.00 8.80 .26 26 8.33 9.00 8.71 .29 
 
Those considered high in EX-EXP at week five had a significantly greater 
reduction in cigarette craving following an acute bout of exercise 
when compared to those lower in EX-EXP (F[1,39] = 5.591, p < .05, η2 = 
.113) (Figure 3.2). Similar results were demonstrated for EX-CRED at 
week five, with those in the high EX-CRED group experiencing a greater 
                                             
2 For ease of expression the two expectancy and credibility groups will be called high 
and low. However, in this instance the low group is only low relative to the high group. 
See Table 3.3 for a breakdown of the group actual frequencies. 
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reduction in craving compared to their counterparts who were lower in 
EX-CRED (F[1,44] = 6.511, p < .05, η2 = .129) (Figure 3.3).  
 
Following an acute bout of exercise at week five, there was no 
significant difference in the magnitude of reduction for psychological 
or sedation withdrawal symptoms between women high in EX-EXP and 
those who were low in EX-EXP (psychological: F[1,39] = 2.556, p = .117, 
η2 = .055; sedation: F[1,39] = .257, p = .615, η2 = .006) (Figure 3.2). Similar 
results were demonstrated for EX-CRED at week five, (psychological: 
F[1,39] = 2.413, p = .127, η2 = .052; sedation: F[1,39] = 1.425, p = .239, η2 = 
.031) (Figure 3.3). It is however worth mentioning that for both EX-CRED 
and EX-EXP those in the high group experienced a greater reduction in 
psychological and sedation withdrawal symptoms following an acute 
bout of exercise. 
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Figure 3.2. Change in withdrawal symptoms before and after an acute bout of 
exercise at week five between recently quit smokers classified as high (n = 14) or low 
(n = 27) in exercise expectancy (EX-EXP) (* p < 0.05).  
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Figure 3.3. Change in withdrawal symptoms before and after an acute bout of 
exercise at week five between recently quit smokers classified as high or low in 
exercise credibility (EX-CRED). Craving: high (n = 25) low (n = 21); psychological and 
sedation: high (n = 22) low (n = 19) (* p < 0.05).  
 
Irrespective of EX-EXP and EX-CRED beliefs significant reductions in 
cigarette craving at week five were demonstrated following exercise 
for all participants regardless of week five exercise EX-EXP (n = 41) or EX-
CRED (n = 46) score (EX-EXP: F[1,39] = 45.952, p < .001, η2 = .541; EX-
CRED: F[1,44] = 50.453, p < .001, η2 = .534). Significant reductions in 
psychological symptoms related to nicotine abstinence were also 
demonstrated at week five following exercise regardless of EX-EXP or 
EX-CRED beliefs at week five  (n=41) (EX-EXP: F[1,39] = 19.941, p < .001, 
η2 = .338; EX-CRED: F[1,39] = 15.181, p < .001, η2 = .280). Similarly, a 
significant reduction in the nicotine withdrawal symptom of sedation 
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was demonstrated at week five for all participants regardless of EX-EXP 
or EX-CRED beliefs reported at week five (n=41) (EX-EXP: F[1,39] = 
12.504, p < .001, η2 = .243; EX-CRED: F[1,39] = 10.153, p < .003, η2 = .207).  
 
3.3.2 Expectancy and credibility change throughout the programme 
A significant increase over time for ratings of NRT expectancy (NRT-EXP) 
and exercise expectancy (EX-EXP) was demonstrated for women who 
were smoke free at week 14 (CO<6ppm) (F[2,108] = 3.720, p < .05, η2 = 
.064) (Figure 3.4). There was no significant group (NRT, exercise) by time 
interaction (F[2,108) = .021, p = .980, η2 = .000) (Figure 3.4).  
 
 
Figure 3.4. Exercise and NRT expectancy scores for women considered non-smokers at 
the end of the programme (n = 28; CO < six ppm). Significant change over time for 
both exercise and NRT expectancy (p < 0.05).  
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A significant increase over time for ratings of NRT credibility (NRT-CRED) 
and exercise credibility (EX-CRED) was demonstrated for women who 
were smoke free at week 14 (CO < six ppm) (F[2,108] = 8.920, p < .001, 
η2 = .252) (Figure 3.5). Overall there was no significant time by group 
interaction (F[2,108] = 1.990, p = .147, η2 = .070) (Figure 3.5). Between 
baseline and week 14 both EX-CRED and NRT-CRED increased; from 
week five to week 14 EX-CRED reduced slightly whereas NRT-CRED 
increased slightly. However, due to the exploratory nature of the 
research a univariate ANOVA was conducted to determine if there was 
a significant difference between week 14 EX-CRED (M – 7.399, SD – 
1.659) and NRT-CRED (M – 8.016, SD – 1.125) for these non-smokers. No 
significant difference was demonstrated (F[1,58] = 2.837, p = .097, η2 = 
.047) (Figure 3.5).  
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Figure 3.5. Exercise and NRT credibility scores for women considered non-smokers at 
the end of the programme (n = 28, CO < six ppm). Significant change over time for 
both exercise and NRT credibility (p < 0.05).  
 
No significant change over time for ratings of EX-EXP were observed for 
women considered smokers at week 14 (CO > six ppm) and women 
considered non-smokers at week 14 (CO < six ppm) (F[2,70] = 1.068, p = 
.355, η2 = .059) (Figure 3.6). Both groups of women (week 14 smokers, 
non-smokers) showed a slight increase from baseline to week five for 
EX-EXP and then diverged, with non-smokers demonstrating a slight 
increase from week five to week 14 and smokers showing a slight 
decrease from week five to week 14. However, there was no significant 
difference over time between these two groups on EX-EXP (F[2,70] = 
1.180, p = .319, η2 = .065) (Figure 3.6). Again, due to the exploratory 
nature of the research a univariate ANOVA was conducted to 
determine if there was a significant difference between week 14 EX-EXP 
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for smokers (M – 7.233, SD – 1.165) and non-smokers (M – 7.799, SD – 
1.176). No significant difference was demonstrated (F[1,58] = 1.748, p = 
.194, η2 = .044) (Figure 3.6). 
 
 
Figure 3.6. Exercise expectancy scores for women considered smokers (n = 9, CO > six 
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme.   
 
A significant change over time for ratings of EX-CRED was observed for 
women considered smokers at week 14 (CO > six ppm) and women 
considered non-smokers at week 14 (CO < six ppm) (F[2,70] = 4.968, p < 
.01, η2 = .124) (Figure 3.7). Both groups of women showed an increase 
from baseline to week five for EX-CRED and a slight decrease from 
week five to week 14. However, EX-CRED at week 14 for both groups 
was higher than at baseline (Figure 3.7). There was no significant 
difference between over time these two groups on EX-CRED (F[2,70] = 
.036, p = .965, η2 = .001) (Figure 3.7). 
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Figure 3.7. Exercise credibility scores for women considered smokers (n = 9, CO > six 
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme. 
Significant change over time for exercise credibility (p < 0.05).  
 
No significant change over time was demonstrated for ratings of NRT-
EXP for women who were smoking at week 14 and those who were not 
smoking at week 14 (F[2,70] = 1.751, p = .181, η2 = .048) (Figure 3.8). 
There was no significant interaction effect between smokers and non-
smokers in NRT-EXP (F[2,70] = .322, p = .726, η2 = .009) (Figure 3.8).  
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Figure 3.8. NRT expectancy scores for women considered smokers (n = 9, CO > six 
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme.  
 
A significant increase over time for ratings of NRT-CRED was observed 
for smokers and non-smokers (F[2,70] = 7.355, p < .001, η2 = .174) (Figure 
3.9). There was no significant interaction effect between smokers and 
non-smokers in NRT-CRED (F[2,70] = .175, p = .840, η2 = .005) (Figure 3.9).  
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Figure 3.9. NRT credibility scores for women considered smokers (n=9, CO>6ppm) and 
non-smokers (n=28, CO<6ppm) at the end of the programme. Significant change 
over time for NRT credibility (p < 0.05). 
 
3.3.3 Were EX-EXP and EX-CRED changes over time different between 
those who were high vs. low in these variables? 
No significant difference in change in EX-EXP over time (baseline to 
week five) was demonstrated between the low and high EX-EXP groups 
(F[1,40] = 3.390, p = .073, η2 = .078). Similarly, no significant difference in 
EX-CRED over time (baseline to week five) was demonstrated between 
the low and high EX-CRED groups (F[1,40] = 3.320, p = .076, η2 = .077) 
However, a trend effect was observed for both EX-EXP and EX-CRED, 
with the high expectancy and credibility groups exhibiting a greater 
increase in EX-EXP and EX-CRED than the low expectancy and 
credibility groups (Table 3.4). 
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Table 3.4. Baseline and week five exercise expectancy and credibility scores for high 
and low exercise expectancy and credibility groups. 
 Exercise Expectancy Exercise Credibility 
 LOW (n = 28) HIGH (n = 14) LOW (n = 19) HIGH (n = 23) 
 Mean SD Mean SD Mean SD Mean SD 
Baseline 7.00 1.14 7.97 0.93 6.49 1.41 7.46 1.25 
Week five 7.05 1.16 8.78 0.28 6.89 1.30 8.71 0.29 
 
3.3.4 Correlations 
No significant correlations (p > .05) were found between previous 
patch use experience and NRT-EXP (baseline [r = .198]; week five [r = 
.030]; week 14 [r = -.036]) or NRT-CRED (baseline [r = .150]; week five [r = 
-.098]; week 14 [r = -.134]). Similarly, no significant correlations were 
demonstrated between the percent of previous quit success attributed 
to the patch and NRT-EXP (baseline [r = .382]; week five [r = .027]; week 
14 [r = .047]) or NRT-CRED (baseline [r = .100]; week five [r = .006]; week 
14 [r = .013]).  
 
No significant correlations (p > .05) were found between exercise 
programme attendance and EX-EXP (baseline [r = -.044]; week five [r = 
.144]; week 14 [r = .257]) or EX-CRED (baseline [r = -.162]; week five [r = 
.241]; week 14 [r = .192]).  
 
A significant correlation (p < .05) was found between EX-CRED and 
NRT-CRED (r = .447, p < .01). However, no significant correlation (p > .05) 
was found between EX-EXP and NRT-EXP (r = .227). 
 
3.3.5 Smoking cessation outcomes  
48.1% (n = 38) of participants were able to quit smoking on the week 
four quit date (CO < six ppm). At the end of the programme (week 14) 
60.3% of participants were considered smoke free (CO < six ppm). 
Smoking abstinence was related to attendance to the exercise 
programme (x2[2, n = 58] = 14.758, p = .001) (Table 3.5).  
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Table 3.5. Breakdown of participants smoking status at week 14 in relation to 
attendance to the exercise portion of the programme (n = 58) 
 Exercise Programme Attendance  
 80-100% 60-80% <60% Total 
Non-smoking at week 14     
   Number of participants 27 2 6 35 
   Percent of total 46.6% 3.4% 10.3% 60.3% 
Smoking at week 14     
   Number of participants 6 4 13 23 
   Percent of total 10.3% 6.9% 22.4% 39.7% 
 
3.4 Discussion 
 
3.4.1 Exercise expectancy and credibility scores as a factor of craving 
and withdrawal relief 
Similar to the work of Daniel et al. (2007), participants were categorised 
as either high or low in EX-EXP and EX-CRED at week five. Interestingly, it 
was demonstrated that individuals who were categorised as high in EX-
EXP and EX-CRED had a significantly greater reduction in craving 
following an acute 20 minute bout of moderate intensity exercise, 
compared to those who were categorised as low in these two 
variables. This finding contradicts the findings of Daniel et al. (2007), but 
is in accordance with the psychotherapy outcome research that 
underscores the influence of these two variables (Newman & Fisher, 
2010; Smeets et al., 2008). However, no significant differences between 
high and low groups were found for either psychological withdrawal, or 
the withdrawal symptom of sedation, findings that concur with those 
reported by Daniel et al. (2007). In addition, in accordance with Daniel 
and colleagues (2007), regardless of EX-EXP and EX-CRED beliefs all 
participants experienced a reduction in craving and withdrawal 
following an acute bout of moderate intensity exercise. Taken together, 
these findings suggest that expectancy and credibility beliefs are not a 
major mechanism by which exercise reduces the debilitating effects of 
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nicotine abstinence amongst both temporarily and recently quit 
smokers, but they may play some role.       
 
Overall, the findings relating to the magnitude of craving and 
withdrawal relief experienced following exercise, both contradict and 
corroborate those of Daniel et al. (2007). This disparity may best be 
explained by examining the differences between these two studies. In 
the first instance, the participants that took part in the Daniel et al. 
(2007) study were required only to engage in temporary abstinence 
(12-15 hours) whereas the women who took part in the present study 
signed up for a 14 week exercise aided quit smoking programme. 
Therefore, the women in this study were fully invested in a quit attempt 
at week five of the programme, when the difference in craving 
between groups was observed. In the psychotherapy literature, there is 
evidence to suggest that the more invested in treatment outcomes an 
individual is, the greater the influence of expectancy and credibility 
beliefs on therapeutic effects (Greenberg, Constantino, & Bruce, 2006). 
 
Recently, change in expectancy has been suggested as a mechanism 
by which cognitive behavioural therapy leads to symptom change in 
generalised anxiety disorder (Newman & Fisher, 2010). Within the 
present paradigm, women in the high EX-EXP and EX-CRED group 
demonstrated an increase in these variables from baseline to week five 
whereas those in the low EX-EXP and EX-CRED groups did not. Although 
this difference was not significant, it provides support for the notion that 
positive changes in expectancy and credibility beliefs, in relation to 
treatment, support improvement in symptoms.  
 
The results of Daniel and colleagues (2007) were based on a 
manipulated EX-EXP. In contrast, participants EX-EXP in the present 
study developed throughout the five weeks they were taking part in 
the intervention. As such, naturally occurring exercise expectancy 
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scores in the high EX-EXP group (mean 8.8/9) were greater than those in 
the Daniel et al. (2007) manipulated high EX-EXP group (mean 7.5/10). 
Perhaps, to experience an added reduction in craving recently quit 
smokers had to believe, almost without a doubt, that exercise would 
reduce the cigarette cravings associated with nicotine abstinence.  
 
Daniel and colleagues (2007) based their findings on the manipulation 
of expectancy measured on a credibility scale. Although expectancy 
and credibility beliefs may share commonalities they are essentially 
different (Devilly & Borkovec, 2000). Smokers may think that a new 
treatment such as exercise is credible, but this may differ from what 
they really feel or expect will be the outcome of treatment. As such, 
the findings of Daniel et al. (2007) may not actually be based on 
participants’ expectancies and should be interpreted with caution.  
 
In the present study participants engaged in 20 minutes of moderate 
intensity exercise as opposed to 10 minutes. In the acute exercise and 
smoking literature 20 minutes of moderate intensity exercise has been 
shown to have a greater impact on craving and withdrawal symptoms 
in temporarily abstinent smokers compared to 10 minutes of the same 
intensity exercise (Taylor et al., 2007). Perhaps, duration of exercise and 
EX-EXP interact in a way that impacts the influence of this variable on 
craving outcomes following an acute bout of exercise. 
 
All women in the present study were using NRT in conjunction with 
exercise to help them quit smoking. Smokers in the Daniel et al. (2007) 
study were only temporarily abstinent and as such were not on NRT. In 
this instance, it is difficult to explain how NRT use might have influenced 
the results. Previous NRT and expectancy research has demonstrated 
that smokers strongly believe NRT will effectively reduce cigarette 
cravings (Juliano & Brandon, 2004). Possibly, the simultaneous 
administration of exercise with NRT, a well established credible quit 
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smoking aid, guided participants to believe exercise to be a relevant 
and logical quit smoking aid also. That is, participants’ predictions 
regarding the beneficial effects of exercise were bolstered because 
they believed they could fall back on NRT. It was demonstrated that 
week five EX-CRED and NRT-CRED were highly related, which supports 
this notion, but it is refuted by the lack of correlation between EX-EXP 
and NRT-EXP at week five. This finding also underscores the difference 
between expectancy and credibility as constructs. 
 
A number of demographic variables were different between the two 
studies. For instance, women in the present study were more likely to 
be: older, employed, smoking for longer, smoked more per day, and 
were more heavily addicted. There were also gender differences. 
Namely, the present study was a cohort of women only whereas Daniel 
et al. (2007) included both men and women. It is perhaps unlikely that 
any of these variables made any real contribution to the resultant 
differences however it is worth acknowledging them. 
  
EX-EXP and EX-CRED do not invariably carry the burden of craving and 
withdrawal outcome following an acute bout of exercise. However, 
individuals who held strong EX-EXP and EX-CRED beliefs did experience 
an added reduction in cigarette craving following an acute bout of 
moderate intensity exercise. The question is whether or not this added 
reduction in craving is clinically relevant (Smeets et al., 2008). Cigarette 
cravings are one of the most often expressed difficulties related to 
quitting. The intensity of craving experienced by an abstinent smoker 
over the first few days of quitting is often predictive of their success 
(Ferguson, Shiffman, & Gwaltney, 2006). That being the case, every 
further reduction, no matter how small, may be of clinical relevance. 
Each year at least 70 percent of smokers see a physician (Fiore, Jaen, & 
Baker, 2008). Others come into contact with dentists, nurse 
practitioners, nurses, physical therapists, occupational therapists, 
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pharmacists, and counsellors (Fiore et al., 2008). Therefore, almost all 
clinicians are in a position to intervene with smokers and offer them 
tobacco treatment (Fiore et al., 2008). If clinicians were to advocate 
exercise as an adjunct cessation aid it may serve to bolster smokers EX-
EXP and EX-CRED beliefs. The challenge with this rests not so much on 
the smoker as it does on the clinician.     
 
3.4.2 Comparison of exercise and NRT expectancy and credibility 
beliefs 
Expectancy and credibility are intervention components common to all 
treatment modalities (Newman & Fisher, 2010). One aim of the present 
study was to compare smokers’ expectancy and credibility beliefs 
concerning exercise as a quit smoking aid with their beliefs pertaining 
to NRT as a quit smoking aid. The framework of the present study 
provided the opportunity to investigate initial expectancy and 
credibility beliefs, as well as an examination of change in these 
variables over time. Although expectancy and credibility scores at 
week five were found to be highly correlated, previous research 
provides evidence that these two variables are related yet separate 
(Devilly & Borkovec, 2000). As such, separate analyses of these 
variables were conducted and commentary on each is provided. 
 
Amongst women who were successfully quit at week 14 of the NRT plus 
exercise aided cessation programme both NRT-EXP and EX-EXP showed 
a significant increase over time. To appreciate the importance of this 
finding a major perceptual difference between these two cessation 
aids needs to be highlighted. The nicotine patch has been sold over 
the counter since 1996 and is a well established smoking cessation 
treatment, recognised and used by many smokers (TTS, 2010). In 
contrast, exercise is a comparatively unknown and novel adjunct quit 
smoking therapy (Ussher, Taylor, & Faulkner, 2008). Despite this, this 
group of women believed they would derive benefit from both 
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treatments offered. By no means does this result imply that NRT and 
exercise are equally effective quit smoking treatments. It does however 
infer that quitters likely attribute some of their success to the exercise 
portion of the programme (Kazdin, 1979). Two possible consequences 
of this result are worth noting. First, if these women believe exercise to 
be a useful quit smoking aid, then they may be more likely to 
recommend it to others trying to quit. Second, continued exercise 
adherence post intervention is a common problem with intensive 
supervised exercise and smoking cessation programmes (Ussher et al., 
2008). Believing exercise contributes to abstinence may make these 
women more likely to continue exercising upon programme 
termination.  
 
Among those non-smoking at week 14 EX-CRED and NRT-CRED scores 
significantly increased over time. Interestingly, although not statistically 
significant, as these women were about to leave the programme 
(week 14) their EX-CRED beliefs reduced slightly (remaining above 
baseline) whereas their NRT-CRED beliefs increased slightly. These 
women successfully quit using NRT, leaving little doubt in their mind that 
NRT is a credible quit smoking aid. In addition, at the time of 
questionnaire completion they had been without the patch for at least 
one week and were possibly experiencing renewed craving and 
withdrawal symptoms, albeit psychological in nature (TTS, 2010). It is 
speculated that these factors may have influenced their NRT-CRED 
scores. In contrast, EX-CRED may have been eroded at programme 
termination, due to a lack of confidence in exercise without concurrent 
NRT administration and the Getting Physical on Cigarettes programme. 
Perhaps, it may have been possible to bolster EX-CRED for these 
women with an end of programme debrief and counselling session 
(Greenberg et al., 2006).  
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The results indicate that EX-EXP for both smokers and non-smokers (at 
week 14) was comparable. However, it is worth noting that EX-EXP 
increased from week six to week 14 for women who were successful in 
the programme, and decreased during the same period for women 
who were not. Perhaps, if the smoking group had comparable numbers 
to the non-smoking group a significant difference at week 14 may have 
been demonstrated. It is logical that at the end of an exercise aided 
quit smoking programme, women who had not succeeded would lose 
hope in exercise as a cessation strategy. Perhaps, these smokers 
engaged in a form of self-serving bias, whereby they began to doubt 
the value of exercise as a quit smoking strategy in order to attribute 
their cessation failure to an external factor (the exercise programme) 
(Greenberg, Pyszczynski, & Solomon, 1982). Interestingly, no discernable 
pattern for NRT-EXP was demonstrated between smokers and non-
smokers. 
 
Regardless of quit success, during the intervention all women believed 
exercise to be a highly credible quit smoking aid. For the majority of 
smokers quitting is not a one-time event. Seventy six percent of people 
who have quit smoking made at least one attempt before they were 
successful, and approximately 80% of current smokers have attempted 
to quit at least once (TTS, 2010). In addition, six months post intervention, 
relapse is an unfortunate possibility for those who initially achieve 
abstinence (Fiore et al., 2008). In all eventuality, a significant proportion 
of these women will attempt to quit smoking again in the 12 months 
following programme termination (TTS, 2010). Strong positive credibility 
beliefs make it more likely that they will try to quit smoking using 
exercise in the future (Juliano & Brandon, 2004).  
 
Expectancy and credibility are variables common to all smoking 
cessation treatment strategies. Research in the field of clinical 
psychology substantiates that these variables exert some influence 
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over behavioural outcomes, and that this influence should be utilised 
(Kirsch & Lynn, 1999). In the present study, EX-EXP and EX-CRED 
remained high throughout the course of the programme, without any 
explicit intervention or manipulation. It would seem that taking part in 
the programme was sufficient enough to keep EX-EXP and EX-CRED 
ratings high. Researchers in the expectancy and credibility area have 
demonstrated that actual experience with therapeutic treatment 
exerts a powerful influence over these two variables (Kazdin, 1979). Any 
quit smoking treatment that smokers can believe in from pre- to post-
quit and beyond has merit. That is, exercise may be a cost effective 
quit smoking aid because it spans the gamut, from an initial quit 
smoking treatment to relapse prevention strategy.  
 
It was demonstrated that EX-EXP and EX-CRED were not related to 
adherence. Previous research with clinically depressed individuals has 
shown that those who believed in the effectiveness of their therapy 
were less likely to drop out, and more likely to adhere to the treatment 
offered (Elkin, Yamaguchi, Arnkoff, Glass, Sotsky, & Krupnick, 1999). 
Finding EX-EXP and EX-CRED to be unrelated to adherence in an 
exercise aided quit smoking programme seems counterintuitive. 
However, the clinical implications are great. Specifically, it provides 
some indication that smokers’ who do not have complete faith in 
exercise as a quit smoking strategy, may still be willing to adhere to a 
programme such as this. As previously mentioned, adherence is one of 
the biggest hurdles with exercise aided smoking cessation programmes. 
This finding implies that factors other than these variables are 
implicated in adherence difficulties related to an exercise aided quit 
smoking programme.  
 
3.4.3 Limitations 
A potential bias regarding EX-EXP and EX-CRED beliefs can be 
identified. Expectancy and credibility scores for this group of women 
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were high upon entry into the programme (EX-EXP and EX-CRED mean 
of 7/9). The results were obtained from a group of female smokers who 
agreed to participate in a research programme involving exercise. It is 
possible that offering exercise to these women as a quit smoking aid 
may have had some bearing on their expectancy and credibility 
beliefs. For example, it is likely that they believed exercise to be a 
credible quit smoking aid and hoped that it would help them to quit 
smoking, because it was being offered through a reputable institution. 
Similarly, the manipulated scores reported by Daniel et al. (2007) were 
relatively high even in the low condition (five and a half out of 10 on 
the credibility scale). In addition, when compared to a control group, 
Ussher et al. (2009) found that temporarily abstinent smokers who 
engaged in 10 minutes of isometric exercise believed it to be a credible 
quit smoking strategy, and reported that they would recommend it to 
other smokers trying to quit (Ussher, Cropley, Playle, Mohidin, & West, 
2009). Therefore, generalising results obtained to smokers who do not 
take part in research studies such as this may not be possible. Perhaps, 
the only way to truly minimise this expectancy effect would be to enrol 
participants into an acute exercise study, and conceal the exercise 
portion of the intervention until the last moment. Such a study design 
would only be feasible in an acute setting due to the deception 
involved. 
 
A factor known to influence expectancy and credibility is knowledge 
gained from others (Wilson, Lisle, Kraft, & Wetzel, 1989). It is possible that 
women in this study discussed their own personal experiences and 
beliefs in relation to the quit smoking aids offered. Such interactions 
would potentially be an influencing factor in the change demonstrated 
in these variables over time. To control for this, it may have been 
prudent to separate women according to their expectancy and 
credibility beliefs upon entering into the programme.  
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Although the group size of week 14 smokers was small (n = 9), and was 
not equal to that of week 14 non-smokers (n = 28), the research was 
exploratory in nature, and as such it was deemed acceptable to 
compare these two groups. However, these results should be 
interpreted with caution. To rectify this, and gain an accurate profile of 
smokers who were unsuccessful, it would have been ideal to obtain 
questionnaire data by phone or email during missed assessment times.  
 
3.4.4 Future research 
Interestingly, no differences were found between EX-EXP and NRT-EXP 
or between EX-CRED and NRT-CRED amongst women who were 
successfully quit at week 14. Regardless of the accuracy of these 
beliefs, stronger positive beliefs would likely increase the use of exercise 
as a quit smoking aid and perhaps improve treatment outcomes 
(Juliano & Brandon, 2004). Physical activity is a behavioural strategy 
that is increasingly advocated by tobacco treatment specialists and 
often reportedly used by quitters (Abrams, Niaura, Brown, Emmons, 
Goldstein, & Monti, 2003; Everson, Taylor, & Ussher, 2010; O'Connell, 
Gerkovich, Cook, Shiffman, Hickcox, & Kakolewski, 1998). Thus, it seems 
important to determine the impact clinicians might exert on EX-EXP and 
EX-CRED beliefs in the real world, and how such strategies might 
influence cessation outcomes (Greenberg et al., 2006).  
 
3.4.5 Conclusions 
In general, people who join a novel exercise aided smoking cessation 
intervention have some expectation that exercise will help them quit 
smoking and believe it to be a credible quit smoking aid. Regardless of 
exercise expectancy and credibility, all recently quit smokers received 
a significant reduction in craving and withdrawal relief following an 
acute bout of moderate intensity exercise. Nevertheless, the results 
provide some evidence that expectancy and credibility may have 
some influence on treatment outcomes. The aim is not to denigrated 
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the value of exercise as an adjunct smoking cessation aid (Kirsch & 
Lynn, 1999). Rather, tobacco treatment specialists should be trying to 
maximise expectancy and credibility beliefs amongst smokers 
attempting to quit and using exercise as a means to control craving 
and withdrawal. 
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4 CHAPTER FOUR: EXERCISE MAY BE AN EFFECTIVE 
BEHAVIOURAL SUPPORT STRATEGY FOR COPING 
WITH SMOKING TEMPTATIONS DURING A QUIT 
ATTEMPT 
 
 
4.1 Introduction 
Cigarette smoking is the single greatest cause of preventable death 
worldwide because it is associated with numerous dire health 
consequences; these adverse effects include an increased risk of heart 
attack, stroke, chronic obstructive pulmonary disorder, and many 
cancers (USDHHS, 2010). Although tobacco use has declined markedly 
since the 1960’s, there has been a levelling off of cessation since the 
1990’s (Fiore, Jaen, & Baker, 2008). Approximately one quarter of the 
North American population currently smoke (Fiore et al., 2008). 
Tobacco dependence treatment has improved greatly and there is 
now much support available for smokers who want to quit. Despite this, 
the likelihood of remaining abstinent, six months post-quit, even with the 
most comprehensive of programmes (pharmacotherapy plus 
cognitive-behavioural support) is only between 25-30% (Fiore et al., 
2008). Smoking relapse rates are also alarmingly high. Between 60% 
and 98% of quit attempts will end in relapse within the first year, with the 
majority (44%) occurring in the first two weeks (Garvey, Bliss, Hitchcock, 
Heinold, & Rosner, 1992). 
 
There are a number of reasons why dependent smokers find it 
incredibly difficult to remain smoke-free. Specifically, there are three 
distinct constructs known to entice smoking relapse (Brownell et al., 
1986; Velicer et al., 1990), and include: (1) individual factors which 
involve affect, in particular negative emotional states (N/A); (2) 
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situational factors which involve environmental and social factors (P/S); 
and (3) physiological factors which correspond to the subjective 
feelings of craving, urges, and withdrawal associated with nicotine 
deprivation (H/A) (Brownell, Marlatt, Lichtenstein, & Wilson, 1986). 
 
To reduce relapse and maintain abstinence in high-risk situations 
cognitive (e.g., positive self-talk) and behavioural (e.g., exercise) 
coping strategies are recommended (Abrams, Niaura, Brown, Emmons, 
Goldstein, & Monti, 2003). Self-quitters report the use of behavioural 
coping skills more often than cognitive coping strategies (O'Connell, 
Gerkovich, Cook, Shiffman, Hickcox, & Kakolewski, 1998). Physical 
activity is a behavioural strategy that is increasingly advocated by 
tobacco treatment specialists and often reported as beneficial by 
quitters (Abrams et al., 2003; Everson, Taylor, & Ussher, 2010; O'Connell 
et al., 1998). Abstinent smokers are encouraged by health professionals 
to substitute smoking for the alternative health behaviour of exercise to 
prevent smoking relapse  (TTS, 2010).  
 
Research on relapse has consistently shown that individuals are much 
more likely to relapse when they experience negative affect (Zeidner & 
Endler, 1996). Smokers turn to cigarettes as a way of managing 
negative affect; they learn to rely on cigarettes to cope with situations 
that induce feelings of anger, frustration, depression, and anxiety 
(Abrams et al., 2003). It is posited that when nicotine deprived 
dependent individuals find themselves in stressful situations it activates 
nicotine craving, which may lead to relapse if not managed by an 
alternative to smoking (i.e., a coping strategy) (Shadel & Mermelstein, 
1993). Exercise may be an appropriate coping strategy because it has 
been shown to reduce negative affect experienced by individuals 
attempting to quit (Bock, Marcus, King, Borrelli, & Roberts, 1999). In 
addition, exercise is known to reduce withdrawal symptoms such as 
stress, anxiety, tension, and irritability in temporarily abstinent smokers 
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(Taylor, Ussher, & Faulkner, 2007). Conversely, smokers also turn to 
cigarettes to enhance already pleasurable situations (e.g., at the bar 
with friends) (Velicer, DiClemente, Rossi, & Prochaska, 1990). Whether 
an alternative behaviour such as exercise might work as a coping 
strategy or substitute behaviour in this type of high-risk situation is 
unknown. 
 
One of the reasons smokers find it difficult to quit is because smoking 
becomes a learned habit through years of repetition (Abrams et al., 
2003). This renders the abstinent smoker susceptible to cue-induced 
cravings when in situations previously linked to smoking (e.g., getting up 
in the morning). There is evidence to suggest that following moderate 
intensity exercise, temporarily abstinent smokers are less likely to 
respond to a smoking cue (e.g., lit cigarette or smoking related images) 
(Janse Van Rensburg, Taylor, Hodgson, & Benattayallah, 2009; Taylor & 
Katomeri, 2007). Therefore, an exercise aided quit smoking programme 
may reduce the intensity of cue-induced craving and in turn reduce 
the likelihood of relapse (Ferguson & Shiffman, 2009). 
 
Exercise and smoking are two behaviours that do not normally co-
occur (Prochaska, 2008). To suggest that smokers will use exercise as a 
strategy to cope with temptation implies that these two behaviours can 
be concurrently altered. Unfortunately, many exercise and smoking 
cessation studies do not report changes in physical activity, which limits 
the understanding of whether smokers can simultaneously quit smoking 
and adopt exercise. There is however research to suggest that as a 
smoker increases in confidence to quit smoking, he/she increases in 
confidence to undergo other health behaviour changes, such as 
exercise (Prochaska, 2008). Data concerning whether these two 
behaviours can be simultaneously modified would provide valuable 
information for developing cost-effective strategies for multiple 
behaviour interventions (King, Marcus, Pinto, Emmons, & Abrams, 1996). 
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The present study provided an ideal platform to examine co-variation; 
defined as two behaviours that do not normally co-occur changing 
together. 
 
The exercise and smoking literature supports exercise as a meaningful 
coping resource during abstinence to prevent relapse (Taylor, 
Katomeri, & Ussher, 2006). Exercise has been proposed as a strategy to 
enhance coping ability and confidence to remain smoke free (Ussher, 
Taylor, & Faulkner, 2008). However, it is not known if abstaining smokers 
would confidently report replacing smoking with exercise when 
imagining a relapse-inducing situation. It is also unknown whether the 
quitter’s confidence in exercise as a behavioural support strategy is 
situation specific. With this in mind, the purpose of the present study 
was to determine: (1) if women taking part in a combined nicotine 
replacement therapy (NRT) and exercise aided smoking cessation 
programme report a temporal progression from smoking to exercising in 
high risk situations; (2) whether confidence to use exercise as a coping 
strategy is situation dependent; and (3) whether concurrent behaviour 
change would occur (e.g., exercise increase and smoking decrease). 
 
It was hypothesised that women engaging in an exercise aided quit 
smoking programme would naturally substitute smoking for exercise as 
a means of coping with situations that promote the resumption of 
smoking. It was also hypothesised that of all high-risk relapse situations 
those related to affect, particularly negative affect, would be the most 
amenable to exercise as a coping strategy. Finally, it was hypothesised 
that women who showed an increase in confidence to quit smoking 
would demonstrate a reciprocal increase in exercise confidence.  
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4.2 Methods 
 
4.2.1 Participants 
Participants included 58 females undertaking the third round of the 
Getting Physical on Cigarettes (GPOC) trial (Jung, Fitzgeorge, 
Prapavessis, Faulkner, & Maddison, 2010). The inclusion and exclusion 
criteria were the same as that outlined in section 2.2.1. 
 
4.2.2 Ethical approval 
Ethical approval to amend the GPOC trial to contain the necessary 
questionnaires was obtained from the University of Western Ontario 
Health Sciences Research Ethics Board (#16306).  
 
4.2.3 Design 
 
4.2.3.1 Getting Physical on Cigarettes 
See section 2.2.3.1 for details. 
 
4.2.3.2 The Exercise and Health Psychology Laboratory 
See section 2.2.3.2 for details.  
 
4.2.3.3 General procedure 
Participants engaged in a 14 week exercise programme at the Exercise 
and Health Psychology Laboratory at the University of Western Ontario. 
On the fourth week of the exercise programme participants began a 
smoking cessation attempt and the 10 week NicoDerm® nicotine 
replacement therapy (NRT) transdermal patch programme. Pre-
intervention assessments were completed before week one, at 
baseline; post-intervention assessments were completed on a date 
after the participants’ last exercise session, when they had finished the 
NRT programme, on week 14.  
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Questionnaires that were completed during the trial were done 
immediately following the first exercise session on the appropriate week 
(see Table 4.1). To be eligible for analyses, the participants 
demonstrated smoking abstinence (i.e., breath CO < six ppm), 
adhered to the NRT programme, and followed the exercise regime. To 
answer the research questions participants completed questionnaires 
every week with the exception of week 11 and 13. A flow-chart of the 
research design is displayed in Figure 4.1 and a timeline of the 
measurements and assessments in Table 4.1. 
 
Table 4.1. Schedule of Assessments 
 Week 
 Base-
line 
2 3 4 5 6 7 8 9 10 11 12 13 14 
Quit Smoking 
 
Demographics Questionnaire 
Smoking Ladder 
Exercise Readiness  
 
 
 
X 
X 
X 
  X           
               
Temptations Questionnaire X X X X X X X X X X  X  X 
               
Smoking Variables               
Carbon Monoxide Assessment X X X X X X X X X X X X X X 
Fagerström Nicotine 
Dependence 
X              
Smoking Information X              
Cessation Self-Efficacy (SE) X     X        X 
               
Exercise Variables               
Actical Exercise Behaviour X              
Godin Leisure Time 
Questionnaire 
X             X 
Peak VO2 Fitness Assessment X             X 
Exercise Task SE X     X        X 
Exercise Scheduling SE X     X        X 
Exercise Barrier SE X     X        X 
Note. Baseline refers to pre-trial and week 14 refers to post-trial. Participants began 
their smoking cessation attempt and nicotine replacement therapy on week four. 
  
  
Figure 4.1. R
 
4.2.4 Exe
See sectio
 
4.2.5 Nic
All partic
transderm
patches f
manufac
 
4.2.5.1 Ni
See sectio
  
esearch de
rcise regi
n 2.2.4 fo
otine rep
ipants w
al patch
or 24 hou
turer’s rec
coDerm®
n 2.2.5.1 
sign and fl
men 
r details. 
lacement
ere prov
es. Partic
rs a day, 
ommend
 three step
for detail
 
ow of partic
 therapy 
ided with
ipants w
seven da
ations. 
 program
s.  
ipants thro
regimen 
 NRT in 
ere aske
ys a wee
me 
ugh the tria
the form
d to we
k, for 10 w
l. 
 of Nico
ar the n
eeks as p
125 
 
Derm® 
icotine 
er the 
126 
 
 
 
4.2.5.2 NicoDerm® two step programme 
See section 2.2.5.2 for details. Seven of the 58 participants were on the 
two step programme.   
 
4.2.6 Demographic measures 
See section 2.2.6 for measurement details. These variables are 
described in Table 2.2. 
 
4.2.7 Nicotine dependence and other smoking characteristics 
See section 2.2.6.2 for measurement details. These variables are 
described in Table 2.2. 
 
4.2.7.1 Smoking ladder scale 
See section 3.2.6.4 for details. This variable is described in Table 2.2. 
 
4.2.8 Physical activity behaviour  
 
4.2.8.1 Godin leisure time exercise questionnaire (GLTEQ) 
See section 3.2.7.1 for details. These variables are described in Table 
2.2. 
 
4.2.8.2 Actical® accelerometer 
See section 2.2.7.1 for details. This variable is described in Table 2.2. 
  
4.2.8.3 Peak VO2 fitness assessment 
See section 2.2.7.2 for details. These variables are described in Table 
2.2. 
 
4.2.8.4 Stage of exercise readiness 
See section 3.2.7.4 for details. This variable is described in Table 2.2. 
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Table 4.2. Demographic characteristics, exercise and smoking behaviour. 
Variable 
 
Mean (SD), % 
Demographics: 
Age 
Language spoken at home (% English) 
Married 
Yearly household income: 
     Below $50,000 
     Between $50,000 and $75,000  
     Above $75,000  
Number of children 
Occupation: 
     Employed  
     Student  
     Unemployed  
 
42.72 (13.43) 
96 % 
32 % 
 
56 % 
11 % 
33 % 
1.89 (2.35) 
 
73 % 
13 % 
14 % 
Readiness for Change: 
    Cessation Readiness:  
         Pre-contemplation  
         Contemplation 
         Preparation 
         Action 
         Maintenance 
    Exercise Readiness: 
         Pre-contemplation 
         Contemplation 
         Preparation 
         Action 
         Maintenance 
 
 
0 % 
0 % 
53 % 
40 % 
7 % 
 
0 % 
51 % 
35 % 
7 % 
7 % 
Exercise behaviour: 
     Objective physical activity (Actical) 
          Pre-intervention (minutes per week MVPA) 
          Pre-intervention (number of bouts > 10 minutes) 
     Self-report physical weekly activity (Godin) 
          Pre-intervention (metabolic equivalent) 
          Post-intervention (metabolic equivalent) 
 
 
99.50 (73.31) 
0.802 (1.545) 
 
18.22 (17.13) 
39.69 (21.86) 
Peak VO2 (ml/kg/min): 
     Pre-intervention 
     Post-intervention 
 
 23.23 (6.32) 
31.16 (6.82) 
Carbon monoxide (CO) reading: 
Pre intervention (baseline) 
Post intervention (14 weeks) 
 
11.96 (9.25) 
6.83 (11.07) 
Smoking behaviour: 
Cigarettes per day 
Number of years smoking 
Fagerström test of nicotine dependence 
Percentage of family and friends that smoke: 
     Between 0 and 10% 
 
17.80 (8.24) 
22.54 (12.93) 
5.02 (2.16) 
 
32 % 
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     Between 10 and 20% 
     Above 20% 
Number of previous quit attempts 
14 % 
54 % 
6.49 (14.54) 
 
4.2.9 Primary outcome measures 
 
4.2.9.1 Temptations questionnaire 
The temptations questionnaire is a 25 item questionnaire that combined 
two questionnaires: The Revised Self-Efficacy Temptations scale long 
form (SET) (Velicer et al., 1990) and the Cessation Self-Efficacy 
questionnaire (CSE) (DiClemente, 1981). Both of these questionnaires 
have shown reliability and validity in terms of assessing smokers’ 
confidence in their ability to avoid smoking in relapse inducing 
situations (DiClemente, 1981; Velicer et al., 1990). The scales of these 
two questionnaires were modified such that participants had to choose 
how likely they would be to either smoke or to exercise in situations 
known to induce smoking urges. Participants were required to choose 
between the response of smoking and exercising on a nine point scale 
(four points on the exercise side + unsure + four points on the smoking 
side). The scale was scored such that a score of -4 = extremely likely to 
smoke and -1 = a little likely to smoke, 0 = unsure, 4 = extremely likely to 
exercise and 1 = a little likely to exercise.  
 
For the purpose of analysis the scale was separated into four 
components, corresponding to: cessation self-efficacy (12 items from 
DiClemente, 1981), negative/affect (N/A – six items from Velicer et al., 
1990), positive/social (P/S – six items from Velicer et al., 1990), 
habit/addiction (H/A – five items from Velicer et al., 1990). There was 
some overlap between questionnaires (i.e., some items appeared on 
both questionnaires). The three categories of the SET scale (N/A, P/S, 
H/A) were used to determine whether participants in an exercise-aided 
smoking cessation programme reported a progression from smoking to 
exercising when faced with a relapse inducing situation, and to 
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determine whether or not exercise is a situation dependent coping 
strategy. The items from the CSE scale were used to determine if 
participants may be more or less likely in specific situations to exercise 
as a relapse coping strategy. This questionnaire was administered 
weekly from baseline to week eight, and at week 10, 12, and 14. 
Reliability analyses (Cronbach’s alpha scores) were computed at all 
time points for the constructs (P/S, N/A, H/A). All alpha values reflected 
an acceptable level of reliability and are presented in Appendix 16 
(Kline, 1993). See Appendix 10 for a copy of this questionnaire. 
 
4.2.10 Secondary outcome measures 
 
4.2.10.1 Smoking abstinence 
Smoking abstinence was verified post-intervention by self-report, and a 
breath carbon monoxide reading of less than six ppm. Participants who 
failed to attend the post-intervention assessment appointment, scored 
greater than six ppm breath carbon monoxide, and/or self-reported 
smoking behaviour were considered a smoker at week 14 (post-
intervention). 
 
4.2.10.2 Cessation self-efficacy 
Participants’ confidence in their ability to avoid smoking was assessed 
with the Cessation Self-Efficacy Questionnaire (DiClemente, 1981). This 
questionnaire was administered at baseline, week six and week 14 of 
the trial. The scale consisted of 12 items on a seven point scale (one = 
completely sure – seven = completely unsure). For ease of 
interpretation the raw data was reverse scored, such that a higher 
score on this questionnaire indicates a higher confidence in ability to 
avoid smoking in various situations. Reliability analyses (Cronbach’s 
alpha scores) were computed at baseline, week six, and week 14. All 
alpha values reflected an acceptable level of reliability and are 
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presented in Appendix 16 (Kline, 1993). See Appendix 11 for a copy of 
this questionnaire.  
 
4.2.10.3 Exercise task self-efficacy 
Participants’ confidence in their ability to engage in increasing 
intensities and durations of physical activity was assessed at baseline, 
week six and week 14 using the exercise task self-efficacy questionnaire 
(McAuley & Mihalko, 1998). Responses to nine items were given on a 0% 
to 100% scale ranging from not at all confident (0%) to extremely 
confident (100%). The scale consisted of three items pertaining to 
light/mild intensity physical activity (e.g., “How confident are you that 
you can complete 10 minutes of physical activity at a light intensity 
three times next week?”), three items on moderate intensity physical 
activity, and three items on hard/vigorous intensity physical activity. 
Reliability analyses (Cronbach’s alpha scores) were computed at 
baseline, week six, and week 14. All alpha values reflected an 
acceptable level of reliability and are presented in Appendix 16 (Kline, 
1993). The results of this questionnaire are presented on a 0-10 scale, 
where 0 corresponds to 0% confidence and 10 corresponds to 100% 
confidence. See Appendix 12 for a copy of this questionnaire. 
 
4.2.10.4 Exercise scheduling self-efficacy 
Participants’ confidence in their ability to schedule exercise into their 
daily routine was assessed at baseline, week six and week 14 using the 
seven item exercise scheduling self-efficacy measure (Woodgate, 
Brawley, & Weston, 2005). Responses were given on a 0% to 100% scale 
ranging from not at all confident (0%) to extremely confident (100%). 
Reliability analyses (Cronbach’s alpha scores) were computed at 
baseline, week six, and week 14. All alpha values reflected an 
acceptable level of reliability and are presented in Appendix 16 (Kline, 
1993). The results of this questionnaire are presented on a 0-10 scale, 
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where 0 corresponds to 0% confidence and 10 corresponds to 100% 
confidence. See Appendix 14 for a copy of this questionnaire. 
 
4.2.10.5 Exercise barrier self-efficacy 
Participants’ confidence in their ability to engage in exercise when 
faced with various barriers to do so was assessed using a five item 
questionnaire modified from the barrier self-efficacy scale (Garcia & 
King, 1991). Participants reported their confidence to participate in 60 
minutes of physical activity when faced with situations known as 
barriers to exercise. Responses were given on a 0% to 100% scale 
ranging from not at all confident (0%) to extremely confident (100%). 
Reliability analyses (Cronbach’s alpha scores) were computed at 
baseline, week six, and week 14. All alpha values reflected an 
acceptable level of reliability and are presented in Appendix 16 (Kline, 
1993). The results of this questionnaire are presented on a 0-10 scale, 
where 0 corresponds to 0% confidence and 10 corresponds to 100% 
confidence. See Appendix 13 for a copy of this questionnaire. 
 
4.2.11 Challenges and considerations 
 
4.2.11.1 Smoking abstinence 
See section 2.2.2.1 for details.   
 
4.2.11.2 Physical activity measurement 
See section 3.2.9.2 for details. 
 
4.2.11.3 Nicotine replacement therapy  
See section 2.2.2.3 for details.  
 
4.2.11.4 Participant retention 
See section 2.2.2.4 for details. The number of participants differed 
between analyses due to attrition, absenteeism and/or smoking lapses 
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(e.g., baseline to week four temptations questionnaire, n = 41; week 
five to week eight, n = 33; week 10 to week 14, n = 29) (Figure 4.1). A 
total of 12 participants provided continuous, baseline to week 14, 
temptation questionnaire data.  
 
4.2.12 Power calculation 
Due to the exploratory nature of this study, no power calculation was 
computed. 
 
4.2.13 Statistical analyses  
Separate repeated ANOVAs were used to analyse differences in the 
temptation constructs of the Temptation Questionnaire at different time 
points (baseline – week four, week five – week eight, week 10 – week 
14), and to determine change over time. Planned comparison t-tests 
were used to determine at what time point (week) differences 
between the scales occurred. For these analyses Bonferroni correction 
set the alpha at .005. Separate repeated ANOVAs were also used to 
analyse differences in the self-efficacy scales over time. For the self-
efficacy scales that were measured at three time points, planned 
comparison t-tests were used to compare baseline to week six and 
baseline to week 14 if differences were found. Pearson product 
moment correlations were used to examine relationships between 
exercise self-efficacy’s and smoking cessation self-efficacy (change 
from baseline to week six, CO < six ppm at week 14). A univariate 
ANOVA was used to compare baseline exercise self-report behaviour 
to week 14 exercise self-report behaviour. A chi-square was used to 
determine the relationship between week 14 smoking abstinence and 
exercise programme adherence.  
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4.3 Results 
 
4.3.1 Baseline to quit week (week four) 
A significant change over time (baseline to week four, n = 41) occurred 
for all three temptation constructs (Positive/Social [P/S], 
Negative/Affect [N/A], Habit/Addictive Qualities [H/A]) (F[3,360] = 
94.529, p < .001, η2 = .706) (Figure 4.2). Scores changed from smoking in 
relapse provoking situations (at baseline) to being ‘unsure’ or ‘a little 
likely’ to exercise in such situations (at week four). Significant 
differences in scores over the weeks are presented in Table 4.3. There 
were no differences over time (baseline to week four) between the 
three categories of temptation 3 (F[6,360] = .898, p = .497, η2 = .015). 
  
                                             
3 Scores on the three temptation constructs over time for women who attended each 
assessment time point and were continuously abstinent from week four onwards (n = 
12) were no different to those who were continuously abstinent at the distinct time 
points (baseline – week four; week five – week eight; week 10 – week 14). 
134 
 
 
 
Table 4.3. Baseline to week four change in score over time t-test results. Baseline – 
week two, n = 51; week two – week three, n = 44; week three – week four, n = 44.  
Construct Comparison Mean (sd) T Sig. η2 
Positive  
Social 
Baseline – week two -2.85 
(1.01) 
-2.81 
(1.18) 
-0.268 .789 .001 
 
 Week two – week three -2.73 
(1.17) 
-2.07 
(1.12) 
-7.013 .001 .534 
 Week three – week four -2.14 
(1.03) 
-0.29 
(1.27) 
-7.573 .001 .572 
Negative  
Affective 
Baseline – week two -3.06 
(1.01) 
-2.38 
(1.37) 
-3.915 .005 .235 
 Week two – week three -2.32 
(1.37) 
- 2.16 
(1.52) 
-1.104 .276 .028 
 Week three – week four -2.23 
(1.53) 
- 0.20 
(1.69) 
-6.464 .001 .493 
Habit 
Addiction 
Baseline – week two -2.15 
(1.21) 
-1.60 
(1.51) 
-2.937 .005 .147 
 Week two – week three -1.50 
(1.48) 
-1.32 
(1.46) 
-1.162 .251 .001 
 Week three – week four -1.32 
(1.43) 
0.56 
(1.52) 
-6.909 .001 .526 
 
4.3.2 Week five to week eight 
No significant change over time (week five to week eight, n = 31) was 
demonstrated for any of the three temptation constructs (F[3,288] = 
.282, p = .838, η2 = .003) (Figure 4.2). Values remained between zero 
(unsure) and one (a little likely to exercise). It should be noted that 
none of the post quit scores were negative (negative score denotes 
likely to smoke). There was no difference in participants scores between 
the three categories of temptation during this time period (F[6,288] = 
.529, p = .786, η2 = .011).  
 
4.3.3 Week 10 to end of programme (week 14) 
No significant change over time (week 10 to week 14, n=29) was shown 
for the three temptation constructs (F[2,168] = 3.252, p = .061, η2 = .037) 
(Figure 4.2). Similar to mid-intervention scores (week five to eight) 
participants scores remained consistently between zero (unsure) and 
one (a little likely to exercise). Again, it should be noted that none of 
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the post quit date reports leaned towards smoking. There were no 
differences between the three categories of temptation during this 
time period (week 10 to 14) (F[4,168] = 1.125, p = .346, η2 = .026). 
 
 
Figure 4.2. Scores on the three temptation constructs over time. Minus four = 
‘extremely likely to smoke’ vs. four = ‘extremely likely to exercise’. Baseline – week four, 
n = 41; week five – week eight, n = 33; week 10 – week 14, n = 29. Week four denotes 
quit week; the y-axis reference line denotes a score of zero (unsure). 
* p < 0.05 increase in confidence to exercise in relapse inducing situations. 
** p < 0.001 increase in confidence to exercise in relapse inducing situations.   
 
4.3.4 Are certain individual temptations more responsive to exercise 
behaviour as a coping strategy than others? 
The frequencies of each question on the temptations inventory at week 
five and week 14 are presented in Appendix 17. Participants answered 
that they would be highly likely to exercise in the scenario ‘when I see 
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that I am gaining weight’ (question 25 [week five – 40% responded with 
three or four out of four; week 14 – 38% responded with three or four out 
of four]). They reported being highly likely to smoke at both week five 
and 14 in the scenario ‘when I experience an emotional crisis (i.e., an 
accident or death in the family)’ (question 24 [week five – 26% 
responded with minus three or minus four out of minus four; week 14 – 
21% responded with minus three or minus four out of minus four]). 
 
4.3.5 Exercise self-efficacy  
Exercise self-efficacy was measured at three time points over the 
course of the programme (baseline, week six, week 14). The results 
demonstrated that individuals who were considered abstinent (CO < six  
ppm) and provided data at each time point showed a significant 
difference over time for exercise task self-efficacy (n = 28; F[2,54] = 
3.421, p < .05, η2 = .112). Exercise task self-efficacy significantly improved 
from baseline to week six (t = -2.150, p < .05, η2 = .146) and from 
baseline to week 14 (t = -2.325, p < .05, η2 = .167) (Figure 4.3).  
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Figure 4.3. Exercise task self-efficacy scores for women considered abstinent (CO < six  
ppm at week six and 14) and competed questionnaires at all three time points (n = 
28). 
 * p < 0.05 significant difference between baseline and week six and week 14. 
 
No change over time was found for either exercise scheduling self-
efficacy (n = 27; F[2,52] = 7.674, p = .073, η2 = .096 [baseline – M = 7.042 
SD = 3.020; week six – M = 6.814, SD = 2.778; week 14 – M = 7.830, SD = 
2.249]) or exercise barrier self-efficacy (n = 27; F[2,52] = 1.491, p = .235, 
η2 = .054 [baseline – M = 7.725, SD = 2.249; week six – M = 7.377, SD = 
2.874; week 14 – M = 7.007, SD = 2.167]).  
 
4.3.6 Cessation self-efficacy 
Cessation self-efficacy was measured at three time points over the 
course of the programme (baseline, week six, week 14). The results 
demonstrated that individuals who were considered abstinent (CO < six 
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ppm) and provided data at each time point showed a significant 
difference over time for smoking cessation self-efficacy (n = 26; F[2,50] 
= 57.859, p = .000, η2 = .698).  Smoking cessation self-efficacy was 
significantly greater at week six (t = -10.510, p = < .001, η2 = .804) and 
week 14 (t = -7.959, p = < .001, η2  = .701) when compared to baseline 
(Figure 4.4). 
 
 
Figure 4.4. Cessation self-efficacy scores for women considered abstinent (CO < six 
ppm at week six and 14) and competed questionnaires at all three time points (n = 
26). 
 * p < 0.001 significant difference between baseline and week six and week 14. 
 
4.3.7 Exercise behaviour  
Self-reported leisure time physical activity behaviour questionnaire 
scores significantly increased from pre- to post-exercise for those 
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participants that provided data (n = 36; F[1,35] = 44.536, p < .001, η2 = 
.560)   
 
4.3.8 Correlations 
No significant correlations were found between change in cessation 
self-efficacy over time (baseline to week six) and change in any of the 
exercise self-efficacy variables over the same time period (task [r = .319,  
p = .091]; scheduling [r = -.077, p = .697]; barrier [r = .294, p = .121]). 
However, a trend effect for change over time (baseline to week six) 
was demonstrated between cessation self-efficacy and task self-
efficacy. 
 
4.3.9 Smoking cessation outcomes  
48.1 percent (n = 38) of participants were able to abstain from 
cigarettes on the week four quit date (CO < six ppm). At the end of the 
programme (week 14) 60.3% of participants were considered smoke 
free (CO < six ppm). Smoking abstinence was related to attendance to 
the exercise programme (x2[2, n=58] = 14.758, p < .001) (Table 3.5).  
 
Table 4.4. Breakdown of participants smoking status at week 14 in relation to 
attendance to the exercise portion of the programme (n = 58) 
 Exercise Programme Attendance  
 80-100% 60-80% <60% Total 
Non-smoking at week 14     
   Number of participants 27 2 6 35 
   Percent of total 46.6% 3.4% 10.3% 60.3% 
Smoking at week 14     
   Number of participants 6 4 13 23 
   Percent of total 10.3% 6.9% 22.4% 39.7% 
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4.4 Discussion 
Successfully coping with situations that invoke the desire for a cigarette 
is essential to quit success. The present study sought to determine 
whether women undergoing a NRT and exercise aided quit attempt 
would report a temporal progression away from smoking in tempting 
situations. It was hypothesised women engaging in 14 weeks of 
structured exercise would report incrementally swapping smoking 
behaviour for exercise behaviour when faced with relapse provoking 
situations. Certainly this was the case from baseline to quit week (week 
four). During this time period there was a significant shift in reported 
response from smoking to exercise on all three temptation constructs 
(positive/social, negative/affective, habit/addiction). This finding 
indicates that smokers engaging in regular exercise could imagine how 
exercise might help them cope with the urge to smoke when faced 
with a smoking trigger.  
 
An additional hypothesis addressed in the present study was that from 
quit week to the end of the programme (week 14) participants who 
had successfully quit smoking and continued to take part in the 
intervention would report confidence in exercising instead of smoking in 
tempting situations. This was not however the case; the results suggest 
that women undergoing a quit attempt are not likely to report exercise 
as a coping mechanism to deal with future potential smoking urges. 
 
Due to the complexity of quitting smoking the null findings for switching 
to exercise post-target quit date are clinically relevant. The exercise 
intervention progressed quitters to the point where they did not believe 
they would smoke in tempting situations; although, they reported that 
they would not exercise either. Considering that quitting smoking is a 
process that unfolds over time and that abstinent smokers often 
relapse, any quit smoking aid that steers the recent quitter away from 
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succumbing to smoking temptation is worthwhile (Shiffman, Kassel, 
Gwaltney, & McChargue, 2005).  
 
One of the most commonly reported immediate coping strategies 
utilised by self-quitters is informal exercise (O'Connell et al., 1998). 
However, coping skills training research shows that in order for a coping 
strategy to be reliably utilised when abstinence is threatened it needs 
to be well learned, such that it becomes a habitual response (Shiffman 
et al., 2005). Perhaps additional intensive exercise coping skills training 
was required and simply engaging in exercise on a regular basis was 
not sufficient to perceive exercise as a behavioural coping strategy in 
high-risk situations. Perhaps, had these women received intensive 
training in the use of exercise as a relapse coping strategy they may 
have reported more confidence in its use. If this is the case then it 
challenges the cost effectiveness and scalability of an intervention 
such as this for relapse prevention. However, it should be noted that 
recent research in both the United Kingdom and New Zealand have 
demonstrated that it is feasible to embed the promotion of physical 
activity into existing smoking cessation services (Maddison, Roberts, 
Bullen, McRobbie, Jiang, Prapavessis, Glover, Taylor, & Brown, 2010; 
Taylor, Everson-Hock, & Ussher, in press).  
 
The preferred coping response inventory was separated into three 
distinct constructs known to entice smoking relapse (Velicer et al., 
1990). This allowed for investigation into the perceived utility of exercise 
as a strategy for coping with each construct separately. Given the 
effects of exercise in the general population, and the acute smoking 
and exercise literature, it was hypothesised that participants would be 
more likely to report using exercise as a strategy to cope with a 
negative emotional state (N/A construct). This was not the case; there 
was no difference in perceived likelihood of using exercise to prevent 
relapse between the different constructs. These three constructs are 
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not only predictors of relapse they are also associated with the 
maintenance of smoking behaviour. For example, some people 
continue to smoke to reduce negative affect whereas for others 
smoking is maintained through the social networks of family and friends 
(TTS, 2010). In addition, subjective impressions of craving and 
withdrawal are also important; physical nicotine dependence also 
varies for individuals and may be a central determinant of smoking 
maintenance (Brownell et al., 1986). Perhaps a participant’s response 
to the use of exercise as a relapse coping strategy was contingent on 
what maintains their smoking behaviour. For example, if an individual 
continues to smoke because it is their social norm, they may not be 
able to imagine exercising when faced with a temptation (e.g., at a 
party). 
 
Previous researchers have posited that exercise is likely to be a less than 
practical solution to counter craving in many environments where 
abstinence is enforced (e.g., a bar or workplace) (Ussher, Nunziata, 
Cropley, & West, 2001). The results from the current study concur with 
this notion and suggest that recently quit smokers were unable to 
comprehend how exercise would be an appropriate response in many 
tempting situations. The relevance of exercise as a coping strategy 
may have been undermined by the fact that these women were 
engaging in aerobic exercise only; a type of exercise that may not be 
a natural coping choice in many situations (e.g., when with friends at a 
party). The majority of acute exercise and smoking research has 
investigated aerobic exercise but there are an increasing number of 
studies researching the effects of isometric exercise on craving and 
withdrawal symptoms (Ussher, Cropley, Playle, Mohidin, & West, 2009; 
Ussher, West, Doshi, & Sampuran, 2006). The findings from these studies 
are promising and short bouts of isometric exercise (five or 10 minutes) 
seem to reduce desire to smoke and withdrawal symptoms in 
temporarily abstinent smokers. Additionally, individuals engaging in this 
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type of exercise believed it to be a credible strategy for dealing with 
craving and withdrawal (Ussher et al., 2009). The present study findings 
for the week five to week 14 time period would suggest that extensive 
training is needed before individuals will confidently use exercise as a 
behavioural coping strategy. Imagined future use of exercise to 
prevent relapse may have been boosted had participants been 
schooled in different types of exercise strategies for different situations 
(e.g., at a bar socialising - use isometric contractions; stressed at work - 
go for a walk at lunch time). The results highlight that simply engaging 
in exercise does not constitute situation specific relapse prevention 
training.  
 
In addition to examining each relapse category and how it may relate 
to exercise as a coping strategy, each of the questions on the coping 
with temptation inventory was examined individually. Of the 25 items 
pooled from the Revised Temptations Inventory and the Cessation Self-
Efficacy Questionnaire (DiClemente, 1981; Velicer et al., 1990), two 
items stood out as worthy of mention. First, a large number of 
participants (40% at week five, 38% at week 14) responded that they 
would be highly likely to exercise to avoid relapse ‘when I see that I am 
gaining weight’. Nicotine has been found to have powerful effects on 
the regulation of body weight. When a smoker quits it can lead to 
physiological pressure to gain weight (Grunberg & Bowden, 1985). The 
weight gain associated can have negative psychological 
consequences for the quitter and result in the resumption of smoking 
(Brownell et al., 1986; Schneider & Waters, 2007). Therefore, identifying 
adjunct therapies that can assist quitters in avoiding weight gain is 
clinically important. A recent review of exercise interventions for 
smoking cessation found that such programmes do not consistently 
report an end of programme reduction in weight gain (Ussher et al., 
2008). However, the results from the present study suggest that ex-
smokers consider exercise a useful strategy to deal with post cessation 
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weight gain. This implies that though exercise may not always be 
enough to ward off weight gain it may help with the negative affective 
portion of this weight gain that drives quitters to relapse (Schneider & 
Waters, 2007). The second stand out item was ‘when I would 
experience an emotional crisis (i.e., an accident or death in the 
family’). In this instance many of the participants (26% at week five, 21% 
at week 14) responded that they would be highly likely to go back to 
smoking. This result indicates that while exercise might help with daily 
stressors, participants require additional cognitive coping strategies to 
avoid smoking in an emotional crisis.  
 
Smoking and a sedentary lifestyle are two behaviours that co-occur 
(Nagaya, Yoshida, Takahashi, & Kawai, 2007), and the smokers in the 
present study were no exception. Nagaya and colleagues (2007) 
examined the longitudinal impact of quitting smoking and relapse on 
exercise behaviour in a group of Japanese men (n = 750). They found 
smoking cessation to be associated with an increase in exercise 
behaviour whereas smoking relapse was associated with reduced 
exercise behaviour. It may be that these two behaviours are closely 
linked and that the process of change in one is similar to the other. 
Indeed, it was demonstrated that an abstinent smoker’s increase in 
confidence to perform exercise paralleled confidence in her ability to 
successfully quit smoking. In addition, although change in task self-
efficacy from baseline to week six was not significantly related to 
change in cessation self-efficacy over this same time period, a trend 
effect was observed. Perhaps, the complex cognitions involved in these 
two behaviours share similarities, which may be an underlying factor as 
to why these women were unsure of their ability to use exercise as a 
temptation coping strategy. That is, imagining urge inducing situations 
led them to feel weakness for both behaviours. 
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The majority of participants, coming into the programme, were not 
meeting the current Canadian Society for Exercise Physiology 
guidelines for physical activity (150 minutes of moderate to vigorous 
intensity aerobic physical activity per week, in bouts of 10 minutes or 
more) (CSEP). Likely, when this group of women began the programme 
they did not consider themselves to be exercisers. Although they did 
increase their confidence in their ability to exercise, they did not 
experience an increase in their confidence to overcome barriers to 
being active or to schedule exercise into their lives. It is possible that 
after being sedentary, 14 weeks of exercise was not enough time for 
them to truly imagine exercise as a coping strategy and believe they 
could overcome barriers to its use (Anderson & Cychosz, 1995). 
 
Smoking cessation rates were highest when individuals attended more 
than 80% of the programme. Engaging in exercise may have reinforced 
participant’s commitment to making healthy lifestyle changes, in 
particular giving up smoking (Prochaska, Hall, Humfleet, Munoz, Reus, 
Gorecki, & Hu, 2008). It has been reported in the literature that 
individuals who believe they can increase their physical activity levels 
are also confident about reducing their smoking behaviour and vice 
versa (Boudreaux, Francis, Carmack Taylor, Scarinci, & Brantley, 2003; 
King et al., 1996; Prochaska et al., 2008). The present study 
demonstrated a similar result (i.e., exercise task and cessation self-
efficacy increased over time). These findings taken together make it 
possible to suggest that female smokers who are confident in their 
ability to change their smoking behaviour also have an increased 
confidence in their ability to improve their exercise regimen (Prochaska, 
Spring, & Nigg, 2008). It is also postulated that developing confidence 
to exercise provided quitters with confidence not to give in to the urge 
to smoke and resulted in temptation scores staying above zero. 
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It should be noted that these results were demonstrated when exercise 
behaviour was specifically targeted. Other researchers have found that 
targeting a single behaviour for change does not necessarily translate 
into healthy changes in other behaviours (Dutton, Napolitano, Whiteley, 
& Marcus, 2008). Therefore, changes in physical activity may not simply 
occur because the individual quits smoking or vice versa. In addition, 
the majority of participants were highly motivated and ready to 
change both behaviours entering into the programme. As such, it is not 
possible to say that change in one lifestyle behaviour increases an 
individual’s confidence to improve behaviours that they lack 
motivation for or are not ready to change.  
 
Interventions designed to concurrently change multiple health 
behaviours are often challenged by poor adherence as participants 
may find them overwhelming (Prochaska et al., 2008). Indeed, previous 
exercise and smoking cessation trials are often limited by a lack of 
exercise adherence (Ussher et al., 2008). To improve exercise 
adherence rates in the current study the two behaviours were 
sequentially introduced (i.e., four weeks of exercise before attempting 
to quit smoking) and participants were identified as being ready to 
change both their smoking and exercise behaviour (Prochaska et al., 
2008). As previously mentioned, smoking cessation was highest when 
individuals attended more than 80% of the programme and almost half 
of all participants did so. While this adherence rate is not dismal it is 
somewhat sobering and considering that exercise programme 
attendance influenced quit status, attendance stands out as one of 
the greatest barriers to multiple behaviour change programme 
success.  
 
4.4.1 Limitations 
All participants received a comprehensive intervention that involved 
NRT and exercise in a group setting. Pharmacotherapy and social 
147 
 
 
 
support are considered essential components of any effective quit 
smoking programme (Fiore et al., 2008). Therefore, it is possible that the 
significant change in the temptation inventory demonstrated between 
baseline and quit week was not solely due to exercise. However, this 
notion is somewhat mitigated by the fact that exercise task self-
efficacy increased from baseline to week six. This increase suggests that 
any increase in confidence to exercise in high-risk situations would be 
related to the exercise portion of the intervention. 
 
Newly abstinent smokers reported that when confronted with a trigger 
they would neither smoke nor exercise. A limitation of this research is 
that alternative behavioural (e.g., do something else) or cognitive (e.g., 
positive self-talk) coping strategies were not measured. Asking 
participants at an exit interview how they dealt with temptations may 
have provided valuable insight into the type of coping strategies being 
used over and above exercise.  
 
The study was also limited by the fact that participants had to imagine 
whether or not they would exercise when faced with a trigger. A more 
ecologically valid way to measure the use of exercise as a relapse 
coping strategy would have been through real time reporting with 
electronic devices (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). 
 
The findings from the present study are only generalisable to female 
abstinent smokers who completed the questionnaire assessments. A 
large number of individuals were excluded from the analyses because 
they were not considered smoke-free at the time of assessment. Future 
research should examine the temptation inventory responses of non-
abstinent smokers. However, the majority of participants considered to 
have relapsed were also those who stopped attending the programme 
and as such these data were scant. Similarly, it would have been 
advantageous to examine self-efficacy to quit smoking and exercise 
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based on adherence to the exercise programme. Unfortunately, 
because only a few participants with poor adherence attended the 
three self-efficacy assessment time points these comparisons could not 
be made. To rectify this it would have been worthwhile to contact 
absent participants and have them email or provide their answers over 
the phone.   
 
Due to the time frame of the research it was not possible to obtain an 
objective measurement of post-intervention physical activity behaviour 
for this group of participants. Therefore, in terms of pre- and post-
intervention physical activity behaviour only self-report data was 
available and reported in this study. It has been demonstrated that 
people tend to over report their physical activity data when they self-
report, making it a less accurate measurement of physical activity than 
when objectively measured (Taber, Stevens, Murray, Elder, Webber, 
Jobe, & Lytle, 2009). 
 
Finally, there were many criteria that had to be met (e.g., CO < six 
ppm, consistent exercise attendance) before an individual was 
included in the dataset. The strict inclusion criteria led to a small sample 
size for the self-efficacy data set (n = 25), which resulted in these 
analyses being underpowered. Had these analyses been adequately 
powered we may have found significant change in the other exercise 
self-efficacy variables. 
  
4.4.2 Future research 
When planning a relapse prevention intervention psychological and 
situational factors that underlie why an individual smokes should be 
considered. For example, if an individual smokes to suppress anger and 
frustration at work, they will need to be taught alternative anger 
management skills to use in preparation for cessation (Abrams et al., 
2003). The point is, in the future it may be beneficial to determine what 
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sustains cigarette use for the individual and determine if exercise proves 
to be an effective adjunct under the circumstances.  
 
Multiple health behaviour change interventions may be the future of 
preventive medicine. There is a growing body of research to suggest 
that concurrently and successfully targeting change in health 
behaviours is possible (Prochaska, 2008). However, there is also 
evidence to suggest that it is not as simple as a change in one 
behaviour translating to a change in another behaviour (Dutton et al., 
2008). Finding that individuals experience a simultaneous increase in 
confidence to quit smoking and exercise leads to a number of 
important questions worthy of future research: (1) does confidence to 
change one behaviour come before confidence to change the other 
i.e., increased confidence in changing exercise behaviour leads to 
confidence to quit smoking or vice versa?; (2) are smokers who 
become regular exercisers likely to spontaneously quit smoking?; (3) in 
the interest of cost effectiveness, what is the minimum treatment 
required to get these two behaviours to change together?; (4) how 
many ex-smokers continue to exercise at six and 12 months post 
intervention?; and (5) are there identifiable individual factors that 
contribute to success in multiple health behaviour change programmes 
involving exercise and smoking cessation?  
 
4.4.3 Conclusions 
The findings from the present study highlight the importance of focusing 
interventions on behavioural problem solving treatments (e.g., exercise) 
leading up to a quit attempt. They also suggest that smokers, who are 
preparing to quit, can realise how exercise might be a useful strategy 
to help them resist the urge to resume smoking in tempting situations. 
However, despite the appeal of exercise as a coping strategy, recently 
quit smokers may require intensive behavioural coping skills training 
before they accept using exercise in future tempting situations. Finding 
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that greater exercise adherence increased smoking cessation, and 
that amongst those who remained abstinent, cessation self-efficacy 
and exercise self-efficacy both increased provides evidence that it is 
possible to successfully change these two incompatible behaviours at 
once. Finally, when an individual is confident in her ability to change a 
complex behaviour it may be a good time to capitalise on her being in 
a time for multiple complex behaviour changes. 
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5 CHAPTER FIVE: GENERAL DISCUSSION 
 
 
The research contained within this dissertation provided valuable 
information about the mechanisms underlying how exercise might assist 
female smokers deal with the craving and withdrawal symptoms 
associated with nicotine deprivation, and how it might help them to 
quit. Elucidating the mechanisms behind the beneficial effects of 
exercise on smoking cessation outcomes is important for designing 
maximally effective interventions. Additionally, identification of such 
mechanisms might increase the prescription of exercise as an adjunct 
smoking cessation aid by tobacco treatment specialists. Exercise is an 
important health behaviour in its own right. Therefore, anything 
researchers can do to improve the odds of exercise being accepted 
and recommended as a smoking cessation aid is worthwhile.  
 
The studies contained within this dissertation were all based on a 
female population. This was done for a number of reasons: (1) women 
are able to refrain from smoking for shorter periods and report greater 
nicotine withdrawal compared to men (USDHHS, 2001); (2) the 
underlying factors for relapse may be different for men and women 
(e.g., females specifically site concerns about post-cessation weight 
gain as a barrier to quitting) (Marcus, Albrecht, King, Parisi, Pinto, 
Roberts, Niaura, & Abrams, 1999); and (3) for the comfort and 
satisfaction of the participants, creating a female only exercise 
environment was necessary. In line with profiling and tailoring of 
interventions it is possible that there may be a difference between 
intervention saliency when gender is considered, and the findings may 
not be generalisable to male smokers. Future research to determine 
whether these results hold for a group of male smokers undergoing a 
quit attempt may be warranted. 
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The results of the present dissertation were obtained in a design that 
overcame some of the limitations of previous acute exercise and 
smoking cessation research. For instance, the majority of studies 
investigating the acute effects of exercise on smoking involve smokers 
undergoing a period of temporary smoking abstinence before 
engaging in an acute bout of exercise. It is assumed from these 
experimental studies that cigarette craving and nicotine withdrawal 
symptom outcomes can be extrapolated to smokers going through a 
real quit attempt (Taylor & Katomeri, 2007). Presumably, as these types 
of studies involved temporarily abstinent smokers rather than quitters 
per se, it was not appropriate to have participants wear the nicotine 
patch, and therefore the effects of exercise in conjunction with NRT 
were understudied. Additionally, the majority of acute exercise and 
smoking research took place in a lab setting, which limited the 
ecological validity of the findings. The acute exercise research 
conducted in both study one (Chapter two) and study two (Chapter 
three) overcame these limitations by: (1) engaging smokers in a serious 
quit attempt; (2) participants were using the patch; and (3) the setting 
for the exercise bout was more like a gym than a laboratory. 
 
The specific aims of this dissertation were: (1) to determine whether an 
acute bout of exercise would further reduce craving and withdrawal 
symptoms in a group of female quitters using the nicotine patch; (2) an 
exploration of whether the magnitude of withdrawal and craving relief 
experienced following an acute bout of exercise would relate to quit 
success in this same group of women; (3) to examine whether recently 
quit smokers expectancy and credibility beliefs regarding exercise as a 
quit smoking treatment had any bearing on self-reported craving and 
withdrawal relief following an acute bout of exercise; (4) to compare 
smokers expectancy and credibility beliefs regarding a well established 
quit smoking aid such as NRT with a novel quit smoking aid such as 
exercise; (5) to determine if women taking part in a combined NRT and 
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exercise aided smoking cessation programme would report using 
exercise as a relapse prevention aid. 
 
Within the limitations of the studies contained within this dissertation the 
following conclusions were drawn: 
 
The results of study one indicated that an acute bout of moderate 
intensity aerobic exercise reduced symptoms of nicotine withdrawal 
and cigarette craving for women on NRT who are attempting to quit. 
Three to five days into the quit attempt an acute bout of exercise 
reduced craving and withdrawal symptoms (psychological and 
sedation) for recently quit smokers using NRT (nicotine patch). The first 
few days and weeks of the quit attempt often determine success or 
failure (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). The results also 
demonstrated that the effects of exercise seven to nine weeks into an 
NRT assisted quit attempt were still visible though not as large as those 
demonstrated during the first week of the quit attempt. These findings 
demonstrated that the beneficial effects of a bout of exercise did not 
become redundant when combined with NRT. Similarly, in study two, 
the week five result shown in study one was replicated. That is, women 
in the first week of their quit attempt using the patch showed a 
reduction in cigarette craving, psychological withdrawal, and sedation 
following an acute bout of moderate intensity exercise. A review of the 
acute exercise and smoking literature suggests that a single session of 
exercise has the ability to reduce craving and withdrawal amongst 
temporarily abstinent smokers (Taylor, Ussher, & Faulkner, 2007). Study 
one and two add to this body of research by demonstrating that these 
results hold with a group of women who are not only undergoing a real 
quit attempt but using NRT as well. 
 
It is well demonstrated that the nicotine patch, which delivers a steady 
release of nicotine, does not help quitters manage cue-induced 
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craving (Ferguson & Shiffman, 2009). Finding that a bout of exercise 
reduced craving amongst quitters using the patch has important 
implications for tobacco treatment. Namely, it implies that exercise and 
the patch are compatible, and exercise could be an alternative to 
nicotine gum or lozenges to manage cue-induced cravings. Being able 
to offer quitters an alternative to buying and using NRT (gum and 
lozenges) is beneficial because: (1) it will save the consumer money 
(i.e., exercise is free and gum and lozenges are not); (2) ultimately 
engaging in exercise is a healthier behaviour than using NRT; and (3) it 
may reduce the time it takes the ex-smoker to wean off nicotine 
altogether. 
 
In study one it was determined that the magnitude of craving and 
withdrawal relief experienced did not differ between women who were 
successfully quit at week 14 and those who were unsuccessful at week 
14. That is, all newly quit smokers at week five experienced a reduction 
in craving and withdrawal regardless of what the end of programme 
outcome was. This finding highlights the complexity of quit success and 
suggests that numerous factors are involved in determining an 
individual’s quit status. It also suggests that the benefits of exercise are 
not discriminatory, and implies that health practitioners can confidently 
recommend exercise as a cessation aid to any woman attempting to 
quit and looking for an adjunct therapy to help manage craving and 
withdrawal. 
 
Individuals who strongly believed exercise to be a credible quit smoking 
aid, and/or expected that they would derive benefit from exercise, 
experienced a greater reduction in cigarette craving following an 
acute bout of moderate intensity exercise. This contradicted the 
findings of Daniel et al. (2007), but is in accordance with the 
psychotherapy outcome research that underscores the influence of 
these two variables (Smeets, Beelen, Goossens, Schouten, Knottnerus, & 
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Vlaeyen, 2008; Newman & Fisher, 2010). However, no significant 
differences between high and low expectancy and credibility groups 
were found for either psychological withdrawal, or the withdrawal 
symptom of sedation, findings that concur with those reported by 
Daniel et al. (2007). Nevertheless, the intensity of craving experienced 
by an abstinent smoker during the first few days of quitting is often 
predictive of his/her success (Ferguson, Shiffman, & Gwaltney, 2006), 
which may make this further reduction in craving of clinical 
importance. Although, exercise expectancy and credibility beliefs may 
not be a major mechanism involved in the acute effects of exercise on 
craving and withdrawal amongst temporarily and recently quit smokers 
they may play some role.  
 
The concurrent measurement of exercise expectancy and credibility 
with NRT expectancy and credibility amongst a group of female 
smokers, who were provided with both cessation aids, allowed for a 
comparison of actual expectancy and credibility beliefs related to 
these two treatments (study two). It was demonstrated that women 
who managed to successfully quit smoking by the end of the 
programme believed both exercise and NRT had merit as quit smoking 
aids. By no means does this imply that exercise and NRT are equally 
effective smoking cessation strategies. However, it does imply that  
quitters likely attributed some of their success to the exercise portion of 
the programme (Kazdin, 1979).  
 
Throughout the programme both NRT and exercise expectancy and 
credibility beliefs fluctuated over time and often showed a different 
pattern of change depending on participants quit success. One thing 
that remained constant is that for all participants who attended the 
programme exercise expectancy and credibility beliefs remained high. 
Expectancy and credibility are variables common to all smoking 
cessation treatment strategies, and research in the field of clinical 
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psychology substantiates that these variables exert some influence 
over behavioural outcomes, and that this influence should be utilised 
(Kirsch & Lynn, 1999). Any quit smoking treatment that smokers can 
believe in from pre- to post-quit and beyond has merit. This implies that 
exercise may be a cost effective quit smoking aid because it spans the 
gamut, from an initial quit smoking treatment to relapse prevention 
strategy.  
 
The results of study three (Chapter four) suggested that leading up to a 
quit attempt smokers who are regularly engaging in exercise can 
envisage how exercise might help them to cope once they quit and 
find themselves in relapse provoking situations. Once they actually quit, 
and experienced tempting situations either first hand or hypothetically, 
they were no more likely to report that they would exercise in such 
situations than they were to report that they would smoke. Smoking 
relapse rates are alarmingly high (between 60-98% at one year), and 
unfortunately a number of women who at first achieve quit success will 
be smoking again at 12 months (Garvey, Bliss, Hitchcock, Heinold, & 
Rosner, 1992). Considering this, progressing these women to the point 
where they did not believe they would smoke in tempting situations 
may still be relevant. That is, regardless of whether they chose to use 
exercise to cope with temptation, perhaps becoming regular exercisers 
helped them to resist the urge to smoke (Shiffman, Kassel, Gwaltney, & 
McChargue, 2005). This notion is strengthened by the finding that 
abstinent smokers who increased in their confidence to change their 
smoking behaviour also showed an increased confidence in their ability 
to improve their exercise behaviour and vice versa. It is possible that 
simultaneously being confident in changing these two complex 
behaviours resulted in participants reporting they would not give in to 
the urge to smoke. 
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The majority of participants, coming into the programme, were inactive 
and not meeting the current Canadian Society for Exercise Physiology 
guidelines for physical activity (CSEP). Although they were engaging in 
exercise on a regular basis throughout the programme, intensive 
exercise coping skills training may be required before they perceive 
exercise as a behavioural coping strategy in high-risk situations. 
Providing participants with such training would not have been out of 
the question. These skills could have been taught weekly at the end of 
the first exercise session over a 15-20 minute session. Alternatively, in the 
interest of cost and for improved scalability of such an intervention they 
could have been administered over the internet or in a take-home 
package.    
 
One of the aims of study three was to determine under what 
circumstances smokers or abstinent smokers would perceive exercise to 
have the greatest utility as a relapse coping strategy. No difference 
was observed between the different relapse constructs investigated. It 
is possible that imagined future use of exercise to prevent relapse may 
have been improved by instructing participants as to different types of 
exercise strategies for different situations (e.g., at a bar socialising - use 
isometric contractions; stressed at work - go for a walk at lunch time).  
 
Quitting tobacco involves three phases: (1) preparation or getting 
ready to quit; (2) cessation or actually quitting; and (3) maintenance or 
relapse prevention (TTS, 2010). Any effective treatment plan must 
address all three phases. The results of the present dissertation provide 
evidence that exercise is an adjunct therapy that covers all three to 
varying degrees. 
 
When preparing to quit, smokers are advised to begin the process of 
investigating alternative coping behaviours to smoking (TTS, 2010). Both 
varenicline and bupropion, pharmacotherapy for smoking cessation, 
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were designed to be initiated before the smoker attempts to quit. 
Similarly, exercise is a smoking cessation aid that can be effectively 
provided to smokers before their quit date. There is evidence in study 
three to suggest that sedentary female smokers who successfully 
increased their exercise behaviour demonstrated both an increased 
confidence to exercise and an increased confidence to quit. Although, 
it is not possible to say which change occurred first, it is possible that 
exercise helped these women prepare to quit by increasing their 
confidence in their ability to change in general.  
 
Cigarette cravings are one of the most often expressed difficulties 
related to quitting, and the intensity of craving experienced by an 
abstinent smoker over the first few days of quitting often predicts their 
success (Ferguson et al., 2006). The results of study one and two showed 
that an acute bout of exercise not only relieved nicotine craving and 
withdrawal symptoms (psychological and sedation) but it did so for a 
group of abstinent smokers supplementing their nicotine with the 
patch. These findings provide evidence for exercise supporting the 
cessation phase (and the relapse phase) of becoming smoke-free. 
Further, study two showed that an acute bout of exercise has the 
potential to reduce cigarette craving even further if women 
undergoing a quit attempt believe it to be an effective smoking 
cessation treatment.  
 
For both cohorts of women who took part in this research (study one, 
two, and three) smoking cessation rates were highest when more than 
80 percent of the programme was attended. Engaging in exercise may 
have reinforced a participant’s commitment to making healthy lifestyle 
changes, in particular giving up smoking (Prochaska, Hall, Humfleet, 
Munoz, Reus, Gorecki, & Hu, 2008). In addition, these findings support 
the notion that exercise and smoking are incompatible behaviours and 
as such complement one another other when an individual is going 
163 
 
 
 
through a period of lifestyle change (King, Marcus, Pinto, Emmons, & 
Abrams, 1996). 
 
Evidence for exercise as a relapse prevention strategy comes from the 
craving and withdrawal relief demonstrated following an acute bout of 
exercise in study one and two. In addition, study three also provided 
some evidence that exercise can assist with relapse prevention. 
Specifically, a large number of participants (40% at week five, 38% at 
week 14) responded that they would be highly likely to exercise to 
avoid relapse ‘when I see that I am gaining weight’. Nicotine has been 
found to have powerful effects on the regulation of body weight. When 
a smoker quits it can lead to physiological pressure to gain weight 
(Grunberg & Bowden, 1985). The weight gain associated can have 
negative psychological consequences for the quitter and result in 
resumption of smoking (Brownell, Marlatt, Lichtenstein, & Wilson, 1986; 
Schneider & Waters, 2007). Therefore, although study three did not 
show quitters to consistently report that they would use exercise to help 
them remain abstinent, they did report that they would use exercise to 
counter this leading cause of relapse. 
 
The results of the present dissertation also provided some evidence for 
exercise as an effective harm reduction strategy. It is presumed that 
there will always be a percentage of smokers that find it extremely 
difficult to quit. These so called hardened smokers, likely smoke many 
cigarettes a day and have been doing so for many years (TTS, 2010). 
Although, completely quitting smoking is always best, a harm reduction 
strategy may be appropriate for smokers who find it extremely difficult 
to quit and are repeatedly unsuccessful (TTS, 2010). In order for a 
smoking cessation treatment to be considered an effective harm 
reduction strategy it must fulfil a number of criteria (eight criteria in 
total) (deRuiter & Faulkner, 2006). Pertaining to this dissertation, 
evidence for exercise as a harm reduction strategy was found for the 
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following five criteria: (1) the harm-reduction strategy should not 
increase or contribute to the individuals level of nicotine dependence; 
(2) the strategy should not sabotage the likelihood of eventual 
cessation; (3) the strategy should not lead to an increased population 
prevalence of tobacco dependence; (4) the strategy should 
eventually allow the smoker to become nicotine free; and (5) 
information that might ultimately lead an individual to quit smoking 
should be able to be incorporated into the harm-reduction strategy 
(Hatsukami, Henningfield, & Kotlyar, 2004; deRuiter & Faulkner, 2006).  
 
Evidence from study one and two suggests that an acute bout of 
exercise in a more natural setting (e.g., gym setting) amongst those 
who had recently quit had the effect of reducing craving and 
withdrawal symptoms. Therefore, as exercise lessens craving and 
withdrawal symptoms it is unlikely to increase or contribute to the 
individual’s level of nicotine dependence. On the contrary, reducing 
craving and withdrawal would likely increase the time between 
cigarettes (Taylor & Katomeri, 2007). Additionally, the intensity of 
craving and withdrawal symptoms experienced during a quit attempt 
are a good indicator of relapse. The ability of an acute bout of exercise 
to ameliorate craving and withdrawal symptoms, demonstrated in 
study one and two, make it possible that exercise participation would 
contribute to the individual eventually becoming nicotine free. 
 
The results of study three indicated that an increase in exercise 
behaviour would not lead to an increase in population prevalence of 
tobacco dependence. Specifically, it was demonstrated that 
participants concurrently increased in both cessation and exercise self-
efficacy, and those who maximally attended the exercise sessions were 
more likely to quit. These two findings suggest that exercise and 
smoking are not compatible behaviours. Therefore, it is unlikely that 
exercise would sabotage eventual cessation.  
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More and more, tobacco treatment specialists are integrating physical 
activity promotion into their smoking cessation programmes (TTS, 2010). 
Indeed, exercise and smoking cessation research has shown it is 
possible to successfully incorporate exercise as part of a multi-
component cessation strategy (Marcus et al., 1999; Ussher, West, 
McEwen, Taylor, & Steptoe, 2003). In study two it was demonstrated 
that smokers believed exercise and NRT to be equally as credible and 
expected both cessation strategies would help them quit smoking. 
Thus, it is likely that the incorporation of smoking cessation and physical 
activity messages would be well received by smokers. 
 
However, it should be noted that the promising results in this dissertation 
were found when exercise behaviour was specifically targeted, which 
challenges the cost effectiveness and scalability of an exercise aided 
intervention such as this. Nevertheless, exercise as a smoking cessation 
adjunct has great potential as both a harm reduction strategy and as a 
multi-phase treatment. For these reasons, finding a way to incorporate 
exercise into cessation treatment such that it becomes widely available 
and easily accessible has great public health potential (Fiore, Jaen, & 
Baker, 2008; Maddison, Roberts, Bullen, McRobbie, Jiang, Prapavessis, 
Glover, Taylor, & Brown, 2010). In study three of this dissertation 
evidence was garnered to suggest that it is possible to concurrently 
change these two behaviours (smoking behaviour and physical activity 
behaviour). Research in New Zealand is currently underway to 
determine the feasibility of incorporating two national services (Quitline 
and Green Prescription) (Maddison et al., 2010). Similarly, a group of 
researchers in the United Kingdom have investigated the feasibility of 
embedding physical activity promotion into existing smoking cessation 
services (Taylor, Everson-Hock, & Ussher, in press). The results of these 
two trials are eagerly awaited and will pave the way for future exercise 
and smoking cessation work. As an alternative to incorporating exercise 
into smoking programmes, smoking cessation treatment could be 
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incorporated into exercise environments such as in gyms or in 
community centres. 
 
Overall, the present dissertation addressed the need for research on 
the mechanisms responsible for exercise effects on smoking cessation. It 
did so in a more natural environment with women undergoing a real 
quit attempt and using NRT. In addition, evidence was provided that 
exercise may be a smoking cessation strategy that can help a smoker 
quit and resist relapse. Finally, evidence is provided to further the cause 
for exercise as a potential harm reduction strategy. Ultimately it is 
hoped that the information contained within this dissertation will assist 
researchers and clinicians to improve cessation rates.  
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Appendix 1. Sociodemographic questionnaire 
 
CONTACT INFORMATION: 
 
First Name:_________________________         Last Name:________________________ 
 
Address:___________________________________________________________________ 
                          STREET ADDRESS, CITY, POSTAL CODE 
 
Home Phone: ________- _________-_________ 
 
Email Address: __________________________________________@_____________________ 
 
Date of Birth: ________/________/___________               
                             DD       MM           YYYY 
 
Section A 
 
1. Age:_________ (in years) 
 
 
2. What language do you speak most often at home? 
 
(Please check one) ? English 
? French 
? Cantonese 
? Mandarin 
? Italian 
? German 
? Punjabi 
? Spanish 
? Polish 
? Portugese 
? Arabic 
? Other (specify:____________ ) 
 
3. Were you born in Canada? (Please check one) ? Yes ? No 
 
4. Marital status:   (Please check one) 
? single      ? separated     ? married 
 ? divorced     ?  widowed     ? common law 
 
 
Section B – Children 
Please complete the following questions about any children you may have. 
5.    Do you have any children? (Please check one) ? Yes ? No 
 
6. If yes, please list their ages, separated by commas:  
170 
 
 
 
 
Section C – Education & Employment            
 
7. What is the highest grade (or year) of regular school have you completed? 
(please check one) 
 
Elementary             High school           College/University     Graduate school 
? 01 ? 09 ? 01 ? 01 
? 02 ? 10 ? 02 ? 02 
? 03 ? 11 ? 03 ? 03 
? 04 ? 12 + ? 04 + ? 04  
? 05 
? 06 
? 07 
? 08 
 
8. What is the highest degree you earned?  
(Please check one) ? High school diploma   
  ? College certificate 
  ? Bachelor’s degree 
   ? Masters degree 
   ? Doctorate 
   ? Professional (MD, LLB, DDS, etc.) 
   ? Other (specify:  ______________________ ) 
   ? None of the above  
 
9. Which of the following best describes your main daily activities and/or 
responsibilities?  
(Please check one) ? Working full-time 
 ? Working part-time 
 ? Unemployed or laid-off 
 ? Looking for work 
 ? Student 
 ? Keeping house or raising children full-time 
 
10. Are you currently working? (Please check one)       ? Yes  ? No 
  If YES, approximately how many hours/week are you working?______________ 
 
11. Which of these categories best describes your total combined family income for 
the past 12 months?  This should include income (before taxes) from all sources, 
wages, rent from properties, social security, disability and/or veteran’s benefits, 
unemployment benefits, workman’s compensation, help from relatives (including 
child payments and alimony), and so on. 
(Please check one) 
 
? Less than $5 000 
? $5 000 - $11 999 
? $12 000 - $15 999 
? $16 000 - $24 999 
? $25 000 - $34 999 
? $35 000 - $49 999 
? $50 000 - $74 999 
? $75 000 - $99 999 
 
? $100 000 + 
? don’t know 
? no response 
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Section D – Smoking History & Current Practices 
 
12. What is the approximate date and time of the last cigarette you have smoked? 
  
   Date:  ______________ Time: ________________ 
 
13. Does anyone in your household currently smoke?  
(Please check one) ? Yes  ? No 
 
14. In your best estimate, what percentage of your friends and family smoke?  
(Please check one)  ? 0 – 10%  
? 11 – 20%  
? 21 - 30%  
? 31 - 40%  
?  41 - 50%  
  ? 51% + 
 
Section E – Medical Information 
 
To the best of your knowledge, do you have: Please list your current drugs & medications (i.e., 
blood pressure pills, prescribed medicine): 
 Yes No   
High blood pressure       ? ?  
High blood cholesterol ? ?  
High blood sugar ? ?  
Diabetes (Type II) ?   ?  
    
  
Do you drink Alcohol?  ? Yes ? No 
 
If yes, number of drinks per week?   _______       _______        ________ 
          (Beer) (Wine)     (Hard Liquor) 
 
Section F 
 
How did you hear about our programme?  
 
? UWO Staff email  
? UWO Student email 
? Your place of work (please name workplace) ________________ 
? The Londoner Newspaper 
? The London Free Press 
? Smokers’ Helpline 
? The Canadian Cancer Society 
? The Health Unit 
? Other (please specify) _____________________________ 
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Appendix 2. Fagerström nicotine dependence 
 
1. How many cigarettes per day do you usually smoke?  _______________  
  
 
 
2. How soon after you wake up do you smoke your first 
cigarette? 
(circle one response) 
Within 5 minutes 
 
6-30 minutes 
 
31 or more 
 
 
 
 
 
3. Do you find it difficult to refrain from smoking in places 
where it is forbidden (e.g. in the mall, at the library, in 
the cinema?) 
(circle one response) 
No 
 
Yes 
 
 
4. Which cigarette would you most hate to give up? 
(circle one response) 
 
 
The first of the  
morning 
 
Other 
 
 
 
 
 
5. Do you smoke more frequently in the first hours after 
waking than during the rest of the day? (circle one 
response) 
 
No 
 
Yes 
 
 
 
 
 
6. Do you smoke if you are so ill that you are in bed most 
of the day? 
(circle one response) 
 
No 
 
Yes 
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Appendix 3. Motivation to quit smoking and smoking and physical activity history 
 
1. Do you want to quit smoking for good?  
a. Yes 
b. No 
c. Unsure 
 
 
2. Do you intend to make a serious attempt to stop smoking for good?  
a. Yes 
b. No 
c. Unsure 
 
 
3. How many cigarettes do you smoke, on average, per day? 
___________ cigarettes/day 
 
 
4. How many years have you been smoking the above number of cigarettes per 
day? 
___________ years  
 
 
5. How many years ago did you begin to smoke regularly? 
___________ years  
 
 
6. Have you tried to quit smoking in the past? 
a. Yes 
b. No  
 
 
7. If you have attempted to quit smoking in the past, how many times have you 
tried? 
_________ times  
 
 
8. Think about your physical activity behaviour in the past month. On average, how 
many times per week have you engaged in 30 minutes or more of regular 
moderate (e.g., jogging, playing tennis, riding your bike) to vigorous (e.g., running, 
spin classes, high impact aerobics classes) physical activity during your spare 
time? 
_________ times per week 
 
 
9. How many months have you been exercising at the above frequency per week? 
_________ months 
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Appendix 4. Shiffman-Jarvik withdrawal scale  
 
INSTRUCTIONS: Please CIRCLE the number to the right of each question that most 
accurately reflects how you feel at this moment. 
 
  Definitely not                    Definitely 
1. If you could smoke freely, would you like a 
cigarette right now? 
1 2 3 4 5 6 7 
2. Is your heart beating faster than usual? 1 2 3 4 5 6 7 
3. Do you feel more calm than usual? 1 2 3 4 5 6 7 
4. Are you able to concentrate as well as usual? 1 2 3 4 5 6 7 
5. Do you feel wide awake? 1 2 3 4 5 6 7 
6. Do you feel content? 1 2 3 4 5 6 7 
7. Are you thinking of cigarettes more than 
usual? 
1 2 3 4 5 6 7 
8. Do you have fluttery feelings in your chest? 1 2 3 4 5 6 7 
9. Do you feel hungrier than usual for this time of 
day? 
1 2 3 4 5 6 7 
10. If you were permitted to smoke, would you 
refuse a cigarette right now? 
1 2 3 4 5 6 7 
11. Do you feel more tense than usual? 1 2 3 4 5 6 7 
12. Do you miss a cigarette? 1 2 3 4 5 6 7 
13. Do you have an urge to smoke a cigarette 
right now? 
1 2 3 4 5 6 7 
14. Are you feeling irritable? 1 2 3 4 5 6 7 
15. Are your hands shaky? 1 2 3 4 5 6 7 
 
 
Scoring: 
Craving – 1, 7, 10 reversed, 12,13 
Physical – 2, 8, 15 
Sedation – 5 reversed 
Psychological – 3 reversed, 4 reversed, 6 reversed, 11,14 
Appetite – 9  
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Appendix 5. Smoking ladder 
 
Below are some thoughts that smokers have about quitting. On this ladder, circle the 
one number that shows what you think about quitting. Please read each sentence 
carefully before deciding. 
 
 
10 I have quit smoking and I will never smoke again. 
9 I have quit smoking, but I still worry about slipping back, so I need to keep 
working on living smoke free. 
8 I still smoke, but I have begun to change, like cutting back on the number 
of cigarettes I smoke. I am ready to set a quit date. 
7 I definitely plan to quit smoking with the next 30 days. 
6 I definitely plan to quit smoking in the next 6 months. 
5 I often think about quitting smoking, but I have no plans to quit. 
4 I sometimes think about quitting smoking, but I have no plans to quit. 
3 I rarely think about quitting smoking, and I have no plans to quit. 
2 I never think about quitting smoking, and I have no plans to quit. 
1 I enjoy smoking and have decided not to quit smoking for my lifetime. I 
have no interest in quitting. 
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Appendix 6. Godin leisure-time exercise questionnaire 
 
During the last 7 days, how many times did you do the following kinds of exercise for 
more than 15 minutes during your free time (write on each line the appropriate 
number)? 
 
         Times Per Week 
a) STRENUOUS EXERCISE (heart beats rapidly) 
 
 (e.g., running, jogging, hockey, football, soccer,  
squash, basketball, cross country skiing, judo,  
roller skating, vigorous swimming,  
vigorous long distance bicycling).                   ______ times  
 
 
b) MODERATE EXERCISE (not exhausting) 
 
  (e.g., fast walking, baseball, tennis, easy bicycling,  
volleyball, badminton, easy swimming, alpine skiing,  
  popular and folk dancing).       ______ times  
 
 
c) MILD EXERCISE (minimal effort)         
 
(e.g., yoga, archery, fishing from river bank, bowling,  
horseshoes, golf, snow-mobiling, easy walking).     ______ times  
 
 
 
 
 
During the last 7-Day period (week), in your leisure time, how often did you engage in 
any regular activity long enough that your heart would beat rapidly (work up a 
sweat)?  
 
  
 1.  Often _______ 2. Sometimes _______ 3. Rarely/Never _______ 
 
  
177 
 
 
 
Appendix 7. Stage of exercise readiness 
 
Please place a tick (√) next to the statement that best applies to you. Only tick one 
statement. 
 
___ I do not currently exercise and am not seriously thinking about changing in the 
next 6 months. 
 
___ I do not currently exercise but I am seriously thinking about changing in the 
next 6 months. 
 
___ I exercise sometimes but not regularly. 
 
___ I have started to exercise regularly (most days of the week for at least 45 
minutes each time) in the last 6 months. 
 
___ I exercise regularly (most days of the week for at least 45 minutes each time) 
and have done so for longer than 6 months. 
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Appendix 8. Previous patch experience form 
 
ID Number: _______________________ 
 
The questions below ask about your previous experience with the patch (nicotine 
replacement therapy e.g. NicoDerm, Nicorette). Please answer the questions as 
honestly as possible there are no right or wrong answers. 
 
1. Have you ever tried to quit smoking using the patch before? 
 
a. Yes 
b. No 
 
2. If you have, how many times have you used the patch? 
 
_______________ 
 
3. How would you rate your previous experience with using the patch? 
 
Extremely poor Unsure Extremely good 
1 2 3 4 5 6 7 
 
 
4. If you have managed to quit using the patch before, how much of your quit 
success do you attribute to the patch? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
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Appendix 9. Expectancy and credibility questionnaire 
 
INSTRUCTIONS: We would like you to indicate how much you believe, right now, that 
the two quit smoking aids [NicoDerm® patch (NRT) and EXERCISE] you receive during 
this programme will help you to quit. Belief usually has two aspects to it: (1) what you 
think will happen; and (2) what you feel will happen. Sometimes these are similar, 
sometimes they are different. Please answer the questions below. In the first set, 
answer in terms of what you think. In the second set answer in terms of what you really 
and truly feel.  
 
Set I 
 
1. At this point, how logical do the quit smoking aids offered to you seem?  
 
 Not at all Somewhat Extremely 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
2. At this point, how successfully do you think these treatments will manage your 
craving and withdrawal symptoms? 
 
 Not at all Somewhat Extremely 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
3. How confident would you be in recommending these treatments to a friend who 
wants to quit smoking? 
 
 Not at all Somewhat Extremely 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
4. By the end of the programme how much of your success do you think will be 
attributed to each of the quit smoking aids offered? 
 
 None Some All 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
 
5. How important is quitting smoking to you? 
 
Not at all Somewhat Extremely 
1 2 3 4 5 6 7 8 9 
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Set II 
 
For the next two questions, close your eyes for a few moments, and try to identify 
what you really feel about the quit smoking aids offered. Then answer the following 
questions.    
 
 
1. At this point, how much do you really feel that the quit smoking aids offered will 
help you to manage your craving and withdrawal symptoms? 
 
 Not at all Somewhat Extremely 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
2. By the end of the programme, how much of your quit success do you really feel 
will be related to the quit smoking aids offered? 
 
 None Some All 
NRT 1 2 3 4 5 6 7 8 9 
EXERCISE 1 2 3 4 5 6 7 8 9 
 
 
Questionnaire adapted from the Credibility/Expectancy Questionnaire (Devilly and 
Borkovec, 2000). 
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Appendix 10. Temptations questionnaire 
 
INSTRUCTIONS: Listed below are situations that lead some people to smoke. We would like to 
know HOW LIKELY you would be to SMOKE OR EXERCISE in each situation. 
 
Please answer the questions using the four point scale with 1 = A LITTLE LIKELY and 4 = 
EXTREMELY LIKELY. You may choose to respond by either SMOKING OR EXERCISE. Please circle 
ONLY ONE RESPONSE. 
 
REMEMBER: Circle the answer that best reflects how you would respond. There is no right or 
wrong answer. It is very important that you are honest. 
 
HOW LIKELY ARE YOU TO SMOKE?      HOW LIKELY ARE YOU TO EXERCISE? 
Extremely 
likely 
Very 
likely 
Somewhat 
likely 
A little 
likely 
Unsure A little 
likely 
Somewhat 
likely 
Very 
likely 
Extremely 
likely 
4 3 2 1 0 1 2 3 4 
 
  SMOKE  EXERCISE 
1. When I am desiring a cigarette 4 3 2 1 0 1 2 3 4 
2. When things are just not going the way I want and I am 
frustrated 
4 3 2 1 0 1 2 3 4 
3. With my spouse or close friend who is smoking 4 3 2 1 0 1 2 3 4 
4. When there are arguments and conflicts with my family 4 3 2 1 0 1 2 3 4 
5. When I am very angry about something or someone 4 3 2 1 0 1 2 3 4 
6. When I see someone smoking and enjoying it 4 3 2 1 0 1 2 3 4 
7. When I realise that quitting smoking is a difficult task for me 4 3 2 1 0 1 2 3 4 
8. When I am craving a cigarette  4 3 2 1 0 1 2 3 4 
9. When I first get up in the morning 4 3 2 1 0 1 2 3 4 
10. When I feel I need a lift  4 3 2 1 0 1 2 3 4 
11. When I begin to let down on my concern about my health 4 3 2 1 0 1 2 3 4 
12. When I am depressed 4 3 2 1 0 1 2 3 4 
13. When I am anxious and stressed 4 3 2 1 0 1 2 3 4 
14. When I realise I haven’t smoked for a while 4 3 2 1 0 1 2 3 4 
15. When alone and feeling depressed 4 3 2 1 0 1 2 3 4 
16. When I am nervous 4 3 2 1 0 1 2 3 4 
17. With friends at a party 4 3 2 1 0 1 2 3 4 
18. Over coffee while talking and relaxing  4 3 2 1 0 1 2 3 4 
19. At work when I am experiencing some pressure in my job 4 3 2 1 0 1 2 3 4 
20. At a bar or cocktail lounge having a drink 4 3 2 1 0 1 2 3 4 
21. When I wake up in the morning and face a tough day 4 3 2 1 0 1 2 3 4 
22. When I am happy and celebrating 4 3 2 1 0 1 2 3 4 
23. When I am bored and have nothing to do 4 3 2 1 0 1 2 3 4 
24. When I would experience an emotional crisis (i.e. an accident or 
death in the family) 
4 3 2 1 0 1 2 3 4 
25. When I see that I am gaining weight 4 3 2 1 0 1 2 3 4 
 
Velicer, W. F., DiClemente, C. C., Rossi, J. S., & Prochaska, J. O. (1990). Relapse situations and self-
efficacy an integrative model. Addictive Behaviors, 15, 271-283 
 
DiClemente, C. C. (1981). Self-efficacy and smoking cessation maintenance: a preliminary report. 
Cognitive Therapy and Research, 5(2), 175-187.  
 
Negative/affective questions – 2, 4, 5, 12, 13, 24 Positive/social questions – 3, 6, 17, 18, 20, 22 
Habit/addictive questions – 7, 9, 10, 11, 14 Cessation self-efficacy questions – 3, 15-25 
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Appendix 11. Cessation self-efficacy  
 
For each the items below, please rate your degree of certainty that you could avoid 
smoking in each of the situations.  
 
 Completely 
sure 
 Completely 
unsure 
1. When alone and feeling depressed 1 2 3 4 5 6 7 
2. When I am nervous 
 1 2 3 4 5 6 7 
3. With friends at a party 
 1 2 3 4 5 6 7 
4. Over coffee while talking and relaxing 1 2 3 4 5 6 7 
5. With my spouse or a close friend who is 
smoking 1 2 3 4 5 6 7 
6. At work when I am experiencing some 
pressure in my job 1 2 3 4 5 6 7 
7. At a bar or cocktail lounge having a 
drink 1 2 3 4 5 6 7 
8. When I wake up in the morning and 
face a tough day 1 2 3 4 5 6 7 
9. When I am happy and celebrating 1 2 3 4 5 6 7 
10. When I am bored and have nothing to 
do 1 2 3 4 5 6 7 
11. When I would experience an 
emotional crisis (i.e. an accident or 
death in the family) 
1 2 3 4 5 6 7 
12. When I see that I am gaining weight 1 2 3 4 5 6 7 
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Appendix 12. Exercise task self-efficacy 
 
The next questions ask how confident you are that you can participate in physical 
activities classified as “light”, “moderate” and “hard”.  The word “confident” refers to 
the belief that you have in yourself that you can do something well. Please circle the 
number that best represents your confidence level to do the following: 
 
1. How confident are you that you can complete 10 minutes of physical activity at a 
light intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident      confident                 confident 
 
2. How confident are you that you can complete 30 minutes of physical activity at a 
light intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident      confident                 confident 
  
3. How confident are you that you can complete 60 minutes of physical activity at a 
light intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident      confident                confident 
 
4. How confident are you that you can complete 10 minutes of physical activity at a 
moderate intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident     confident                 confident 
 
5. How confident are you that you can complete 30 minutes of physical activity at a 
moderate intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident     confident                 confident 
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6. How confident are you that you can complete 60 minutes of physical activity at a 
moderate intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident     confident                 confident 
 
7. How confident are you that you can complete 10 minutes of physical activity at a 
hard intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat      extremely 
confident     confident                 confident 
 
8. How confident are you that you can complete 30 minutes of physical activity at a 
hard intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident     confident                 confident 
 
9. How confident are you that you can complete 60 minutes of physical activity at a 
hard intensity level three times next week? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident     confident                 confident 
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Appendix 13. Exercise barrier self-efficacy 
 
How confident (from 0% - 100%) are you that when faced with one of the situations 
below, you will still be able to participate in 60 minutes of physical activity most days 
next week? 
 
10. If it is bad weather? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all     somewhat     extremely 
confident     confident                 confident 
 
11. If I am tired? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    extremely 
confident      confident                 confident 
 
12. If I am sore? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat     extremely 
confident      confident                 confident 
 
13. If I have work to do? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all     somewhat     extremely 
confident     confident                 confident 
 
14. If I have family obligations? 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    extremely 
confident      confident                confident 
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Appendix 14. Exercise scheduling self-efficacy 
 
The following is a list of behaviours associated with participating in INDEPENDENT 
exercise for the next week. Please consider each specific behaviour as it applies to 
you.   
 
In addition to attending your weekly exercise program sessions, how confident are 
you that you can … 
 
 
1. Participate in independent exercise three times per week next week. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                confident 
 
2. Plan for participation in my independent exercise sessions in my daily activities 
next week. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                 confident 
 
3. Arrange my schedule to do independent exercise regularly no matter what next 
week. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                 confident 
 
4. Maintain a definite plan to restart my independent exercise if I should miss any 
sessions next week.  
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                confident 
 
5. Make up times when I miss my regular independent exercise sessions next week. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                confident 
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6. Make sure that I do not miss more than one day of independent exercise due to 
other obligations next week. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                 confident 
 
7. Organize next week’s time and responsibilities around each of my independent 
exercise sessions no matter what. 
 
 
0        10          20          30          40         50          60          70           80         90           100 
 
not at all      somewhat    completely 
confident      confident                 confident 
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Appendix 15. Physical activity readiness questionnaire  
 
1. Has your doctor ever said that you have a heart condition and that you should 
only do physical activity recommended by a doctor? 
[   ] Yes 
[   ] No 
 
2. Do you feel pain in your chest when you do physical activity? 
[   ] Yes 
[   ] No 
 
3. In the past month, have you had chest pain when you were not doing physical 
activity? 
[   ] Yes 
[   ] No 
 
4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
[   ] Yes 
[   ] No 
 
5. Do you have a bone or joint problem that could be made worse by a change in 
your physical activity? 
[   ] Yes 
[   ] No 
 
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood 
pressure or heart? 
[   ] Yes 
[   ] No 
 
7. Do you know of any other reason why you should not do physical activity? 
[   ] Yes 
[   ] No 
 
 
___________________________________    _____________________________________ 
Name        Signature 
 
___________________________________             
Date  
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To be completed by Physician: 
 
 
Patient is fit to start an exercise programme 
 
? Recommended/Approved      ? Contraindicated 
 
 
Patient is fit to use NicoDerm patch                
 
? Recommended/Approved      ? Contraindicated  
 
 
 
___________________________________            ________________________________ 
Physician’s Name      Signature 
 
 
___________________________________    
Date  
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Appendix 16. Cronbach’s alphas 
 
Chapter Two 
 
Shiffman-Jarvik withdrawal scale 
Time Craving Psychological Physical 
Week 5 .834 .817 .680 
Week 11 .770 .790 .779 
Week 13 .854 .833 .669 
 
Chapter Three 
 
Temptation questionnaire 
Time EX-EXP EX-CRED NRT-EX NRT-CRED 
Baseline .709 .829 .781 .824 
Week 5 .891 .891 .930 .886 
Week 14 .923 .857 .932 .722 
(question 2 
removed) 
 
Shiffman-Jarvik withdrawal scale 
Time Craving Psychological 
Week 5 .875 
(question 10 removed) 
.767 
 
 
Chapter Four 
 
Temptation scale 
Time Positive/Social Negative/Affective Habit/Addiciton 
Baseline .799 .759 .669 
Week 2 .798 .837 .734 
Week 3 .802 .926 .775 
Week 4 .785 .913 .846 
Week 5 .864 .882 .785 
Week 6 .861 .859 .825 
Week 7 .909 .772 .813 
Week 8 .928 .924 .862 
Week 10 .891 .922 .826 
Week 12 .881 .909 .840 
Week 14 .874 .876 .772 
 
Exercise and cessation self-efficacy 
Time Barrier Task Scheduling Cessation 
Baseline .940 .954 .977 .842 
Week 6 .921 .921 .961 .880 
Week 14 .965 .959 .985 .849 
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Appendix 17. Temptations questionnaire frequencies  
 
Question 
Number 
Week 5 Week 14 
Response Frequency Percent Response Frequency Percent 
1 -4.00 1 2.1 -4.00 1 2.5 
  -3.00   -3.00 3 7.5 
 -2.00 2 4.3 -2.00 2 5.0 
 -1.00 8 17.0 -1.00 6 15.0 
 .00 9 14.8 .00 10 25.0 
 1.00 17 36.2 1.00 9 22.5 
 2.00 5 10.6 2.00 5 12.5 
 3.00 3 6.4 3.00 4 10.0 
 4.00 2 4.3 4.00   
2 -4.00   -4.00   
 -3.00 4 8.5 -3.00 4 10.0 
 -2.00 5 10.6 -2.00 2 5.0 
 -1.00 3 6.4 -1.00 6 15.0 
 .00 8 17.0 .00 12 30.0 
 1.00 17 36.2 1.00 8 20.0 
 2.00 4 8.5 2.00 7 17.5 
 3.00 6 12.8 3.00 1 2.5 
 4.00   4.00   
3 -4.00 1 2.1 -4.00   
 -3.00 2 4.3 -3.00 3 7.5 
 -2.00 3 6.4 -2.00 1 2.5 
 -1.00 12 25.5 -1.00 9 22.5 
 .00 13 27.7 .00 19 47.5 
 1.00 8 17.0 1.00 5 12.5 
 2.00 4 8.5 2.00 2 5.0 
 3.00 3 6.4 3.00   
 4.00 1 2.1 4.00 1 2.5 
4 -4.00 2 4.3 -4.00   
 -3.00 2 4.3 -3.00 4 10.0 
 -2.00 2 4.3 -2.00 1 2.5 
 -1.00 12 25.5 -1.00 7 17.5 
 .00 15 31.9 .00 13 32.5 
 1.00 7 14.1 1.00 7 17.5 
 2.00 3 6.4 2.00 6 15.0 
 3.00 3 6.4 3.00   
 4.00 1 2.1 4.00 2 5.0 
5 -4.00 2 4.3 -4.00   
 -3.00 1 2.1 -3.00 3 7.5 
 -2.00 4 8.5 -2.00   
 -1.00 10 21.3 -1.00 4 10.0 
 .00 6 12.8 .00 13 32.5 
 1.00 11 23.4 1.00 6 15.0 
 2.00 66 12.8 2.00 9 22.5 
 3.00 5 10.6 3.00 3 7.5 
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 4.00 2 4.3 4.00 2 5.0 
6 -4.00 2 4.3 -4.00   
 -3.00   -3.00   
 -2.00 1 2.1 -2.00 2 5.0 
 -1.00 11 23.4 -1.00 8 20.0 
 .00 19 40.4 .00 17 42.5 
 1.00 7 14.9 1.00 6 15.0 
 2.00 1 2.1 2.00 4 10.0 
 3.00 5 10.6 3.00 1 2.5 
 4.00 1 2.1 4.00 2 5.0 
7 -4.00 2 4.3 -4.00   
 -3.00   -3.00   
 -2.00 2 4.3 -2.00   
 -1.00 5 10.6 -1.00 6 15.0 
 .00 12 25.5 .00 16 40.0 
 1.00 12 25.5 1.00 8 20.0 
 2.00 8 17.0 2.00 6 15.0 
 3.00 3 6.4 3.00 3 7.5 
 4.00 3 6.4 4.00 1 2.5 
8 -4.00   -4.00 1 2.5 
 -3.00 2 4.3 -3.00   
 -2.00 3 6.4 -2.00 3 7.5 
 -1.00 5 10.6 -1.00 8 20.0 
 .00 13 27.7 .00 8 20.0 
 1.00 13 27.7 1.00 10 25.0 
 2.00 6 12.8 2.00 6 15.0 
 3.00 3 6.4 3.00 3 7.5 
 4.00 2 4.3 4.00 1 2.5 
9 -4.00 1 2.1 -4.00 1 2.5 
 -3.00 2 4.3 -3.00   
 -2.00 2 4.3 -2.00 1 2.5 
 -1.00 6 12.8 -1.00 7 17.5 
 .00 12 25.5 .00 16 40.0 
 1.00 14 29.8 1.00 4 10.0 
 2.00 3 6.4 2.00 3 7.5 
 3.00 5 10.6 3.00 7 17.5 
 4.00 2 4.3 4.00 1 2.5 
10 -4.00 1 2.1 -4.00   
 -3.00   -3.00   
 -2.00 1 2.1 -2.00 1 2.5 
 -1.00 2 4.3 -1.00 3 7.5 
 .00 10 21.3 .00 11 27.5 
 1.00 13 27.7 1.00 7 17.5 
 2.00 11 23.4 2.00 9 22.5 
 3.00 6 12.8 3.00 7 17.5 
 4.00 3 6.4 4.00 2 5.0 
11 -4.00   -4.00 1 2.5 
 -3.00 2 4.3 -3.00   
 -2.00 1 2.1 -2.00 1 2.5 
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 -1.00 7 14.9 -1.00 3 7.5 
 .00 9 19.1 .00 11 27.5 
 1.00 11 23.4 1.00 5 12.5 
 2.00 7 14.9 2.00 7 17.5 
 3.00 9 19.1 3.00 8 20.0 
 4.00 1 2.1 4.00 4 10.0 
12 -4.00 1 2.1 -4.00 1 2.5 
 -3.00 3 6.4 -3.00 1 2.5 
 -2.00 3 6.4 -2.00 1 2.5 
 -1.00 1 2.1 -1.00 5 12.5 
 .00 15 31.9 .00 11 27.5 
 1.00 10 21.3 1.00 9 22.5 
 2.00 8 17.0 2.00 5 12.5 
 3.00 4 8.5 3.00 4 10.0 
 4.00 2 4.3 4.00 3 7.5 
13 -4.00 1 2.1 -4.00 1 2.5 
 -3.00 1 6.4 -3.00 2 5.0 
 -2.00 7 6.4 -2.00 1 2.5 
 -1.00 5 2.1 -1.00 5 12.5 
 .00 7 31.9 .00 11 27.5 
 1.00 13 21.3 1.00 6 15.0 
 2.00 5 17.0 2.00 9 22.5 
 3.00 5 8.5 3.00 3 7.5 
 4.00 3 4.3 4.00 2 5.0 
14 -4.00   -4.00   
 -3.00 2 4.3 -3.00 1 2.5 
 -2.00 1 2.1 -2.00   
 -1.00 2 4.3 -1.00 5 12.5 
 .00 16 34.0 .00 21 52.5 
 1.00 15 31.9 1.00 5 12.5 
 2.00 5 10.6 2.00 6 15.0 
 3.00 4 8.5 3.00 1 2.5 
 4.00 2 4.3 4.00 1 2.5 
15 -4.00 1 2.1 -4.00 1 2.5 
 -3.00 2 4.3 -3.00   
 -2.00 4 8.5 -2.00   
 -1.00 7 14.9 -1.00 6 15.0 
 .00 14 29.8 .00 14 35.0 
 1.00 9 19.1 1.00 6 15.0 
 2.00 6 12.8 2.00 7 17.5 
 3.00 3 6.4 3.00 3 7.5 
 4.00 1 2.1 4.00 3 7.5 
16 -4.00 1 2.1 -4.00 1 1.5 
 -3.00 1 2.1 -3.00 1 1.5 
 -2.00 5 10.6 -2.00   
 -1.00 7 14.9 -1.00 5 12.5 
 .00 16 34.0 .00 17 42.5 
 1.00 8 17.0 1.00 3 7.5 
 2.00 5 10.6 2.00 10 25.0 
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 3.00 3 6.4 3.00 1 2.5 
 4.00 1 2.1 4.00 2 5.0 
17 -4.00 3 6.4 -4.00 1 2.5 
 -3.00 1 2.1 -3.00 1 2.5 
 -2.00 3 6.4 -2.00 2 5.0 
 -1.00 7 14.9 -1.00 12 30.0 
 .00 24 51.1 .00 20 50.0 
 1.00 6 12.8 1.00 1 2.5 
 2.00 1 2.1 2.00 3 7.5 
 3.00 2 4.3 3.00   
 4.00   4.00   
18 -4.00   -4.00   
 -3.00 2 4.3 -3.00   
 -2.00 4 8.5 -2.00 1 2.5 
 -1.00 4 8.5 -1.00 7 17.5 
 .00 24 51.1 .00 27 67.5 
 1.00 9 19.1 1.00 2 5.0 
 2.00 4 8.5 2.00 3 7.5 
 3.00   3.00   
 4.00   4.00   
19 -4.00 1 2.1 -4.00   
 -3.00 1 2.1 -3.00   
 -2.00 4 8.5 -2.00 1 2.5 
 -1.00 6 12.8 -1.00 4 10.0 
 .00 19 40.4 .00 22 55.0 
 1.00 8 17.0 1.00 5 12.5 
 2.00 3 6.4 2.00 3 7.5 
 3.00 5 10.6 3.00 5 12.5 
 4.00   4.00   
20 -4.00 1 2.1 -4.00 1 2.5 
 -3.00 1 2.1 -3.00 1 2.5 
 -2.00 6 12.8 -2.00 3 7.5 
 -1.00 8 17.0 -1.00 8 20.0 
 .00 19 40.4 .00 23 57.5 
 1.00 9 19.1 1.00 1 2.5 
 2.00 1 2.1 2.00 3 7.5 
 3.00 1 2.1 3.00   
 4.00 1 2.1 4.00   
21 -4.00 1 2.1 -4.00   
 -3.00 4 8.5 -3.00 2 5.0 
 -2.00 4 8.5 -2.00   
 -1.00 2 4.3 -1.00 7 17.5 
 .00 14 29.8 .00 14 35.0 
 1.00 11 23.4 1.00 5 12.5 
 2.00 7 14.9 2.00 7 17.5 
 3.00 3 6.4 3.00 3 7.5 
 4.00 1 2.1 4.00 2 5.0 
22 -4.00 1 2.1 -4.00   
 -3.00   -3.00 2 5.0 
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 -2.00 1 2.1 -2.00 2 5.0 
 -1.00 5 10.6 -1.00 5 12.5 
 .00 16 34.0 .00 17 42.5 
 1.00 13 27.7 1.00 6 15.0 
 2.00 4 8.5 2.00 7 17.5 
 3.00 5 10.6 3.00 1 2.5 
 4.00 2 4.3 4.00   
23 -4.00 2 4.3 -4.00   
 -3.00 4 8.5 -3.00 1 2.5 
 -2.00 4 8.5 -2.00   
 -1.00 6 12.8 -1.00 6 15.0 
 .00 15 31.9 .00 13 32.5 
 1.00 5 10.6 1.00 5 12.5 
 2.00 9 19.1 2.00 6 15.0 
 3.00 2 4.3 3.00 5 12.5 
 4.00 47  4.00 4 10.0 
24 -4.00 7 14.9 -4.00 7 17.5 
 -3.00 5 10.6 -3.00 1 2.5 
 -2.00 2 4.3 -2.00 3 7.5 
 -1.00 5 10.6 -1.00 3 7.5 
 .00 19 40.4 .00 16 40.0 
 1.00 5 10.6 1.00 3 7.5 
 2.00 1 2.1 2.00 5 12.5 
 3.00 2 4.3 3.00   
 4.00 1 2.1 4.00 2 5.0 
25 -4.00 1 2.1 -4.00   
 -3.00   -3.00   
 -2.00   -2.00 4 10.0 
 -1.00   -1.00 4 10.0 
 .00 11 23.4 .00 9 22.5 
 1.00 9 19.1 1.00 4 10.0 
 2.00 7 14.9 2.00 4 10.0 
 3.00 9 19.1 3.00 6 15.0 
 4.00 10 21.3 4.00 9 22.5 
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Appendix 18. Letter of information and consent 
 
Study Title:  Getting Physical on Cigarettes 
 
Principal Study Investigator:  
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario) 
519-xxx-xxxx extension: xxxxx 
 
Co-Investigators:  
Guy Faulkner, Ph.D. (Faculty of Physical Education and Health, University of Toronto) 
Ralph Maddison, Ph.D. (Clinical Trials Research Unit, University of Auckland) 
Lyndsay Fitzgeorge, Ph.D. (School of Kinesiology, The University of Western Ontario) 
Therese Harper MSc. (School of Kinesiology, The University of Western Ontario) 
Kevin Shoemaker, Ph.D. (School of Kinesiology, The University of Western Ontario) 
 
You are being invited to participate in a research study looking at the long-term 
effects of exercise on helping women quit smoking. This is a clinical trial (a type of 
research study) which includes eligible volunteers who choose to take part. Please 
take your time to make a decision, and discuss this proposal with your personal 
doctor, family members and friends as you feel inclined. The purpose of this letter is to 
provide you with the information you require to make an informed decision on 
participating in this research and to help us talk to you about smoking cessation 
(quitting). This letter contains information to help you decide whether or not to 
participate in this research study. It is important for you to understand why the study is 
being conducted and what it will involve. Please take the time to read this carefully 
and feel free to ask questions if anything is unclear or there are words or phrases you 
do not understand. We are asking you to take part because you are a woman who 
smokes and wishes to quit. We hope to recruit a total of 420 women and help them 
quit smoking and remain smoke-free over a total of 13 months, as well as examine the 
effect of exercise on maintaining a healthy body weight.  
 
Invitation to Participate in Research and Eligibility Criteria 
You are being invited to take part in this research study because you: 
(a) are between the ages of 18 and 65 
(b) smoke 10 or more cigarettes per day for the past 2 years or more and want to quit 
(c) engage in 2 or less 30-minute bouts of moderate (e.g., jogging, playing tennis) or 
vigorous (e.g., running, spin classes, high impact aerobics) intensity exercise over 
the past 6 months 
(d) do not have a medical condition that prevents you from exercising 
(e) are not pregnant or intending on being pregnant over the next 13 months 
(f) are able to read and write in English 
(g) have a telephone or an email account that we can reach you at over the next 13 
months 
 
 
Please note that if you are pregnant, or wish to become pregnant during the 
course of the study, you are NOT eligible to participate. If you become pregnant 
during the course of the study, you must notify the study researchers immediately. 
This is because low doses of radiation will be administered during one of the tests of 
the study, and this could cause harm to a foetus or breast-fed baby.  
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What is the purpose of this study? 
This study is intended to evaluate how useful an exercise program, nicotine 
replacement therapy (e.g., Nicoderm®), and support and advice from an exercise 
counselor, is at helping women who smoke become smoke-free and remain 
physically active for 13 months. We will also examine the effects of this program on 
body composition (e.g., your weight, the ratio between your body fat and your body 
muscle mass), your physical fitness, and your confidence to perform certain activities.  
 
It has been shown in past research that exercising can help women quit smoking by 
alleviating smoking withdrawal symptoms. Unfortunately, if the exercise program is 
stopped, women often resume smoking. Our goal in this study is to help women learn 
how to stick with an exercise program in their own homes, maintain their health and 
weight through exercise, and subsequently stay motivated to remain smoke-free. The 
information we gather will help guide the development of future programs to help 
women like you who wish to quit.  
Specific questions we hope to answer by conducting this study are: 
1) Does the type of information and support given by the exercise counsellor make a 
difference in terms of how long women who have recently quit smoking can 
remain smoke-free?  
2) Does the type of information and support given by the exercise counsellor make a 
difference in terms of how long women who have recently quit smoking can 
continue with their exercise program? 
 
WHAT YOU ARE ASKED TO DO IN THIS STUDY? 
 
1) Participate in a lab-based exercise program 
Time involvement = 3 x 45 minutes each week for 14 weeks 
If you choose to participate in this study, you will be asked to take part in an exercise 
program three times per week for a total of 14 weeks. These exercise sessions will be 
supervised by a trained exercise counselor, and will all take place in the Exercise and 
Health Psychology Laboratory (EHPL) at the University of Western Ontario in the Arthur 
and Sonia Labatt Health Sciences building. Each exercise session will last 45 minutes, 
and will consist of a warm-up, cardiovascular work-out, and cool-down on pieces of 
equipment such as the treadmill, stationary bike, stepper, and rower. You will be 
asked to wear a heart rate monitor so that your efforts can be monitored to ensure 
that you are working at an effective and safe exercise intensity, based on your fitness 
level. A trained councilor will be there at all times to assist you. If you miss an exercise 
session, you will be asked to make up for the missed session on the weekend at a 
scheduled time.  
 
2) Quit smoking 
Time involvement = 0 minutes 
After 4 weeks of this exercise program, we will ask you to stop smoking cigarettes 
completely. To assist you in doing this, we will be providing you with commercially-
available nicotine replacement therapy (NICODERM®) in the form of daily patches 
that adhere to your skin like a small band-aid. This will be dispersed to you in weekly 
allotments each week from week 4 through 14 at the EHPL after your exercise sessions. 
The dose that you will receive from this patch depends on your current level of 
smoking, but will most likely result in you following the recommended guidelines of: 
A) Wearing a 21mg patch each day for 6 weeks (weeks 4 through 10 of the 
study) 
B) Wearing a 14 mg patch each day for 2 weeks (weeks 11 and 12 of the study) 
C) Wearing a 7 mg patch each day for 2 weeks (weeks 13 and 14 of the study) 
In total, you will wear these daily patches for 10 weeks while you continue to exercise 
at our exercise facility.  
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3) Participate in support group that you are randomly assigned to 
Time involvement = 3 x 15 minutes for a total of 3 weeks 
You will also be provided with group counseling and support information during weeks 
12 through to week 14 of the program. The type of support information you will 
receive during these weeks depends on which group you are randomized to. In other 
words, the participants in the study will be assigned at random (like a flip of a coin), 
that is, by a method of chance, to one of 4 groups. You will have a 1 in 4 chance of 
being in any one of the support groups. The four support groups are as follows: 
1. Lifestyle Exercise Maintenance Group 
2. Relapse Prevention Group 
3. Health and Nutrition Maintenance Group 
4. Lifestyle Exercise Maintenance and Relapse Prevention Group 
ALL support groups will receive information related to health for women from the 
trained exercise counselor you have been working with in a group format (e.g., with 
the other women you have been exercising with). This information will be delivered for 
15 minutes at the end of each exercise session in the EHPL during weeks 12 through 14 
of the study. 
 
The trained exercise counselor you have been working with will also follow-up with 
you via either phone or email (it is your choice which mode of communication you 
would like to be contacted through) to provide support and encourage you to 
remain physically active and remain smoke free after the program has ended for 10 
additional months.  
 
4) Perform tests 
There are a number of tests that you will be asked to do if you choose to participate 
in this study. ALL tests will be performed within the EHPL under trained research staff. 
These tests provide the study researchers with evidence that will help us answer the 
research questions. At baseline testing (before the exercise program begins), we will 
ask you to perform a number of these tests so that we may measure how you are 
doing before you quit smoking and before you begin to exercise.  
 
i) Baseline Testing 
Time involvement = 3 hours 
For baseline testing, you will be asked to visit our exercise facility (the Exercise and 
Health Psychology Laboratory; EHPL) at the University of Western Ontario. Baseline 
testing will begin after you have provided the study researchers with written consent 
from your family physician indicating that he or she supports your involvement in this 
study. Baseline testing will take approximately 4 hours and will include completing a 
number of questionnaires, or surveys, as well as some physical tests. 
 
The surveys will ask you about: 
• Your motivation to quit smoking (“How motivated are you to quit smoking in the 
next 7 days?”) 
• Physical activity (“In the past week, how often did you do light activities, such as 
yoga or slow walking?”, “Has your doctor ever advised you NOT to engage in 
physical activity?”) 
• Your personal goals for quitting smoking (“Please identify your most important 
smoking cessation goal”) 
• Your personal goals for engaging in exercise (“Please identify your most important 
exercise goal”) 
• Smoking history (“In the past week, how many cigarettes did you consume?”) 
• A demographic questionnaire (which asks you about information such as your 
age, education, martial status, income) 
• Your satisfaction with your weight (“How satisfied, or content, are you with your 
current body weight?”) 
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• Your confidence in your abilities to do activities related to exercise and quitting 
smoking (“How confident are you in your ability to exercise for 30min continuously, 
once per week?”)  
• Your smoking cravings (“How irritable do you feel right now?”) 
• Your dependence on nicotine (“How soon after you first wake up do you have a 
cigarette?”) 
• Your sleeping patterns (“In the past week, how often did you have trouble falling 
asleep?”) 
• Your mood (“How often during the past week did you feel full of pep?”) 
It is important to note that there are no correct or incorrect answers to these 
questions, and you may choose to skip any questions you do not feel comfortable in 
answering.  
 
The physical tests will consist of: 
• An aerobic fitness test on a treadmill (often called a maximal oxygen uptake 
treadmill test). A trained research technician will be performing the test on you, 
making sure you are safe and comfortable at all times. This test is performed 
regularly in our laboratory. Length of the treadmill test varies from 9 to 18 minutes, 
depending on your level of physical fitness. The test begins by having you walk at 
an easy pace on a treadmill (e.g., the pace you walk when you walk down the 
street). The speed and incline of the treadmill will then be gradually increased 
every 3 minutes until you indicate to us that you do not wish to continue, or you 
reach your age-predicted maximum heart rate, as determined by a trained 
research technician. During this test you will breath through a mouthpiece 
connected to a computer that will measure your oxygen consumption. By doing 
this test, we will be able to assess your aerobic fitness and also determine the level 
of training intensity that is safe for you to exercise at during the exercise program. 
The test will end with a cool-down, where you will walk at an easy, self-selected 
pace for 5 minutes.  
 
• A non-invasive body composition test. The body composition test uses a machine 
called Dual-Energy X-Ray Absorptiometry (DXA; GE Lunar). This machine measures 
the amount of fat and muscle you have in your body without touching you. We 
will want to measure your body composition throughout the study, so that we may 
look for any changes that may occur due to exercise. Although this machine does 
use an X-ray, the amount of radiation is very minimal. The amount of radiation 
used in one test is extremely small (0.01 mSv). Each day, you receive 
approximately 0.01 mSv of natural background radiation from the earth. In 
comparison, flying on a commercial airplane exposes humans to approximately 
0.03 mSv per trip. All that is required of you is that you lie down on the bed surface 
of the DXA for approximately 5 minutes, while the monitoring arm scans the length 
of your body. You will be asked to take off any metals you may be wearing, such 
as earrings, as they could alter the results of the test. You will feel absolutely no 
pain or discomfort.  
 
• Measures of your smoking status. We will measure your smoking status using 
physical tests in two separate ways. First, we will ask you to breath into a machine 
called the Bedfont Smokerlyzer. This machine measures the amount of carbon 
monoxide (CO) as you breathe out. It does not cause any harm or discomfort to 
you. This smokerlyzer measures how much you have smoked in the past several 
hours. Second, we will ask you to provide us with a saliva sample by spitting 
approximately 10mL into a special test tube. If you have difficulties producing that 
much saliva, you will be given parafilm (an odourless, tasteless product) to chew 
on. From this saliva sample, we will measure cotinine, which tells us about your 
smoking behaviour in the past several days, and 3-hyrdroxycotinine: cotinine ratio, 
which tells us about the rate at which your body metabolizes (breaks down) 
nicotine.   
200 
 
 
 
• A measure of your lung health, using a device called spirometry. To complete this 
test, you will take your deepest possible breath and then let all of the air out 
(exhale) into the sensor on the device. You will breathe out as hard as you possibly 
can, and for as long as you possibly can.  
 
• Measures of your vascular (blood vessel) health. Smoking could cause damage to 
your blood vessels, which is a leading cause for cardiovascular disease. In order to 
measure your vascular health, a trained research technician will perform a total of 
5 non-invasive measures on you. The first is a measure of blood pressure. First, a 
small cuff will be placed around one finger.  Second, a cuff will be placed around 
your upper arm and inflated periodically in the same manner as blood pressure 
measurements made by your family physician. An additional cuff will be placed 
around one of your toes to measure the blood pressure changes in your feet.  In 
addition, a small cuff will be placed around one of your toes in order to measure 
the blood pressure pulse wave in that region. An electrocardiogram will also be 
conducted by placing 3 sticky buttons (electrodes) on your chest in order to 
measure the electrical activity of your heart. The third measure of vascular health 
that will be measured is images of your heart and blood vessels. Specifically, your 
heart and blood vessels in your leg, arm and neck will be measured with an 
ultrasound system. For these tests you will be placed in the supine (lying down) 
position, where you will relax as a “flash-light” sized probe is held gently on your 
skin over your heart and blood vessels and applied for up to 10-15 minutes at 
each site. The fourth measurement of vascular health is similar to the third: a 3-D 
ultrasound measurement of carotid artery and plaque volume. This will measure 
the extent of plaque buildup in the arteries of your neck using ultrasound. The 
same probe used for blood vessel imaging (above) will be mounted in a special 
device that moves the probe in precise, stepped movements along the neck. This 
procedure should take approximately 45 minutes, which includes setup time and 
verification of the data. Finally, we will measure forearm endothelial function. The 
size of the brachial artery in your arm will be measured by the ultrasound in this 
test. You will be asked to lie quietly while a blood pressure cuff is inflated around 
your forearm to prevent blood flow into your hand for 5 minutes.  When this cuff is 
released and blood flow to your hand is restored, you will be asked to lie quietly 
for an additional 5 minutes. 
 
• Wearing an accelerometer.  At the end of baseline testing, we will give you an 
accelerometer (motion detector) to wear around your waist at all times except 
for when sleeping and bathing, for 7 days. This device is small and unobtrusive. 
After one week, you will be asked to return the device to the study researchers. 
We will then download the data from the device you wore onto our computer 
programs.  
 
ii) Post-Testing 
Time involvement = 3 hours 
The same number of tests will be performed again after the study ends, 13 months 
after baseline, so that we may measure the effects of the program.  
 
iii) Testing throughout the study 
Time involvement = approximately 15 minutes each week 
There will also be periodic testing that you will be asked to do throughout the study (in 
between baseline and post-testing). These tests will consist of tests that you already 
did at baseline, so you will be familiar with the procedures. The table that follows 
shows which tests you will be asked to do, and at what times. Please do not hesitate 
to ask for clarification – we realize there is a lot of information in this table.  
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What are the risks associated with my involvement in this study? 
While in the study, you may experience side effects. Known side effects are listed 
below, but other effects may occur that we cannot predict.  
 
Exercise: There are some inherent risks of injury associated with exercise participation, 
particularly among people who are not used to exercising. You may, for example, 
feel mild muscle “tightness” or soreness that lasts for a couple of days after their first 
few bouts of exercise. The possible benefits associated with exercise may outweigh 
the potential minor discomfort of beginning a supervised, laboratory-based exercise 
program. To minimize the physical risks of exercise, proper warm-up/cool-down and 
stretching protocols will be performed, with each exercise session being supervised by 
a trained exercise counsellor.  Additionally, the exercise program delivered will be 
tailored to your individual fitness level, and modified according to your comfort level. 
You will gradually, under the supervision of a trained exercise facilitator, work up to a 
moderate intensity for your aerobic exercise training bouts. Furthermore, you will only 
be allowed to participate in this exercise program if you provide medical clearance 
from your physician, and complete the PAR-Q (Physical Activity Readiness 
Questionnaire) forms to ensure that it is safe for you to begin an exercise program.  
The exercise facilitator will be both CPR and First Aid trained, and experienced in 
working with previously inactive populations. Throughout, if any physical or mental risks 
arise, you will be referred to the Middlesex London Health Unit if issues arise that fall 
outside of the scope of the study. 
 
Quitting Smoking:  You may experience withdrawal symptoms during the first few days 
after you quit smoking in this program. Such symptoms may include feeling edgy and 
nervous, dizzy, sweaty, having trouble concentrating, headaches, difficulty sleeping, 
increased appetite and weight gain, muscular pain, constipation, fatigue, or having 
an upset stomach. All of these symptoms are common for those who quit smoking so 
you should not be alarmed, as these symptoms will go away within a few days. It 
should be noted, however, that this program provides you with tools that we believe 
will help counter these withdrawal symptoms. Specifically, moderate intensity exercise 
has been shown to reduce smoking withdrawal symptoms. The nicotine replacement 
therapy we provide you with should also eliminate or reduce the smoking withdrawal 
symptoms. Another common side effect of quitting smoking is that your “smoker’s 
cough” gets worse for the first few days after you quit. This is your body’s way of 
attempting to rid the lungs of excess toxins. This may not be alleviated by exercise or 
nicotine replacement therapy. Your smoker’s cough will improve to a great extent 
after you have become smoke-free for a number of days.  
 
Nicotine Replacement Therapy (NICODERM®):  It is important to note that while this 
product does contain nicotine, it is considered safer and healthier than smoking. We 
are providing you with this medication as a tool to help you become completely free 
of your addiction to cigarettes. Some individuals who wear the patch experience 
redness, swelling, or a rash on their where the patch is placed. This is due to the 
adhesive material on the patch. Contact your family physician if this occurs. You 
should also contact your family physician if you develop an irregular heart beat, or if 
you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, weakness 
and a rapid heartbeat. These are all potential side effects of taking nicotine 
replacement therapy; however, the chance of you developing one of these side 
effects is minimal.  
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Nicoderm should not be used by people who: 
- Are allergic to nicotine 
- Are non-smokers or occasional smokers 
- Are under 18 years of age 
- Are pregnant or breast-feeding 
- Have just had a heart attack 
- Have life-threatening abnormal heart rhythm 
- Have severe or worsening chest pain 
- Have recently had a stroke 
- Have a generalized skin disorder 
 
Electrocardiogram: The only potential side effect known is a rash that may develop 
due to the adhesive of the ECG electrodes. Should you develop this rash, it will 
disappear over the next 2-3 days. 
Forearm Circulatory Occlusion:  When blood flow to your hand is stopped, you may 
experience pins and needles or numbness in your forearm.  These sensations will be 
followed by a sensation of warmth in the hand once the cuff is released and blood 
flow to the hand resumes.  All of these sensations will resolve within 45 seconds of cuff 
release. 
Blood Pressure Measures: The blood pressure monitoring cuffs used to measure blood 
pressure may cause some mild discomfort, bruising or red blood spots on the arm to 
which it is applied.  There is some discomfort when the cuff is inflated around your arm 
but this feeling goes away when the cuff is deflated. 
Dual-Energy X-Ray Absorptiometry (DXA; GE Lunar): This test uses a small dosage of 
radiation to conduct a non-invasive x-ray on your body. The amount of radiation is 
very minimal, and no known side effects are associated with this minimal amount of 
radiation. The amount of radiation used in one test is extremely small (0.01 mSv). Each 
day, you receive approximately 0.01 mSv of natural background radiation from the 
earth. In comparison, flying on a commercial airplane exposes humans to 
approximately 0.03 mSv per trip. The DXA machine used in the EHPL is tested and 
calibrated daily to ensure it is working optimally at all times. A trained and certified 
research technician will always perform this test on you. 
 
Risk to your foetus or baby: If you are pregnant or breastfeeding, there are also side 
effects that could harm your foetus or baby. Use of nicotine replacement therapy is 
not recommended while pregnant or breastfeeding. Use of this product could cause 
harm to your foetus or baby. You are not eligible to participate in this study if you are 
pregnant or planning on becoming pregnant over the course of this study. If you 
become pregnant, it is important that you tell one of the study researchers 
immediately. It should be noted that pregnant women are advised to limit their 
exposure to radiation due to potential harm to the foetus. As such, women in this 
study who become pregnant, or who have any reason to believe they may be 
pregnant at all will not undergo DXA testing. 
 
Do I have to take part? 
Participation in this study is voluntary.  You may refuse to participate, refuse to answer 
any questions or withdraw from the study at any time with no effect on your future 
care. If you decide to take part you will be given this Letter of Information to keep 
and be asked to sign the consent form.  If you withdraw from the study, you maintain 
the right to request that any data collected from you not be used in the study. If you 
make such a request, all of the data collected from you will be destroyed. Please 
contact the Principal Investigator if you wish to withdraw from the study.  
 
Participation in other studies 
If you are participating in another study at this time, please inform the study 
researchers right away to determine if it is appropriate for you to participate in this 
study.  
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Biological specimens given by you for use in this study 
The sample we are asking of you during the course of this study is saliva. This saliva 
sample will be used for the current study only. Specifically, this saliva will be frozen in 
our laboratory freezer, then shipped and analyzed at the Salimetrics® Laboratory in 
the United States of America for markers of smoking abstinence (cotinine). The saliva 
taken at the baseline measurement time point only will be frozen in our laboratory 
freezer, then shipped and analyzed at the University of Toronto in Canada for an 
indication of how quickly you metabolize (break down) nicotine in your body (3-
hydroxycotinine: cotinine ratio). Bar codes will be used to label your saliva samples, so 
the laboratory technicians analyzing your saliva will have no information as to who 
provided the saliva sample. The samples will be stored for a minimum of 3 years. 
Usage and potential research value will be reviewed annually thereafter. It is typical 
to keep the samples collected from a research study for 6 years after the study has 
been conducted. Once the research value is deemed lower than sufficient to justify 
storage costs, the samples will be destroyed by standard disposal of biohazardous 
waste laboratory policies and procedures.  
 
Any specimen(s) obtained for the purposes of this study will become the property of 
the study researchers and once you have provided the specimens you will not have 
access to them. The specimen(s) will be discarded or destroyed once they have 
been used for the purposes described in the protocol. The specimen(s) will be used 
for research and such use may result in inventions or discoveries that could become 
the basis for new products or diagnostic or therapeutic agents. In some instances, 
these inventions and discoveries may be of potential commercial value and may be 
patented and licensed by the researcher. It is not the purpose of this study to use 
specimens for any inventions or patents, so it is very unlikely that this will occur as an 
outcome of a sample you provide us with. You will not receive any money or other 
benefits derived from any commercial or other products that may be developed 
form use of the specimens. 
 
New findings 
If, during the course of this study, new information becomes available that may relate 
to your willingness to continue to participate, this information will be provided to you 
by the investigator. 
 
What are the benefits of my involvement? 
Involvement in this study could help you to increase your levels of physical activity in a 
safe and supportive setting, and may assist you in remaining smoke free.  It may also 
help you manage your weight and ease weight concerns, and teach you how to 
maintain your levels of physical activity. Ultimately, to be physically active and to quit 
smoking is good for your health, and may prevent you from developing co morbidities 
associated with long-term smoking and from an inactive lifestyle (e.g., cardiovascular 
disease). Furthermore, your participation will help to inform the development of other 
programs in the future.  
 
Are there any costs associated with participation? 
The study medication (NICODERM ®) will be given to you at no cost. You will not be 
paid to take part in the study; however, you will be reimbursed for your expenses such 
as parking for visits required as part of this study.  
 
If you have private medical or life insurance, you should check with your insurance 
company before you agree to take part in the study to confirm your participation in 
this study will not affect your insurance coverage and/or access to benefits. 
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This study is covered by an insurance policy and if during the course of the study any 
injury should occur to you as a result of the administration of the study medication, not 
due to your fault or negligence, all medical expenses necessary to treat such injury 
will be paid provided: a) you comply at all times with the study researcher’s 
instructions b) you promptly report any such injury to the study researchers conducting 
the study, and c) the expenses are not otherwise covered by your provincial health 
care. Financial compensation for such things as lost wages, disability or discomfort 
due to this type of injury is not routinely available. You do not waive any legal rights by 
signing the consent form.  
 
Will information obtained in the study be confidential? 
All the information you provide to the researcher will be kept in the strictest 
confidence.  You will be assigned an identification number and all data collected 
from you will be recorded and stored under this number only, so study researchers will 
have any way of connecting your data to you. All data will be stored in coded form 
on computers accessible only to research staff in a secure office. You will not be 
identified in any documents relating to the research. No information obtained during 
the study will be discussed with anyone outside of the research team. If the results of 
the study are published, your name will not be used.  
 
Representatives of the University of Western Ontario Health Sciences Research 
Ethics Board and regulatory bodies (Health Canada) may contact you or require 
access to your study-related records to monitor the conduct of the research. If we 
find information we are required by law to disclose, we cannot guarantee 
confidentiality. We will strive to ensure the confidentiality of your research-related 
records. Absolute confidentiality cannot be guaranteed as we may have to 
disclose certain information under certain laws.  
 
Alternative treatments 
An alternative to participating in this study would be to see your family physician for 
advice on how to quit smoking. You could also choose to not participate in the study 
and continue on just as you do now.  
 
Questions? 
If you have any questions about your rights as a research participant or the conduct 
of the study you may contact the Office of Research Ethics (Phone: 519-xxx-xxxx; 
Email:).  
If you have any questions about the study, please contact the principal investigator, 
Dr. Harry Prapavessis (Phone: 519-xxx-xxxx ext. xxxxx; Email:. 
 
This letter is for you to keep.  You will be given a copy of this letter of information and 
consent form once it has been signed. If you have any concerns, please feel free to 
contact one of the researchers below.  You may request the general findings of this 
research study from the researchers after the study is complete.  Again, if you have 
any questions about the conduct of this study, or your rights as a participant, you may 
contact the Office of Research Ethics, The University of Western Ontario, 519-xxx-xxxx. 
 
Dr. Lyndsay Fitzgeorge  Dr. Harry Prapavessis  Therese Harper 
Postdoctoral Fellow   Professor   Ph.D. Student 
School of Kinesiology   School of Kinesiology  School of Kinesiology 
UWO     UWO    UWO 
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Informed Consent 
 
Study Title:  Getting Physical on Cigarettes 
 
I have read the Letter of Information, had the nature of the study explained to me 
and I agree to participate.  All questions have been answered to my satisfaction.  I will 
be given a copy of the Letter of Information and consent form once it has been 
signed. 
 
 
 
Consenting Signature: 
 
Participant: ________________________________________________________  
                                  Please Print Name 
 
 
Participant: ________________________________________________________  
                                  Please Sign Name 
 
 
Date: ___________________ 
 
Please send me the overall conclusions from this trial:    Yes □ No □ 
 
 
 
Researcher Signature: 
 
 
Person obtaining informed consent:    _______________________________________      
                                                                          Please Print Name 
 
Person obtaining informed consent:    _______________________________________       
                                                                                     Please Sign Name 
 
Date: ____________________ 
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